|
|
·|û¡Ghung120110149413 µoªí®É¶¡:2020/6/24 ¤U¤È 02:11:23
|
¥«³õº¨£·sÃÄ(¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸) Àø®Ä¤ÀªR p=0.009 6634 ªYÄ£ ªÑ¥»: 3.832»õ ¥Dn·~°È: ¨xŦ¯e¯fªvÀø¤Î¯kµhªvÀø¬ÛÃöÃĪ«¬ã¨s¤Î¶}µo ¸³ºÊ«ùªÑ¤ñ¨Ò: 21.7%(¼W¥[¤¤) ¥~¸ê«ùªÑ¤ñ¨Ò: 0.22%(¼W¥[¤¤) Ä~Äò©¹¤U¬Ý...! ============================================================================= ²£«~01¡GSNP-610 (ªvÀø¯×ªÕ¨x¯e¯f·sÃÄ) ¾AÀ³¯g: «D°sºë©Ê¯×ªÕ¨xª¢ ²£«~Àu¶Õ: 1.¥Ø«e©|µL¼Ð·ÇªvÀøÃĪ« 2.¥«³õº¨£·sÃÄ(First-in-class) 3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 4.µL¦w¥þ©Ê°ÝÃD ¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C Ävª§¤O: 1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢ 2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯× 3.¥i´£¥X¨uÃĥӽСAÀ³¥Î©óªvÀø§³®W«æ©Ê¯×ªÕ¨x ¬ãµo¶¥¬q: 1.¤w³q¹LUSFDA¤ÎTFDA¼f¬d¶i¤JÁ{§É¤G´Á 2.Á{§ÉÀø®Ä¤Î·sªvÀø¾÷ÂàÅçÃÒ Àø®Ä¤ÀªR¡G 1.²Ä¤@´ÁÁ{§É¸ÕÅç¡Gµ²ªGÅã¥Ü¤HÅé¨Ï¥Î¦w¥þ¡A©Ê½è¨}¦n 2.²Ä¤G´ÁÁ{§É¸ÕÅç¨ä¤¤¤ÀªR¡G17¦ìNASH ¯f¤H (p=0.009) ============================================================================= ²£«~02¡GSNP-630 ¾AÀ³¯g:«D°sºë©Ê¯×ªÕ¨xª¢ ²£«~Àu¶Õ: 1.¬°Àu¤Æ(Optimized)¤§·s¤Æ¾Ç¹êÅé(NCE) 2.¥«³õº¨£·sÃÄ(First-in-class) 3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 4.§@¬°²Ä¤@¥N²£«~¤W¥««áªº±µÄò¦û¦³¥«³õ¤§²£«~ ¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C Ävª§¤O: 1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢ 2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯× 3.Àu¤ÆªºÀø®Ä±j«×¡B§@¥Î®É¶¡ 4.µL¦w¥þ©Ê°ÝÃD ¬ãµo¶¥¬q: 1.Á{§É«e 2.¹w©w¥Ó½Ð¬ü°êFDAIND¡B§Ö³t³q¹D(fasttrack)¡C 3.¥Ó½Ð¬ü°ê¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C Àø®Ä¤ÀªR¡G 1. ¥Ø«e¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.05 ============================================================================= ²£«~03¡GSNP-810 (µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯) ¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ (¸Ñ¼öÂíµh¾¯) ²£«~Àu¶Õ: 1.¦w¥þ¤Æ¦Xª«·s²Õ¦X¡BµL¨x¬r©Ê 2.¸Ñ¨M¢¤ÁÂåÀø»Ý¨D (Important urgent unmet medical needs) 3.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¥i¼W¥[¾¯¶q ¥«³õ: ¤AñQÓi×ô¶È¦b¬ü°ê¤@¦~´N¦³40»õ¬ü¤¸ªº¥«³õ Ävª§¤O: 1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ« 2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^ 3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O ¬ãµo¶¥¬q: 1.¤w§¹¦¨§C¾¯¶q¡B°ª¾¯¶qÁ{§É¸ÕÅç 2.¤w¥Ó½ÐUSFDA¼Ï纽Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D 3.µL¨x¬r©Ê¤AñQÓi×ô¸Ñ¬r¾¯¦¨¤À¡A¤w¥Ó½Ð¬dÅçµn°O¥Î¤§Á{§É¸ÕÅç ============================================================================= ²£«~04¡GSNP-830/ SNP-840 ¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃĽƤè(ªvÀø¤¤¡B««×¯kµh) ²£«~Àu¶Õ: 1.µL¨x¬r©Ê¤AñQÓi×ôªº½Æ¤è 2.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¡A¥i¼W¥[¾¯¶q ¥«³õ: ¤AñQÓi×ô³B¤èÃĦb¬ü°ê¤@¦~´N¦³27»õ¬ü¤¸ªº¥«³õ Ävª§¤O: 1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«½Æ¤è 2.½Æ¤è¤w¥Ñ¬ü°êFDAn¨D°¾¯¶q§C©ó325²@§J¡A±N¼vÅTÀø®Ä 3.¦³¨Ï¥Î±M§Q¡A¥iקï©Î§R°£FDA¨x¬rĵ»y 4.¥i¼W¥[¤AñQÓi×ô¾¯¶q ¡]¥Ñ325mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û¦³®Ä¡^¥H¼W¥[Àø®Ä¡A©Î´î¤ÖOpioids¾¯¶q¡A°§C¦¨Å}°Æ§@¥Î 5.¤GªÌ¾Ü¤@±ÂÅv 6.¥i¼W¥[¥«¦û²v ¬ãµo¶¥¬q: 1.SNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç SNP-830 ¤£¬O ·s¦¨¤À ªº·sÃÄ¡A©Ò¥H¤£»Ýn¶i¦æ²Ä¤@¡A¤G¤Î¤T´ÁÁ{§É´úÅç µ¥ SNP-810 ®³¨ìÃÄÃÒ«á¡A¥H ·sÀø®Ä½Æ¤è¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê´úÅç ´N¥i¥HÀò±oÃÄÃÒ ============================================================================= ***************************************************************************** SNP-8 ¨t¦C Àø®Ä¤ÀªR¡G 1. ¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005 1. ¤w¸g§¹¦¨¤§¤HÅé¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005 ============================================================================= ***************************************************************************** ¥¼¨Ó¥Ø¼Ð±ÂÅv¥D¤O²£«~¡G 1. ¯×ªÕ¨xÃÄ¡GSNP-610 ©M SNP-630 ¦U¦³ÀuÂI¡A¥Ø¼Ð¬°¥þ²y±ÂÅv 2. ¤îµhÃÄ(OTC): SNP-810, ¥Ø¼Ð¬°¬ü°ê¤Î¥þ²y±ÂÅv 3. ¤îµhÃÄ(³B¤èÃÄ): SNP-830 ¤Î SNP-840, ¦b°Êª«¤W¬Ò¦³¥¿±ªºµ²ªG¡A¥Ø¼Ð¬°¥þ²y±ÂÅv ============================================================================= ***************************************************************************** ¥Ø«e¤½¥q»P°ê»Ú¤j«¬Ãļt¥¿¦b½Í§Þ³N±ÂÅv©M¦X§@p¹º §Ú¬Ý¹L¤½¥q©xºô©M©Ò´£¨Ñªº¸ê®Æ¡Aı±o¤½¥q«Ü¥Î¤ß¦b¸gÀç¡A¦Ó¥B¸ê®Æ¤]«Ü¸Ô²Ó ¹ï¤½¥qµo®i«Ü¦³¦Û«H¡A¥¼¨ÓªÑ»ùȱo´Á«Ý¡A¦³¾÷·|¬O ¤U¤@Ó ¦X¤@ ÄÆªÑ ----------------------------------------------------------------------------- ¥H¤W¸ê®Æ ³£°Ñ¦Ò ªÑªF·|ij¨Æ¿ý.pdf ©M ¤½¥q©xºô (¦³¿³½ìµÛÅwªï¦A²`¤J¬ã¨s»P°Q½×) |
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/5/14 ¤W¤È 09:13:49²Ä 1122 ½g¦^À³
|
Madrigal³Ì°ª»ù¦b2018.6.11ªº322¤¸¡A¬Q¤é¦¬131.61¡C ¤@¥¹¤½¥¬»PFDA¥Ó½ÐNASHÃÄÃÒ¡A¤j¦³¾÷·|¦A³Ð·s°ª»ù¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/5/14 ¤W¤È 09:00:01²Ä 1121 ½g¦^À³
|
108/07/24 Bio-Asia¨È¬w¥Í§Þ¤j®iÁ|¿ì¤§¤½¥q®i±æ»¡©ú·|:SNP-6Àø®Ä¦w¥þ©ÊÀu©ó«eªuªºMadrigal MGL-3196¡C ¬Q¤éMadrigal¥«È21.83»õ¬ü¤¸(³o®a¤½¥q¤]´N2¤äªvÀøNASHªºÃĪ«MGL-3196(P3) /MGL-3745(Á{§É«e)¥~¡A§OµL¥Lª«!) www.madrigalpharma.com/ourapproach/pipeline/ ¥Ø«eªYÄ£¥«È¤£¤ÎMadrigalªº10%! ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/21 ¤U¤È 03:52:58²Ä 810 ½g¦^À³ SNP-6(P2)Àu©ó·~¬É»{¬°±N¬O²Ä1¤äNASH¤W¥«ÃĪ«ªºMGL3196¡]Resmetirom¡^¡A ¥H¶g¤Madrigal¥«È18.85»õ¬ü¤¸¥«È¡A¸Õ°ÝªYÄ£ªº¹Ú¦³¦h¤j?(¥Ø«eªYÄ£¥«È¤£¤ÎMadrigalªº10%) Madrigal¤½¥q°£¤F2¤äNASHÃĪ«MGL-3196(P3) /MGL-3745(Á{§É«e)¥~¡A[§OµL¥Lª«]! VS ªYÄ£ SNP-610(P2) /SNP-630(P1)¡A¥~¥[º¤äµL¨x¬rSNP-810¡C --------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/9/12 ¤U¤È 02:42:06²Ä 344 ½g¦^À³ SNP-6Àø®Ä¦w¥þ©ÊÀu©ó«eªuªºMadrigal MGL-3196?! ¦ý¬OªYÄ£¥«È«o¤£¤ÎMadrigalªº10%!!! ------------------------------------------------------------------------------------ ·|û¡GROGER588910148151µoªí®É¶¡¡G2020/7/3¤W¤È08:05:38²Ä35½g¦^Î` 108/07/24 Bio-Asia¨È¬w¥Í§Þ¤j®iÁ|¿ì¤§¤½¥q®i±æ»¡©ú·| mops.twse.com.tw/nas/STR/663420190724M001.pdf Phase II study: - The decreases in several clinical parameters from baseline to the end of treatment were greater in SNP-610-12-week treatment than Ocaliva, Cenicriviroc, Elafibranor, MGL3196 or Selonsertib treatment in literature, especially in ALT. |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/5/13 ¤U¤È 11:03:21²Ä 1120 ½g¦^À³
|
´X¦~«e¤O´¹ªÑ»ù¤Q¦h¤¸®É¡AÂE®ü·Qµo®i¥b¾ÉÅé·~¡A´N¦³¤pªÑªF§Æ±æÂE®ü¥X¦n»ù¶R¤U¡Fµ²ªG¤£¬O¨º»ò²³æ´N³Q¨ÖÁÊ¡CªYÄ£ªº6¨t¦C¥þ²y¥ÎÃĶq¬O8¨t¦C7¿¡A¨äªÑ»ù¦X²z»ù¦ìÅ妺¤H¡A²{¦bªº»ù¦ì»·§C©ó¦X²z»ù¦ì¡A¨S¦³ªÑªF·|§Æ±æ½â»ù½æªÑ¥÷¡C |
|
|
·|û¡G¹j¾À¤p¤ý10151762 µoªí®É¶¡:2021/5/13 ¤U¤È 02:52:48²Ä 1119 ½g¦^À³
|
¤½¥q¥«È¤£¶W¹L2»õ¬ü¤¸¡A¬O§A·|®³5_8»õ¬ü¤¸±ÂÅvª÷¶Ü¡Aª½±µªá¤T»õ¬ü¤¸¶R¤U¤½¥q¡A¤°»ò³£¬O§Úªº¡AÁٽͤ°»ò¡A©Ò¦³°t¤èÀH«K¥Î³£¥i¥H |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2021/5/13 ¤U¤È 12:09:27²Ä 1118 ½g¦^À³
|
§Ú¤£¥h°Ñ¥[ªÑªF·| ¦³°Ñ¥[ªº¤j¤j ¥i§_°Ý¤@¤U810ÃĮĸÕÅç¶i«×¦p¦ó¡H ¤~60¤H¡A©Û¶Ò¹ï¹³¡A¨C¤Hµo2¸U¬ü¤¸¡A¦ó»Ý´XÓ¤ë¡H ¥h¦~¤Q¤G¤ë¤½§i¡A³£§Ö5Ó¤ë¤F¡A·d¤°»ò¸¾÷¡H ¸ê°T¨º麽¤£³z©ú¡I ¤½¥q»¡n±ÂÅv¡A³£Á¿¤F´X¦~¤F¡I Ãø¹Dn²{ª÷¼W¸ê¡A¤S¦Aµe¤j»æ¡H Ä~Äòµe¶Ü¡H |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/13 ¤W¤È 11:45:37²Ä 1117 ½g¦^À³
|
¤å¤j§A»¡ªº¹ï ¤£¸Ó¯dªº¸êª÷ §Ú¤µ¤Ñ©â¨«¤F ¥H§K¨ì¥h¾ß¯È½c¤F ³Ñ¤Uªºªø§ë¨S°ÝÃD §Æ±æ810±ÂÅv¦³¦n®ø®§ Åý§Ú¤£n¦AÁ«·l¤F ü |
|
|
·|û¡G¤p¤å¤l10144877 µoªí®É¶¡:2021/5/13 ¤W¤È 08:04:18²Ä 1116 ½g¦^À³
|
ªü§»¤j¡G §A¥Î³oºØ§ë¸ê¤èªk¹ï¥ÍÃįuªº¬O¤j¤j¿ù»~³á¡A¤@©wn¨Ï¥Î¶¢¿ú¡A¤£¯à°Ê¨ì®a¸Ìªººò«æ¹w³Æª÷¡A¦Ó¥B¤ßºAn¦³ªø´Á§Ü¾Ô¦Ü¤Ö2-3¦~³á¡C¡C¡C¤£µM§A§t«ëªº¾÷·|¥i¬O·|«Ü¤j³á¡C¡C¡C |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/13 ¤W¤È 05:47:22²Ä 1115 ½g¦^À³
|
ÁöµMµLÃö¡A¥¼¨Ó¦Ü´LªÑ¤ýÁÙ¬O¦h¤Ö¨ü¨ì¼vÅT¡Aü¡I¤@¶}©l¶R¤Ó¦h¡A¤@ª½½L¶^¡AÁ«·lÂX¤j¡A¤w¸g§Ö³Q¦Ñ±C»°¥h¤½¶é¤F😭 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/5/13 ¤W¤È 05:35:01²Ä 1114 ½g¦^À³
|
5/12¦¨¥æª÷ÃB³Ð¤U¾ú¥v¤Ñ¶q7,794.99»õ¤¸---³o¬ö¿ý¨S¦³«¥®a1¤ò¿ú¡C ---------------------------------------------------------------------------------------------- ·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/12 ¤U¤È 03:03:22²Ä 1113 ½g¦^À³ ³oÀɤS¨S¿Ä¸ê¨é ©ñªÅ¤]ÁȤ£¨ì¿ú §Æ±æ¤j®a¤£n¸òµÛ®£·W¶Ã½æ ÅýªÑ»ùä@¨Ç |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/12 ¤U¤È 03:03:22²Ä 1113 ½g¦^À³
|
³oÀɤS¨S¿Ä¸ê¨é ©ñªÅ¤]ÁȤ£¨ì¿ú §Æ±æ¤j®a¤£n¸òµÛ®£·W¶Ã½æ ÅýªÑ»ùä@¨Ç |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/12 ¤U¤È 12:05:44²Ä 1112 ½g¦^À³
|
¦nªº¥Í§Þ²{¦bÀ³¸Ó¬O«Ü¦nªºÁ×·´ä ³o»ò¦³¼ç¤OªºªYÄ£ ÁܽФj®a¤@°_¨Óªø§ë ¤£n³Q¥Ø«e³o¨Ç··«B«B©Ò¼vÅT |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/12 ¤W¤È 11:50:27²Ä 1111 ½g¦^À³
|
²×©ó¨Ó¤F ºCºC¾ß |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/5/12 ¤W¤È 11:24:31²Ä 1110 ½g¦^À³
|
¥Í§Þ¨¾¬ÌªÑ¤µ¤é±x¼Æº¦°±(°£¤F¼ö¬M)!°ß¤@¤U¶^:ªYÄ£ ------------------------------------------------------------------------------------ 2020-12-23 ¥Í§Þ¨¾¬ÌªÑ ÅD¤H®ð«ü¼Ð ·sÃÄ»â°ì¡A¤¤¤Ñ¶°¹ÎÂà§ë¸ê¤½¥qªYÄ£¥ÍÂå¡AºX¤U¡u¥þ²yº¨ÒµL¨x¬r©Ê¤îµh·sÃÄSNP-810¡v¡Aªñ´Á»P°ê»Ú¤j¼tñq±ÂÅv¦X¬ù¡A±ÂÅvª÷¨ã·Q¹³ªÅ¶¡¡A¤S¦]¸ÓÃĨã³Æ¸Ñ¼ö¡B®øª¢¥\®Ä¦ÓÅE¨¨¾¬Ì·§©ÀªÑ¡A¬Q¤é¿³ÂdªÑ»ù¤@«×¼É½Ä¤C¦¨¡B½Ä¯}¦Ê¤¸¤jÃö¡A»âx¿³Âd¥Í§ÞªÑ¬¡¸õ¸õ¡A¨ä¤¤¡A¿³ÂdÀË´úªÑ§¡¤jº¦¤T¦¨¥H¤W¡A´¶¥Í¬Æ¦Ü¬ð¯}¥|¦¨º¦´T¡C ¥t¡A°ê¹©¥Í§Þ¬Q¤é«Å¥¬¡A¨ä·s«a·sÃÄAntroquinonol¡]Hocena¡^³q¹Lªü®Ú§Ê°ê®aÃĪ«¹«~¤ÎÂåÀø¬ì§ÞºÞ²z§½¡]ANMAT¡^®Öã¡A¦bªü®Ú§Ê¶i¦æ¤HÅé¤G´ÁÁ{§É¸ÕÅç¡FµL¿W¦³°¸¡A¶h¹F¥Í§Þ¬Q¤é¤]¤½§i¡A¬°¤F¶ix·s«a·sÃĤG¡þ¤T´ÁÁ{§É¡A¤½¥q²{ª÷¼W¸ê¤w¦¬¨¬ªÑ´Ú13»õ2,000¸U¤¸¡C ¤f¸n±Ú¸s«í¤j¡]1325¡^¡B«n¤»¡B±d¨º»¡B¬ü¼wÂåÀø-DR¡AÀË´ú±Ú¸s¦X¥@¡B¨È¿Õªk¡B¼ö¬Mµ¥¯É¯É«G¿Oº¦°±¡F°ê¥ú¥Í§Þ¡B°ªºÝ¬Ì]µ¥¤]ÀH¤§¤jº¦¡C¨ä¤¤¡A°ê¥ú¤l¤½¥q¦w¯Sù¥Í§Þ¤]«Å¥¬¡A¨ä¶}µoªº¡uSpeedy·s«¬«aª¬¯f¬r§Üì§Ö³tÀËÅç¸Õ¾¯¡v¤w¥¿¦¡¨ú±o¼Ú·ùCE-IVD»{ÃÒ¡A±N·m§ð¼Ú¬w¥«³õ¾P°â¡C |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/11 ¤U¤È 02:04:33²Ä 1109 ½g¦^À³
|
±K¤Áª`·N¬O§_¦³80¥H¤U¥i¥H¾ß ¥Ø«eªí²{¤ñ°_³o¨Ç¤W¥«Âdºâ±j¤F |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/10 ¤U¤È 05:41:21²Ä 1108 ½g¦^À³
|
¤W¶g¼W¥[¤F¤@¦ì¤@¦Ê¦h±iªº¤j¤á 10±i¥ª¥kªº´²¤á¤]©úÅ㺥¤Ö |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/5/10 ¤U¤È 12:04:17²Ä 1107 ½g¦^À³
|
r¤j¨º¨Ç¸ê®Æ³£¬O«Ü±M·~ªº³N»y¡A«D¦³·§©À¤]¤£¦n»¡²M·¡¡FY¦³¸ê°T±jªº¤j¤j¡A§â¸ê®Æ±Hµ¹¤½¥q·í±N¨Ó¬ã¨s°Ñ¦Ò¤]¬O«Ü¦³°^Äm¡C |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/10 ¤W¤È 08:58:48²Ä 1106 ½g¦^À³
|
¦pªGR¤jÄ@·N¥X®u¡A¨º¯u¬O§Ú̪ººÖ®ð¡A¦ý¤]¯uªºµLªk«j±j¡A§_«h¬Ý¬Ý¬O§_ÁÙ¦³¨ä¥L¥ý¶i¡AÀ°¦£¸ß°Ý´À¤j®aµoÁn¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/5/10 ¤W¤È 08:30:08²Ä 1105 ½g¦^À³
|
¥¿±`ª¬ªp¡A«¥¤£¥X®uªÑªF·|¡A¦U¦ì¥i¦Û¥Ñ¨ú¥Î«¥ªº¸ê®Æ¡A¤£¥Îµù©ú¥X³B¡A³d¥ô¦Ût¡C |
|
|
·|û¡G¤p¤å¤l10144877 µoªí®É¶¡:2021/5/8 ¤U¤È 05:19:03²Ä 1104 ½g¦^À³
|
·PÁÂR¤j¸Ñ´b¡C¡C¡C ¤£ª¾R¤j¬O§_n¥X®uªYÄ£ªºªÑªF·|¡C¡C¡C§Ú¬Û«H¦]³oª©±¦Ó¿ï¾Üªø´Á§ë¸êªº¦U¦ì¥ý¶i¡AÀ³¸Ó³£®ï®ï´Á¬ßR¤j¯à¥X®uªÑªF·|¡AÀ°¤j®a§âÃö»P¸Ñ´b¡C¡C¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/5/8 ¤U¤È 01:56:35²Ä 1103 ½g¦^À³
|
²ÓM§K¬ÌÀøªkÁÙ¦³º©º©ªø¸ôn¨«¡C(¤p¹«¼Ò«¬¤¤ªº¹êÅé¸~½F§¹¥þ®ø°£---µ²ªG¤HÅé¹êÅ祢±Ñ) 1.2017¦~: ·s«¬CAR-TÀøªk¦bÁ{§É«e¬ã¨s¤¤±ÙÀò«½S¦¨ªG kknews.cc/science/xnbpvgo.html P-PSMA-101¦bªvÀø¹Lµ{¤¤ªí²{¥X¤F±j¦³®Äªº§Ü¸~½F¬¡©Ê¥H¤Î«ù¤[ªºÀ³µª¤ÏÀ³¡A¨Ï±o¥ý«e¤£¥iªv¡ªºÄáÅ@¸¢ÀùÁ{§É«e¤p¹«¼Ò«¬¤¤ªº¹êÅé¸~½F§¹¥þ®ø°£¡C P-PSMA-101§@¬°Poseida¤½¥q¥Î©óªvÀøÄáÅ@¸¢ÀùªºPSMA¯S²§©ÊCAR-T²ÓMÔ¿ïÃĪ«¡A¨ä¬O³q¹L¹ï±wªÌ¦Û¨ªºT²ÓM¶i¦æ °ò¦]½s¿è¡A¨Ï¨ä¥i¥H¦w¥þ¦³®Ä¦a®ø°£Äâ±aÄáÅ@¸¢¯S²§©Ê½¤§Üì(PSMA)ªº¸~½F²ÓMªº¤@ºØ¦ÛÅé²ÓMÀøªk¡C ---------------------------------------------------------------------------------------------- µ²ªG:2020¦~8¤ë Á{§É1´Á¥¢±Ñ Poseida«e¦C¸¢ÀùCAR-TÁ{§É¸ÕÅç¶Ç¦º¤`¾DFDA¥s°± ªÑ»ù¶^20% www.gbimonthly.com/2020/08/77673/ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/5/8 ¤U¤È 01:40:41²Ä 1102 ½g¦^À³
|
1.§K¬Ì²ÓMÀøªk·½©ó¬ü°ê°ê¥ß½Ã¥Í¬ã¨s©Ò¡]NIH¡^½T¥ß¤F§K¬Ì²ÓMÀøªk¡]LAKÀøªk¡^ªº°ò¦¡A¬ÛÃö·s³Ð¤½¥q¦h¦p¤û¤ò¡A µL¶·±Ëªñ¨D»·¡An¤£¤ä«ù¥»¤g¤½¥q: ¬ü°ê²ÓMªvÀø¼tªí²{«G²´ ¿EÀy¨|¥@³Õ¤T¶µÁ{§É¥[³t¶i®i(¦³¯d·NÁÙ¨S§ë¸ê) money.udn.com/money/story/10161/5090346 ....¤µ¦~7¤ë¤¤¦¯¡A¨|¥@³Õ¤]´¿«Å¥¬¡A¤½¥qªº²£«~ACE1702¤ÎACE1655¡A¤w»PÃÄ©ú¥¨¿Õ¡]JW Therapeutics¡^¤½¥qñq±MÄÝÀu¥ý±ÂÅv¦X§@¨óij¡A¨Ã¨ú±oñ¬ù±ÂÅvª÷¡B¶¥¬q©Ê¥I´Ú¤Î¾P°âÅv§Qª÷¡C¨ä¤¤ACE1655¡A¬O¼Ð©w¹v¦VCD20ªºoNK²ÓMªvÀø¬ã¨s·sÃÄ¡A¥Î©óªvÀøB²ÓM´c©Ê¦å²G¸~½F¡A¥]¬A¬Y¨Ç§Î¦¡ªº¥Õ¦å¯f¤Î²O¤Ú½F¡C¥~¬É¦ôp¡A¾ãÅé±ÂÅvª÷¤W¬Ý6»õ¬ü¤¸¡]¬ù·s¥x¹ô180»õ¤¸¡^¡C 2.Àù¯g [§K¬ÌÀøªk]»P[²ÓM§K¬Ì²ÓÀøªk]¤£¤@¼Ë! www.commonhealth.com.tw/article/76796 3.¤j³°¦b2016¦~µo¥Í[ÃQ«h¦è¨Æ¥ó]DC-CIK²ÓM§K¬ÌªvÀø....¡C |
|
|
·|û¡G¤p¤å¤l10144877 µoªí®É¶¡:2021/5/8 ¤W¤È 09:35:15²Ä 1101 ½g¦^À³
|
ROGER5889¤j¡G ¸ò§A½Ð±Ð¡A¬üªÑ¥Í§ÞÃþªÑ¦³Ãþ¦üªø¸t±Mª`§K¬ÌÀøªk»P²ÓMªvÀøªº¨ã¼ç¤O¤½¥q¶Ü¡C¡C¡C¯à§_±ÀÂË´XÀɰѦҩO¡C¡C¡CÁÂÁ¡C¡C¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/5/7 ¤U¤È 06:01:36²Ä 1100 ½g¦^À³
|
Ocalivan¬O¤£¦s¦³¨x¬r©Ê°ÝÃD¡AÅK©w¬OFDA®Öã¤W¥«ªº²Ä1¤äNASH·sÃÄ¡C YSNP-630n»POcalivaÁp¥Î¡A¥ý¸Ñ¨MOcalivaªº¨x¬r©Ê°ÝÃD! (SNP-630³æÃĪì¨B¼Æ¾Ú¤wÀu©ó:Ocaliva¡ASNP-630·íµM¤]¯à»P¨ä¥L¦b¬ãNASHÃĪ«Áp¥Î) ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/23 ¤W¤È 06:59:49²Ä 829 ½g¦^À³ Intercept¯u¬O½ß¤F¤Ò¤H¤S§é§L¡A«Îº|¤S³{³s©]«B! ¦]¬°[¨x¬r©Ê]°Æ§@¥Î¡A¥Ó½ÐNASHÃÄÃÒ³Q§_¨M«á¡AFDA¤S¦^ÀY½Õ¬dOcaliva¼ç¦bªº¨x¯f·ÀI! endpts.com/in-another-blow-to-intercept-the-fda-investigates-ocaliva-for-potential-risk-of-liver-disorder/ ³o¤U¤l2016¦~Àò㪺ìµo©ÊÁxºÞª¢¡]PBC¡^ÃÄÃÒ¦³¥i¯à¤S¦]¬°[¨x¬r©Ê]°Æ§@¥Î¦Ó³QºM¾P!? --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/21 ¤U¤È 12:54:38²Ä 807 ½g¦^À³ ¦b³Ì¦³¾÷·|¹Ü±o²Ä1¤äNASH¤W¥«ÃÄÃÒªºOcaliva¡]Intercept¡^¦]¬°[¨x¬r©Ê]°Æ§@¥Î³Q§_¨M«á¡A ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/23 ¤W¤È 07:53:57²Ä 830 ½g¦^À³ ¤°»ò¥s¹Ú´K¥H¨Dªºµª®×??? ¦]¬°SNP-610´Á¤¤¤ÀªR 1.F4(ÄY«ÅÖºû¤Æ)ªvÀø«e«á [¦³ÅãµÛ]®t²§¡C 2.ªì¨B¼Æ¾ÚÀu©ó:Ocaliva , MGL3196¡]Resmetirom¡^, Selonsertib |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/5/7 ¤U¤È 05:44:04²Ä 1099 ½g¦^À³
|
Q1:SNP-630»POcalivaÁp¥Î¡A¨ºOcalivaªº¨x¬r©Ê(FDA§_¨Mì¦])? 1. 19¨Ò±wªÌ¦º¤` Intercept药ª«Ocaliva©Î³y¦¨严«¨x损伤 med.sina.com/article_detail_100_2_34133.html 2.FDA¥¿¦b½Õ¬dOcaliva¬O§_¦s¦b¨xŦ¯e¯fªº¼ç¦b·ÀI endpts.com/in-another-blow-to-intercept-the-fda-investigates-ocaliva-for-potential- risk-of-liver-disorder/ Q2:ª¾¹DSNP-630«ÜÃø¦X¦¨¡A»s³y¦¨¥»¨s³º¦h°ª? -------------------------------------------------------------------------------------------- doc.twse.com.tw/pdf/2021_6634_20210610F02_20210507_172837.pdf ¦b SNP-630 ¨Ö¥Î¨ä¥L¤T´ÁÃĪ«ªº´ú¸Õ¤¤¡A§Ú̵o²{SNP-630 »P¤T´ÁÃĪ« Ocaliva ¨Ö¥ÎªvÀø NASH ¤p¹«¡A¦b¦å ¿}¡B¦åÁx©T¾J¡B¨xŦ¤T»Ä¥Ìªo¯×µ¥¶µ¥Øªº°§C®ÄªG¬ÒÀu©ó³æ¿W¨Ï¥ÎOcaliva©ÎSNP-630 (p<0.05)¡A¦³ÅãµÛªº¨ó¦P§@¥Î¡AÅã¥Ü SNP-630 µo®i½Æ¤èÃĪ«ªº¼ç¤O¡C¦b SNP-630 °t¤èÀu¤Æªº¸ÕÅ礤¡A§ÚÌ´ú¸Õ¤F¦hºØ½á§Î¾¯°t¤è¡A¦bÅé¥~¤ÎÅ餺¸ÕÅ礤¡A¨Ï¥Î·s°t¤è¦¨¥\ªº°§C¤F SNP-630 ªº¨Ï¥Î¾¯¶q¦Ó¤£§ïÅܨäÀø®Ä¡A¦¹µ²ªG±N¦³§U©ó¶i¤@¨B°§C SNP-630 ³æ¦ì¾¯¶q¤§¦¨¥»¡C |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2021/5/7 ¤U¤È 05:01:55²Ä 1098 ½g¦^À³
|
2021¦~ªÑªF±`·|ij¨Æ¤â¥U¤w§ó·s©ó¤½¶}¸ê°T¯¸¡AÀç·~³ø§i¶i®i¤½¥q¦³¥Î²Ê¦rÅé¼Ð¥Ü¡C ¦³¿³½ìªÌ¥i¦Û¦æ¥h¬d¬Ý¡C TO¯È¤W´I¶Q¤j ¤ÀÂI¶i¥X¥i¥Î¥D¤Oª®À»¤âAPP |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2021/5/7 ¤U¤È 03:24:35²Ä 1097 ½g¦^À³
|
µL·¤£°_®ö 810¼Ï¯Ã¸ÕÅç¤j·§¦~ªì¶}©l¡A¦L¶H¤¤¬O»Ýn4Ӥ륪¥k¡A²{¦b¤¤ë¤F µ²ªG¥X¨Ó¡A±ÂÅv¹ï¶H¬Ý§¹¼Æ¾Úº¡¤£º¡·N¿Ñ¦¨a ·|¤£·|°²¤é¬ðµo¦n®ø®§??? µ¥«Ý´N¦n...³o¦^¦Xµ²§ô¡A»\µP!! |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/7 ¤U¤È 01:00:10²Ä 1096 ½g¦^À³
|
§ÚÁÙ¨S¦^¸É ¤£n¬ðµo§Q¦h³á |
|
|
·|û¡G¯È¤W´I¶Q10134993 µoªí®É¶¡:2021/5/6 ¤U¤È 11:43:27²Ä 1095 ½g¦^À³
|
½Ð°Ý¦U¦ì¥ý¶i °£¤FÂd¶R¤¤¤ßªººô¯¸ ³£¦b¨ºÓºô¯¸©Î¥Î¤°»òapp ¬d¸ß¿³ÂdªÑ²¼ªº¤ÀÂI¶R½æ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/5/6 ¤U¤È 10:11:20²Ä 1094 ½g¦^À³
|
1¤ëÀ禬2649000 2¤ëÀ禬498000 VS 3¤ëÀ禬944000 VS 4¤ëÀ禬493000 (¤ñ¨Ò¬ù1:2:1) 2¤ëªº¤u§@¤é´î¥h¹A¾ä¦~°²«á¤j·§¥u¦³3¤ë¥÷ªº1/2¡A4¤ë»P2¤ëÀ禬¬Û·í¡A·Pı¦n¹³¬O¬£û»Y¼t§Þ³N«ü¾Éªº[³Ò°È¦¬¤J]¤w±µªñ§ÀÁn?±µÄò¬O??? |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/6 ¤U¤È 09:45:43²Ä 1093 ½g¦^À³
|
¥i¯à¬O¦³¤j¤á¦^¸É¡A¤£¤p¤ßÂI¤õ¡A¶i¦Ó¨«¤õ¡Aµ²ªG¤SÄF¤F¤@¨Ç¤H¤W¨®ÁÙ°l°ª¡Aµo²{»~·|¤@³õ¡A³o´X¤ÑÀ³¸Ó¤S·|©¹¤U¾ã²z¤F¡A§ÚÁÙ¦bµ¥¦^¸É¡A¤µ¤Ñ¤@¤U©Ô³o»ò³o»ò°ª¡A§Ú¸É¤£¤U¥h°Ú¡C |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/5/6 ¤U¤È 09:27:05²Ä 1092 ½g¦^À³
|
²Ä¤@ª÷µØ¦¿³sÄò¤Ñ¤Ñ˳f¼Æ¤ë¡A³o´X¤Ñ¨S¬Ý¨ì¦A¥X¡A¬O¥X°®²b?QA¦n¹³¤@ª½³£¨S§ó·s°Ú¡A¤×¨ä¥h¦~§ïª©ªº¬ãµo¶i«×ºô¶¶Â¥Õ°t¦â¡A¯u¬Oµ¹¤H¬Ý¤F¹³¦b@~@¤å¡A¤½¥q¯uªº¸Ó¬üµe¤@¤U©xºô¡I! |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2021/5/6 ¤U¤È 08:29:46²Ä 1091 ½g¦^À³
|
1/26¶R68±i¹j¤é¨Rªº¤¸¤j·s¦Ë¸g°ê¤µ¤ÑÁʤJ32±i§¡»ù89.41¡A©Î³\¦³@¤H´M¨ýªºì¦]¡C ©xºôªº°Ý»Pµª¡A«ùÄò¦³§ó·s¤¤ ½Ð°ÝSNP-810²{¦b¬ãµoªº¶i«×¦p¦ó? SNP-810¬°µL¨x¬r©Ê¤îµh¡u·sÀø®Ä·sÃÄ¡v¡C¥Ø«e¤w§¹¦¨³æ¾¯¶q¡B¤p¾¯¶q¤Î¤j¾¯¶qµ¥¦hºØÁ{§É¸ÕÅç¡A¤]Àò¥xÆWFDA®Öã°õ¦æ¼Ï¯Ã©ÊÁ{§É¸ÕÅç¡A¦P®É¤w¥Ó½Ð¬ü°êFDA¼Ï¯Ã©ÊÁ{§É¸ÕÅç¼f¬d¸û¤j¾¯¶qªº¤HÅé¸ÕÅç¡A¥Î¥HÃÒ©úµL¨x¬r¤§¦w¥þ©Ê¡C¬ü°êFDA»{¬°¡A»ÝnGLP¹êÅç«Ç¨ÓÃÒ©ú¨ä°Êª«Àø®Ä(µL¨x¬r©Ê)¡A¥Ø«e¤w§¹¦¨¦¹GLP°Êª«¸ÕÅç¡A¥¿³z¹L°ê»ÚCRO¤½¥q¦P¨B¥HUSFDA Type A meeting¥H¤ÎÁ{§É¸ÕÅçpµe®Ñ×¥¿¡A§¹¦¨Pivotal¸ÕÅç¥Ó½Ð¡C |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/5/6 ¤U¤È 07:35:54²Ä 1090 ½g¦^À³
|
¥|¤ëÀ禬49.3¸U¡A¤µ¤é¥i¯à¬O±ó²îªº§ë¸ê¤HÂk¶¤µ¥«Ý¶}¼ú§a~ |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/5/6 ¤U¤È 01:59:30²Ä 1089 ½g¦^À³
|
¦³¤p§Q¦h¦p¥»°ê810ÃÄÃÒ¤§Ãþ®t¤£¦h¦p¦¹º¦´T¡AY¨S¦³®ø®§¤£´Nªí¥Ü«¥ªYÄ£¦n´Î´Î¡I |
|
|
·|û¡G¬K¤Ñô10143192 µoªí®É¶¡:2021/5/6 ¤U¤È 01:51:21²Ä 1088 ½g¦^À³
|
©ñ³o»ò¤[⋯⋯ ¨ä¥LªÑ³£º¦Â½¤F⋯¡A ¦pªG¤µ¤Ñ³Q¬~±¼¤F¡A¤§«á⋯⋯¬O «Ü¥i±¤⋯⋯ ¦³«°T³Ì¦n⋯⋯⋯ ¨S¦³¤]¨SÃö«Y⋯⋯¤Ï¥¿³£µ¥«Ü¤F⋯⋯ |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/5/6 ¤U¤È 01:33:26²Ä 1087 ½g¦^À³
|
½²¤p¤p¨S¦³¿ú¤F¡A¦´N¥þ¤U¤F¡F¦pªGÁÙ¦³¿ú¤µ¤Ñ³o»ù¦ì¤]´±¦A¶R¡C±ÂÅv®ø®§º¦´T¦Ü¤Ö30¦Ê¤À¤ñ¡A¤£·|³o»ò«È®ð¡C5Ó¤jªGÁÙ¨S¦³¥X²{´Nªñ¦Ê¤¸¡A¨º5Áû¥þ±ÂÅv¥X¥h¤@¤d¤¸¤£¹L¤À³á¡I |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/6 ¤U¤È 12:55:20²Ä 1086 ½g¦^À³
|
½L«á¥i¯à¦³«°T??? ¤S¤£¹³¶Ã©Ô ½Æ²ß¤@¤U ¤AñQÓi×ô¬O¥@¬É¤W·¥«nªº¤îµhÃĤ§¤@¡A¦ý¬O¦³¨x¬r©ÊP¦ºªº¯ÊÂI¡C§Ú̬O¥H·¥¥©§®ªº¤è¦¡¨Ó¸Ñ¨M60¦~¤jÃļt¤@ª½µLªk¸Ñ¨Mªº°ÝÃD¡C¥HÀ°§U¯f¤H´£¨Ñ§ó¦w¥þªºÃÄ«~¡A±ÂÅvª÷±N¬O¦b¤Ï¬M¦¹°^Ämªº»ùÈ¡A¤]±o¨ì°ê»Ú¤j¼tªº»{¥i¡C ÁÙ¬O6¨t¦C±ÂÅv ¶i«×¤Ï¶W? 810¥xÆW¾Ç¦WÃÄ? ÁÙ¬O¦³¦ò¤ß¨Óªº¤H¤h ¨Ó©Ô©ï Åý§Ú§K¤ß¯k Ãø¹D¬O½²¤j¥X¤â¸Ñ¦M Á`¤§¥ýÁÂÁÂ°Õ |
|
|
·|û¡G¹j¾À¤p¤ý10151762 µoªí®É¶¡:2021/5/6 ¤U¤È 12:25:41²Ä 1085 ½g¦^À³
|
²H©w¡A¡A¡A²H©w¡A¡A¡A²H©w´N¦n¡A¥ô¦ó¥i¯à¤U¤È´N·|´¦¾å |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/6 ¤W¤È 11:40:55²Ä 1084 ½g¦^À³
|
R ¤j¡A§ÚÁÙ¨S¦³¸É¦^¨Ó¡A§Ú¬O¤Ï«ü¼Ð¶Ü¡HÁÙ¬O³Q¥D¤O¨n¤W¤F¡A¨SÃö«Yµ¥§A¤U¨Ó¡A§Ú¤£«H¡A·d¤£¦n¬G·N©Ô°ª¥X³f🙄 |
|
|
·|û¡G¦V«e¦æ10140498 µoªí®É¶¡:2021/5/6 ¤W¤È 11:28:56²Ä 1083 ½g¦^À³
|
·|¤£·|¬O810ÃĮĸÕÅçµ²§ô¤F¡H |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/5/6 ¤W¤È 10:47:43²Ä 1082 ½g¦^À³
|
¬ðµM©Ô©ï?¬Oþ¦ì¤j¤á³o»ò¦ò¤ß!ÁÙ¬O¥Ó½Ð¥xÆW¾Ç¦WÃĦ³¶i®iÆ[´ú¯¸¤]¨S¸ê°T~ |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/6 ¤W¤È 10:46:22²Ä 1081 ½g¦^À³
|
¦³¤j¨Æµo¥Í¤F |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/5/6 ¤W¤È 10:43:36²Ä 1080 ½g¦^À³
|
ªü§»¬O±z°l»ù¶R¦^¶Ü? |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/5/5 ¤U¤È 03:16:33²Ä 1079 ½g¦^À³
|
¤µ¤é¶qÁY¨ì§ÖnµLªk©I§l? ¤U©PÀ³¸Ó·|¦³ªÑªF·|¦~³ø¸ê®Æ¤W¶Ç¤½¶}¸ê°TÆ[´ú¯¸! ¦ó®É·|¦³±ÂÅv¶i®i?¬O§_µ¥¤ëÀ禬=0ªí¥Ü³Ò°È¦¬¤J¤w¸gµ²§ô,¦X§@¸ÕÅç¤]µ²§ô!! |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/5 ¤U¤È 02:01:07²Ä 1078 ½g¦^À³
|
¬Ù¦Y»ü¥Îªº´²¤á ¶¢¿ú¤£¦h ¤ß¯k°Ú ¶R¥¼¤W¥«ªº¦n³B¬OµLªk®É¨è¬Ý¨ì·l¯q ¦Ó¥B´I¥Ð³ø¹S³£¬O¥¿ªº ©ê¤F¤G¦~ ¤ß±¡¸û¤£¨ü¼vÅT ³o¿³ÂdªÑ¯à¬Ý¨ì¥æ©ö³nÅ骺·l¯q ¨C¤Ñ¬Ý³ø¹S²v ¶Vt¶V¦h ¨º¤Ñ±þ¨ì70´X ©È¶V±þ¶V§C ±Í¤H¦¨¥»90´X ¶R¤F´X¤Q±i ²´¬Ý½ß´X¤Q¸U ²H©w¤£¤U¥h°Ú ¬Ý¤§«á¦³80¥H¤U¦AºCºC±µ¦^¨Ó¤F ²{¦b¾ãӪѥ«³£¦b×¥¿ ¶R¤Ó¦¤]¬O©È¤@¶R¤S®M |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/5/5 ¤U¤È 01:14:29²Ä 1077 ½g¦^À³
|
§»¤j±zªº§ë¸ê«ä¸ô¥¿½T¡A¬°¦ón½æªÑ²¼¡H¦Aªá´X¸U¶R¶i½æ¥XªºªÑ²¼¡A·íú¾Ç¶O§a¡IªYÄ£¬O§Ú¬Ý¹L¦³¥i¯à·|¾_¾Ù¥xÆWªÑ¥«ªº¤½¥q¡A¤j¬ùn10¦~®É¶¡¡C¥[ªo¡I |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/5/4 ¤U¤È 02:29:48²Ä 1076 ½g¦^À³
|
«¢ ½Ðª©¥DÀ°§Ú¨â½g¼o¨¥ ¼o¤F ÁÂÁ ¥´ÂZ¤F ¤U¦¸½ÐÂÔ·Vµo¨¥¡AÁÂÁ¡IBY¥²´Iºôª©¥D |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/29 ¤W¤È 05:23:50²Ä 1075 ½g¦^À³
|
DGAT1 ªý¤î¯×ªÕÀx¦s¥i¯à¬°ªvÀø³ÌP©Rªº¸£Àù´£¨Ñ¤@ºØ·s¤èªk ¡§¦P¼Ëªº¤èªk¤]¥i¯à¾A¥Î©ó«e¦C¸¢Àù¡Aµ²¸zÀù¡AµÇÀù©M¨ä¥LÀù¯g¡A¥¦Ì¤]Åã¥Ü¥X¯×½èºwªº§Î¦¨¡A¡¨ OSUCCC-James Translational Therapeutics Program¦¨û³¢»¡¡C 2020¦~7¤ë21¤é ªý¤î¯×ªÕÀx¦s¥i¯à¬°ªvÀø³ÌP©Rªº¸£Àù´£¨Ñ¤@ºØ·s¤èªk ½¦½è¥À²ÓM½F¬O¤@ºØP©Rªº¸£Àù§Î¦¡¡A¥¦·|¦b¯×½è¤pºw¤¤¿n»E¯×ªÕ¨Ã±N¨ä¥Î§@§Ö³t²ÓM¤Àµõªº¯à¶q¡C ®Ú¾Ú«X¥è«X¦{¥ß¤j¾Çºî¦XÀù¯g¤¤¤ß-¨È·æ¡P¸â©i´µ¸â©i´µÀù¯gÂå°|©M²z¬d¼w¡PJ¡C¯Á¬¥¤Ò¬ã¨s©Ò¡]OSUCCC-¸â©i´µ¡^¡C GBM¶EÂ_«áªº¥§¡¥Í¦s´Á¬°12-15Ó¤ë¡A³o¤@®É´Á«O«ù¤F¤G¤Q¦~¤£ÅÜ¡C¢¤Á»Ýn·sªº¡A§ó¦³®ÄªºªvÀø¤èªk¡C ¦b§ó¦ªº¤u§@¤¤¡A¦P¤@¬ã¨s¤p²Õ¤F¸Ñ¨ìGBM²ÓM·|²§±`¦a¿n»E°ª¤ô¥ªº¯×ªÕ»Ä¡A¨Ã±N¨ä¥Î§@§Ö³t²ÓM¥Íªø©Ò»Ýªº¯à¶q¨Ó·½¡C ³q±`¡A¹L¶qªº¯×ªÕ»Ä¹ï²ÓM¬OP©Rªº¡C ¦bµoªí©ó¡m²ÓM¥NÁ¡nÂø»x¤Wªº³o¶µ¬ã¨s¤¤¡A¬ã¨s¤Hû¬ã¨s¤F¤@ºØ¥s°µDGAT1ªº酶¡]¤G¥Ìªo¥Ìªo酰°òÂಾ酶1¡^¡C GBM²ÓM¨Ï¥Î³oºØ酶±N¯×ªÕ»Ä¥]¸Ë¦¨¯×½è¤pºw¡C¸Ó酶±N¯×ªÕ»ÄÂà¤Æ¬°ºÙ¬°¥Ìªo¤T»Ä઺¤À¤l¡A¸Ó¤À¤l¥i§@¬°¯×½èºw¦w¥þ¦a¦sÀx¦bÀù²ÓMªº²ÓM½è¤¤¡CªýÂ_DGAT1·|±N¦h¾lªº¯×ªÕ»Ä¤À¤lÂಾ¦Ü²ÓMªº¯à¶q²£¥Í²ÓM¾¹½u²ÉÅé¡A¦Ó¤£¬OÀx¦s¡C ³o¨Ï²ÓM¾¹¤£³ô«t¡A¾ÉP¥¦Ì²£¥Í°ª¤ô¥ªº¯}Ãa©Ê¤À¤l¡AºÙ¬°®ñ¦Û¥Ñ°ò¡]¤]ºÙ¬°¬¡©Ê®ñ¡^¡C ¤Ï¹L¨Ó¡A³o·|¯}Ãa½u²ÉÅé¡A¨ÃIJµo²ÓM³q¹LºÙ¬°ä¤`ªº¹Lµ{¦Û§Ú¯}Ãa¡C º®u¬ã¨sû¡A©ñ®g¸~½F¾Ç±Ð±Â¡A«X¥è«X¦{¥ß¤j¾ÇÀù¯g¥NÁ¤¤¤ß¥D¥ô³¢¼w¨}³Õ¤h»¡¡G¡§³o¨Çµo²{ªí©ú¡A§í¨îDGAT1¥i¯à¬°ªvÀø½¦½è¥À²ÓM½F´£¨Ñ¤@ºØ·sªºªvÀø¤èªk¡C ¡§¦P¼Ëªº¤èªk¤]¥i¯à¾A¥Î©ó«e¦C¸¢Àù¡Aµ²¸zÀù¡AµÇÀù©M¨ä¥LÀù¯g¡A¥¦Ì¤]Åã¥Ü¥X¯×½èºwªº§Î¦¨¡A¡¨ OSUCCC-James Translational Therapeutics Program¦¨û³¢»¡¡C ¹ï©ó³o¶µ¬ã¨s¡AGuo©M¥Lªº¦P¨Æ¤ÀªR¤F±wªÌªº¸~½F²Õ´¡A¦hÓGBM²ÓM¨t©M¤@Ӱʪ«¼Ò«¬¡A¥HÀˬdGBM¤¤ªº¯×ªÕ»Ä¥NÁ©M¯×½èºw§Î¦¨¡C ¸Ó¬ã¨sªº¥Dnµo²{¥]¬A¡G ¥Ìªo¤T»Ä઺Àx¦s©M¯×½èºwªº§Î¦¨¯A¤Î¨âºØ酶DGAT1©MDGAT2¡A¦ý¬ODGAT1¬O¥Dnªº酶¡C §í¨îDGAT1¥i§í¨î¥Ìªo¤T»Äà©M¯×½èºwªº§Î¦¨¡A±q¦Ó¾ÉP½u²ÉÅ餤¯×ªÕ»Äªº°ª¤ô¥®ñ¤Æ¡AÄY«ªº®ñ¤ÆÀ³¿E©MGBM²ÓM¦º¤`¡C ¦b²§ºØ²¾´Ó¼Ò«¬¤¤¡A§í¨îDGAT1§í¨î¤FGBMªº¥Íªø¡A¦Ó¨S¦³©úÅ㪺¬r°Æ§@¥Î¡C ³¢»¡¡G¡§Á`ªº¨Ó»¡¡A§Ú̪ºµo²{¥i¯à·|¾ÉP½T©w½¦½è¥À²ÓM½F©M¨ä¥L´c©Ê¸~½F¯S¦³ªº¯×½è¥NÁ³~®|¡A¨Ã¬°³o¨ÇÀù¯g´£¨Ñ·sªºªvÀø¤èªk¡C¡¨ ¸ê®Æ¨Ó·½¡G «X¥è«X¦{¥ß¤j¾Ç³§J´µ¯ÇÂå¾Ç¤¤¤ß |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/4/28 ¤U¤È 11:56:27²Ä 1074 ½g¦^À³
|
¤½¥qªÑ»ùn°ª±o¾a¤½¥qeps¡A³o¬Oµw¹D²z¡AªYÄ£n¤jÁȯuªºnªø©êªÑ²¼¡C·í²Ä¤@ÁûÃıÂÅvª÷Ãn¥ú¡AªÑ»ù´N·|«Ü¦³·Pı¤F¡I |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/28 ¤U¤È 07:00:33²Ä 1073 ½g¦^À³
|
«¢¡A®ÌÂI§ë¸ê¤HÀ³¸Ó¬O¤£¦Ü©ó¡A¥u¬O³oÀÉ¥»¨Ó´N¬On©êªø¡A¥Ø«eªÑ»ù½L¶^¹Lµ{¡A¹ï¦¨¥»°ªªº§ë¸êªÌ¨Ó»¡·íµM¤ß¯k¡A¹³§Ú´N§â´I¥ÐÁȪº10´X¸U³£¦R±¼¤FÁÙ˽ߡAµL©`¥[¤ß¯k¡C¥u¯àµ¥±ÂÅvª÷¤F😳 |
|
|
·|û¡G¹j¾À¤p¤ý10151762 µoªí®É¶¡:2021/4/28 ¤U¤È 04:58:36²Ä 1072 ½g¦^À³
|
¹ï©ó¼Ï¯Ã¹êÅç¡A¤½¥qµ´¤f¤£´£®É¶¡¸ò¶i«×¡A§A«ç»ò¯à¹w´úÁÙ¦³2Ó¦h¤ë¡A©Î³\³s¶i¦æ³£¨S¦³¡A´N¬O®Ì¤@®Ì§ë¸ê¤H |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/28 ¤U¤È 03:47:21²Ä 1071 ½g¦^À³
|
¤¤¤Ñ¶°¹ÎºX¤UªºÆp¥Û¥Í§Þ«ù¦³ªYÄ£5,615±iªÑ²¼¡AªÑÅv¹O¤@¦¨. Æp¥Û¥Í§ÞÀ³¸Ó¤£¬O¶Ã§ë¸êªº§a ªYÄ£ªº8©M6¨t¦C¥Ø«e¼Æ¾Ú¬Ý°_¨Ó³£ÁÙ¤£¿ù°Ú |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/28 ¤U¤È 03:34:12²Ä 1070 ½g¦^À³
|
Ó¤H«D±M·~ªº»{¬° 810À³¸Ó·|µ¥¼Ï¯Ã¹êÅ秹¦¨¹ï¤è¤~·|½T©w±ÂÅv ²¦³º¬O²Ä¤@ÓµL¨x¬r¤î¯kÃÄ ¼Ï¯Ã¹êÅç¦Ü¤ÖÁÙ¦³2Ó¤ë¥H¤W§a ¦ý§Ú¬Û«H¦pªG¹êÅ秹«á±ÂÅv ±ÂÅvª÷´N¤£·|¤Ó§C¤F «ùÄò¤Û·Q°µ¹Ú¤¤ |
|
|
·|û¡G¹j¾À¤p¤ý10151762 µoªí®É¶¡:2021/4/28 ¤U¤È 03:17:37²Ä 1069 ½g¦^À³
|
·|¤£·|¬O¤@³õ¹CÀ¸¤@³õ¹Ú¡A©Î¬OµL¨¥ªºµ²§½ |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/28 ¤U¤È 01:51:35²Ä 1068 ½g¦^À³
|
¦¹ÀɶR½æ¾÷¨î¬O§_¦³¶Â½c§@·~? ªYÄ£§Oµ¹«¥Ì´I¥ÐÂà¹L¨Óªºº|®ð°Ú |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/28 ¤W¤È 06:39:01²Ä 1067 ½g¦^À³
|
¬Q¤é½L¤¤³Ð1¦~¨Ó·s°ª»ù¡A¤@¥¹µo¥¬¥Ó½Ð²Ä1±iNASHÃÄÃÒ....,À³¸Ó«Ü§Ö´N¬ð¯}¾ú¥v·s°ª280??? ¨ì时Ô¾ã个资¥»¥«场会¥Î«D±`¤£¦Pªº²´¥ú来¬Ý¾ã个领°ì¡C当§ó¦h资¥»¯F进来ªº时Ô¡A¨Æ±¡会变±o«D±`¦³·N«ä¡C ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/24 ¤W¤È 08:31:12²Ä 1060 ½g¦^À³ ¦³¶R¬üªÑªº¡A¥i¯d·N³o®aMadrigal¡A¦ü¥GÄøÄø±ý°Ê? ¦pªG [Madrigal]ªºPh3¤£n¥X¤j问题¡A§Ú们会¦b2023¦~¬Ý¨ì²Ä¤@个获§åªºNASH药ª«!!! .....¦pªG [Madrigal]ªºPh3¤£n¥X¤j问题¡A§Ú们会¦b2023¦~¬Ý¨ì²Ä¤@个获§åªºNASH药ª«¡A¨ì时Ô¾ã个资¥»¥«场会¥Î«D±`¤£¦Pªº²´¥ú来¬Ý¾ã个领°ì¡C当§ó¦h资¥»¯F进来ªº时Ô¡A¨Æ±¡会变±o«D±`¦³·N«ä¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/27 ¤W¤È 10:07:08²Ä 1066 ½g¦^À³
|
SNP-610/630»PSNP-810ªvÀø¸£Àù??? --------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/27 ¤W¤È 09:53:44²Ä 1065 ½g¦^À³ DGAT1¬O¤@个«D±`¦³§Æ±æªv疗恶©Ê胶质¥À细M½F(¤@ºØ³Ì±`¨£¤]¬O³Ì¨ã«Iŧ©Êªº¸£Àù)ªº·sªº药ª«¹v点¡C ------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/14 ¤W¤È 09:08:28²Ä 1026 ½g¦^À³ 2020.10.26¼³¼ö®§µh¹ï½¦½è¥À²ÓM½F²ÓM¼W´Þªº¼vÅT www.turkishneurosurgery.org.tr/pdf/pdf_JTN_2427.pdf µ²½×¡G§Ú̪º¬ã¨sµ²ªGªí©ú¼³¼ö®§µh¹ï½¦½è¥À²ÓM½F²ÓM¨ã¦³§Ü¸~½F§@¥Î¡A¨Ã¥B³oºØ¬¡©Ê¬O ¥Ñ¤£¦Pªº«H¸¹³q¸ô»¤¾É¡C...§Ú̵o²{¼³¼ö®§µh´î¤Öªº²ÓM¼W´Þ¨ú¨M©ó [¾¯¶q]©M[«ùÄò®É¶¡].... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/27 ¤W¤È 09:53:44²Ä 1065 ½g¦^À³
|
DGAT1¬O¤@个«D±`¦³§Æ±æªv疗恶©Ê胶质¥À细M½F(¤@ºØ³Ì±`¨£¤]¬O³Ì¨ã«Iŧ©Êªº¸£Àù)ªº·sªº药ª«¹v点¡C 2020.8.4 www.x-mol.com/news/457072 ªñ¤é¡A¬ü国«X¥è«X¦{¥ß¤j学肿½F¤¤¤ß³¢¼w¨}±Ð±Âªº¬ã¨s团队¡A¥Hµ{²»³Õ¤h©M¯Õ®p³Õ¤h为¦}¦C²Ä¤@§@ªÌ¦bCell Metabolism杂§Ó¤W发ªí题为¡§Targeting DGAT1 ameliorates glioblastoma by increasing fat catabolism and oxidative stress¡¨ªº¬ã¨s论¤å¡A该¬ã¨sº¦¸´¦¥Ü调节¯×ªÕ»Ä储¦s酶¡X¡X¤G酰°ò¥Ìªo-酰°ò转²¾酶¡]DGAT1¡^¡X¡X¬O¤HÊ^恶©Ê胶质¥À细M½F关键ªº¯×质¥¿Å调节¦]¤l¡A¦}´¦¥ÜDGAT1¬O¤@个«D±`¦³§Æ±æªv疗恶©Ê胶质¥À细M½Fªº·sªº药ª«¹v点¡C 该¬ã¨sº¦¸´¦¥Ü¤F¥Ìªo¤Tà©MDGAT1¦b胶质¥À细M½F¯f¤H组织标¥»¤¤°ªªí达¡A¥BDGAT1ªºªí达¶qÉO¯f¤Hªº¾ãÊ^¦s¬¡时间§e负¬Û关¡]图1¡^ |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/25 ¤W¤È 06:05:22²Ä 1064 ½g¦^À³
|
¤j¤á¼W¡A´²¤á´î¤Ö©úÅã¡A®×±¡¤£³æ¯Â¡H¦n®ø®§ªñ¤F¡H¤j¤áÀ£§C¦Y³f¡A´²¤á³QÀ~§Ö¶ô³³☺️ |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2021/4/24 ¤U¤È 10:21:39²Ä 1063 ½g¦^À³
|
¥»¶g400±i¤j¤á¼W1¤H¡A400~600±i¤]¼W1¤H¡A¤jªÑªF«ù¦³¼W¥[402±i¡C A-S Medication Solutions, LLM voluntarily recalled bottles of its Acetaminophen Extra Strength 500 mg tablet ªñ200,000Åø³Q¦¬¦^ www.foxbusiness.com/lifestyle/extra-strength-acetaminophen-recalled-nationwide |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/24 ¤U¤È 02:27:37²Ä 1062 ½g¦^À³
|
2020.05.13 »®»®¦³¦Wªº¬ü¤k¬ì¾Ç®a(¬ü°êÃÀ³N»P¬ì¾Ç°|¥~Äy°|¤h)¡AÃC¹ç½ÒÃD²Õ1Ó¤ë®É¶¡¤º4½g³»¥Z¡C picture.iczhiku.com/weixin/message1592580325817.html ´¦¥Ü¯×ªÕ¦X¦¨ÃöÁä酶DGAT1µ²ºc¤Î¶Ê¤Æ¾÷¨î ... DGAT1¦X¦¨¤T酰°ò¥Ìªoà¡A¬O¤HÃþ¶¼¹¯×ªÕ§l¦¬©M¯×ªÕ¦sÀx©Ò¥²»Ýªº¡C DGAT1Äݩ󽤵²¦XªºO-酰°òÂಾ酶¡]MBOAT¡^¶W®a±Ú¡A¨ä¦¨û¦s¦b©ó©Ò¦³¥Í©R¤ý°ê¤¤¡A¨Ã°Ñ»P¯×½è©M³J¥Õ½èªº酰¤Æ§@¥Î¡C©|¤£²M·¡¤HÃþDGAT1©MMBOAT®a±Úªº¨ä¥L¦¨û¦p¦óÃѧO¨ä©³ª«¨Ã¶Ê¤Æ¨ä¤ÏÀ³¡C¯Ê¥F¤Tºûµ²ºc¤]§«Ãª¤F¥X©óªvÀø¥Øªº¦X²z¹v¦VDGAT1¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/24 ¤W¤È 09:05:08²Ä 1061 ½g¦^À³
|
DGAT1§í»s¾¯ªº¼sªx¨Ï¥Î³Ì²×±N¨ú¨M©ó¦p¦ó§ïµ½ÃĪ«ªºGI(G¸z¹D)@¨ü©Ê¡C 2013/9/3 pubmed.ncbi.nlm.nih.gov/23919406/ ...»sÃĤ½¥q¤w¸g¶}µo¥X³\¦h·s«¬ªºDGAT1§í»s¾¯¡A¨ä¤¤¤@¨Ç¤w¸g¶i¤JÁ{§É¡CÆ[¹î¨ì¥ÎDGAT1§í»s¾¯ªvÀø¤HÅé«á¥Ìªo¤Tà´î¤Ö¡A±q¦ÓÃÒ©ú¤F¹v¼Ðªº°Ñ»P¡C¦ý¬O¡AÁÙ¦³G¸z¹D¤£¨}¨Æ¥ó¡A¨Ò¦päú¤ß¡A¸¡Âm©M¹Ã¦R..³o¨Ç¤£¨}¨Æ¥ó.... .....DGAT1§@¬°ªvÀø¹v¼Ðªº¼ç¤O±N»Ýn§JªAÆ[¹î¨ìªºÁ{§É¤£¨}¨Æ¥ó... ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/22 ¤U¤È 03:41:18²Ä 1053 ½g¦^À³ ³Ò¥hªÑªF·|ªÌ¸ß°Ý: SNP-610(CYP2E1 + DGAT1, ¥´2ÓÂI)NASHÁ{§É¤G´Á36¤H¦³¨S¦³G¸z°Æ§@¥Î??? ¦pªG¯à½T»{¸ó¹LG¸z°Æ§@¥ÎªùÂe»Ùê¡ASNP-610/ SNP-630¦¨¥\¾÷²v´N«Ü¤j¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/24 ¤W¤È 08:31:12²Ä 1060 ½g¦^À³
|
¦³¶R¬üªÑªº¡A¥i¯d·N³o®aMadrigal¡A¦ü¥GÄøÄø±ý°Ê? ¦pªG [Madrigal]ªºPh3¤£n¥X¤j问题¡A§Ú们会¦b2023¦~¬Ý¨ì²Ä¤@个获§åªºNASH药ª«!!! --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/21 ¤U¤È 12:54:38²Ä 807 ½g¦^À³ ¦b³Ì¦³¾÷·|¹Ü±o²Ä1¤äNASH¤W¥«ÃÄÃÒªºOcaliva¡]Intercept¡^¦]¬°[¨x¬r©Ê]°Æ§@¥Î³Q§_¨M«á¡A ±µ¤U¨Ó·~¬É»{¬°²Ä1¤äNASH¤W¥«ÃĪ«·|¬OMadrigal¤½¥qªºMGL3196¡]Resmetirom¡^¡H ¦³«GÂIªº¬OªYÄ£ªºªk»¡·|¸ê®Æ¡]²Ä19〜22¶¡^¡GSNP-610ªºP2ªì¨B¼Æ¾ÚÀu©óMGL3196¡]Resmetirom¡^¡A·íµM¦¨©Î±Ñ±o¬ÝP3³Ì²×µ²ªG¡C -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151µoªí®É¶¡¡G2020/7/3¤W¤È08:05:38²Ä35½g¦^Î` 108/07/24 Bio-Asia¨È¬w¥Í§Þ¤j®iÁ|¿ì¤§¤½¥q®i±æ»¡©ú·| mops.twse.com.tw/nas/STR/663420190724M001.pdf Phase II study: - The decreases in several clinical parameters from baseline to the end of treatment were greater in SNP-610-12-week treatment than Ocaliva, Cenicriviroc, Elafibranor, MGL3196 or Selonsertib treatment in literature, especially in ALT. --------------------------------------------------------------------------------------- 2021.2.3 FDA开讲®y«ü点NASH·s药¬ã发 mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&mid=2247597425&idx=5&sn=5603a91a3d5e1887bf2a13fdd349484d&chksm=ecb2c597dbc54c813151617dccf12977839e42fd2f0716ebdc70ba293bbf63b233b21e5a922f&scene=21#wechat_redirect ..2022¦~¦ô计会¬ONASH领°ì°_飞ªº¤@¦~¡A¦pªG [Madrigal]ªºPh3¤£n¥X¤j问题¡A§Ú们会¦b2023¦~¬Ý¨ì²Ä¤@个获§åªºNASH药ª«¡A¨ì时Ô¾ã个资¥»¥«场会¥Î«D±`¤£¦Pªº²´¥ú来¬Ý¾ã个领°ì¡C当§ó¦h资¥»¯F进来ªº时Ô¡A¨Æ±¡会变±o«D±`¦³·N«ä¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/23 ¤U¤È 08:50:23²Ä 1059 ½g¦^À³
|
®ÄªG¤ñ¸û¦n¬Oª½·o®Ö¤ßªºÃö«Y? SNP-610©ó¤HÅé¤G´ÁÁ{§É¸ÕÅçÃÒ©ú¦w¥þ¦³®Ä¡A¥BÀu©ó°ê»Ú²{¦æ¥|®a¥ýµoªºNASHÃĪ«¡C SNP-610Á{§É¦³¨º¨Ç°Æ§@¥Î??? --------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/21 ¤U¤È 04:22:05²Ä 811 ½g¦^À³ SNP-6:P2¼Æ¾ÚÀu©ó¹w´Á·|¦b2020®Öã¤W¥«ªº Ocaliva¡]µ²§½¬O³QFDA§_¨M)! ¥çÀu©ó±µ¤U¨Ó·~¬É»{¬°2023¦~²Ä1¤ä¤W¥«ªºNASHÃĪ«: MGL3196¡]Resmetirom¡^? .... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/23 ¤U¤È 08:40:48²Ä 1058 ½g¦^À³
|
±q¾Ç²z¬ã¨sª½·oµo¯f¾÷¨îªº®Ö¤ß·|¦³®Ä¡A¥u¬O²³¦hÃļtªºDGAT1ÃĪ«¹L¤£¤FG¸z°Æ§@¥ÎÃö¥d¡C SNP-610ªºÁ{§É¤G´Á¦¬®×36¤H¦³¨º¨Ç°Æ§@¥Î??? ---------------------------------------------------------------------------------------- 1. 2010.2.18 www.ahajournals.org/doi/full/10.1161/atvbaha.109.201426 ¬ã¨s½T©w¤FDGAT1¬O¤@ºØ«n³J¥Õ¡A°Ñ»P¤FHNF4A¹ïTRLs¨x¤Àªcªº¼vÅT¡C 2. 2015.6.23 Nature½×¤å www.nature.com/articles/ncomms8466 «D°sºë©Ê¯×ªÕ©Ê¨x¯f¡]NAFLD¡^¬O³Ì±`¨£ªº¨x¯f¤§¤@¡A¦ý¨ä¼ç¦b¾÷¨î©|¤£²M·¡¡C¦b³o¸Ì¡A§ÚÌÅã¥Ü¨x²ÓM®Ö¦]¤l4£\¡]HNF4£\¡^...¹v¦V¸Ó³~®|¥i¯à¥Nªí¤F¤@ºØªvÀøNAFLDªº·s¤èªk¡C 3. 2017.12.7 : pubmed.ncbi.nlm.nih.gov/29216278/ ¤ÀªR½T©wHNF4A¬O«D°sºë©Ê¯×ªÕ©Ê¨xª¢µo¯f¾÷²zªº¤¤¤ß°ò¦] ¦]¦¹¡A§Ú̺¦¸¤F¸Ñ¨ì¡AHNF4A¬ONASHµo¯f¾÷¨îªº®Ö¤ß¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/23 ¤U¤È 08:08:02²Ä 1057 ½g¦^À³
|
±µ³s¼Æ®aÃļtªºDGAT1ÃĪ«Á{§É³£¥X²{ÄY«¤£¤@ªºG¸z°Æ§@¥Î¡A©ó¬O»{¬°DGAT1¹vÂIµLªk¦¨ÃÄ¡A¯É¯ÉÂ੹¨ä¥L³~®|.... ©Ò¥HY¯à½T»{SNP-610(CYP2E1 + DGAT1, ¥´2ÓÂI)¸ó¹LG¸z°Æ§@¥ÎªùÂe»Ùê¡ASNP-610/ SNP-630¦¨¥\¾÷²v´N«Ü¤j¡C ªü´µ§Q±dAZD7687(DGAT1ÃĪ«)§ïÅܤF¸z¹D¤¤ªº¯×½è³B²z©M¿E¯À¤Àªc¡A¦ý²£¥Í¤FµLªk§Ô¨üªº°Æ§@¥Î! pubmed.ncbi.nlm.nih.gov/24118885/ µ²½×¡G¦b¥ÎDGAT1§í»s¾¯AZD7687ªvÀø1¶g´Á¶¡...¡A¥Ñ©óAZD7687¤×¨ä¬O¸¡ÂmªºG¸z¹D°Æ§@¥Î...³o¨Ï±oDGAT1§í»s§@¬°¿}§¿¯f©MªÎD¯gªº·s«¬ªvÀø¤èªkªº¹ê¥Î©ÊȱoÃhºÃ¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/22 ¤U¤È 03:41:18²Ä 1053 ½g¦^À³ ³Ò¥hªÑªF·|ªÌ¸ß°Ý: SNP-610(CYP2E1 + DGAT1, ¥´2ÓÂI)NASHÁ{§É¤G´Á36¤H¦³¨S¦³G¸z°Æ§@¥Î??? ¦pªG¯à½T»{¸ó¹LG¸z°Æ§@¥ÎªùÂe»Ùê¡ASNP-610/ SNP-630¦¨¥\¾÷²v´N«Ü¤j¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/23 ¤U¤È 07:57:26²Ä 1056 ½g¦^À³
|
GSK¨Ã¨S¦³©ñ±óDGAT1!(´X®a¤j¼tªºÁ{§É©ú½T¦³Àø®Ä¡A¤]³£¥X²{»P¾¯¶q©úÅã¬ÛÃöªºG¸z°Æ§@¥Î) ©³¤U¬OGSK·s¶}µoªº·s«¬DGAT1ÃĪ«GSK2973980A¡A¨ã¦³§ó¦nªºG¸z@¨ü©Ê! [with potentially better GI tolerability] 2017.9.19: file:///C:/Users/USER/Downloads/19787-Article%20Text-36724-1-10-20181214.pdf Conclusion: Our data suggest that the impaired TG clearance model in the rat can be used to identify DGAT1 inhibitors with potentially better GI tolerability. ------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/22 ¤U¤È 03:41:18²Ä 1053 ½g¦^À³ .... GSKªºGSK3008356(DGAT1§í¨î¾¯,¥´1ÓÂI)¡A¦bNASHÁ{§É¤]¬OG¸z°Æ§@¥Î(©Ô¨{¤l)¡A½æµ¹¤p¼tªvÀøÚµ½HÁ{§É¡C |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/22 ¤U¤È 04:35:57²Ä 1055 ½g¦^À³
|
¤Sn¤W¨Óµoµo¨cÄÌ ³o»ò¦nªºªÑ²¼¤]³Q¤j½L±a°I ¯uªºµL©` ü Á«·l«ùÄòÂX¤j §Æ±æªYÄ£¤]¯à©ñ¥X¤@¨Ç810©Î610¶i®iªº¥¿¦V°T®§ ¨ë¿E¤@¤UªÑ»ù §ë¸ê¤H·Qªø©ê ¤]¤~¯à©ê±o¦w¤ß |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/22 ¤U¤È 04:02:21²Ä 1054 ½g¦^À³
|
DGAT1¤]´¿¬OªvÀøNASHªº¼öªù¹vÂI¡A¦ý¬O´X®a¤jÃļtªºÁ{§É±µ³s±Ñ¦bG¸z°Æ§@¥Î¡ADGAT1¤]³Q»{¬°¤£¯à¦¨ÃÄ¡A ©Ò¥H·Q½T»{SNP-610¬O§_¸ó¹LG¸z°Æ§@¥ÎªùÂe»Ùê??? ¦w¶iSotorasib¬D¾Ô³ÌÃøÀù°ò¦]KRAS ¡A²×©ó¬ð¯}KRAS¤£¯à¦¨ÃĪºÅ]©G! 2021.1.31·¥´¶¹MªºPÀù°ò¦] KRAS ¬ðÅÜ¡A²×©ó¦³¼Ð¹vÃĪ«¥i¹ï¥I technews.tw/2021/01/31/kras-mutation-of-the-oncogene-breakthrough-treatment-of-targeted-drugs/ ....30 ¦h¦~¨Ó¡A¬ì¾Ç®a¤@ª½¸Õ¹Ï°w¹ï KRAS ¬ðÅܬãµo§ÜÀùÃĪ«¡A¹Lµ{¤¤¸g¾úµL¼Æ¥¢±Ñ»P®À§é¡A¤@«×»{¬°¬OµLÃÄ¥iªvªºPÀù°ò¦]¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/22 ¤U¤È 03:41:18²Ä 1053 ½g¦^À³
|
³Ò¥hªÑªF·|ªÌ¸ß°Ý: SNP-610(CYP2E1 + DGAT1, ¥´2ÓÂI)NASHÁ{§É¤G´Á36¤H¦³¨S¦³G¸z°Æ§@¥Î??? ¦pªG¯à½T»{¸ó¹LG¸z°Æ§@¥ÎªùÂe»Ùê¡ASNP-610/ SNP-630¦¨¥\¾÷²v´N«Ü¤j¡C ¦]¬°诺华ªºpradigastat(DGAT1§í¨î剂, ¥´1ÓÂI)¦bNASHÁ{§É¦³G¸z°Æ§@¥Î(©Ô¨{¤l)¡A ©Ò¥H½æµ¹¤p¼t§ï§@¥\¯à©Ê«K¯µÁ{§É¡C GSKªºGSK3008356(DGAT1§í¨î¾¯,¥´1ÓÂI)¡A¦bNASHÁ{§É¤]¬OG¸z°Æ§@¥Î(©Ô¨{¤l)¡A½æµ¹¤p¼tªvÀøÚµ½HÁ{§É¡C 2020.09.15 药«~¦W称¡GPradigastat ¤ù ¥ø业¦W称¡G¦w济药业¡]¤W®ü¡^¦³¤½¥q ¥»«~¬O¤G酰°ò¥Ìªo酰°ò转²¾酶¡]DGAT1¡^ªº¤p¤À¤l§í¨î剂¡A¦¹«e¤w¦b¥N谢¯e¯f¤W开®i¤F临§É III ´Á试验¡C2019 ¦~ªì¡A¦w济药业¥¿¦¡从诺华获±o¤F pradigastat ªº±Â权¡A¥»¦¸获§åªºÓì应¯g为¥\¯à©Ê«K¯µ¡C --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/20 ¤W¤È 05:37:39²Ä 526 ½g¦^À³ SNP-610(CYP2E1 + DGAT1, ¥´2ÓÂI)¦b¤@´Á»P¤G´ÁÁ{§É¹êÅçÀ³¸Ó¬O¸ó¹LG¸z°Æ§@¥ÎªùÂe»Ùê¡A¦¨¥\¸ô¤W¦AÁÚªñ¤@¨B! (GSK / ¿ÕµØ/ªü´µ§Q±d/½÷·çªºDGAT1ÃĪ«¤À§O±¾¦bP1»PP2) |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/22 ¤U¤È 02:00:30²Ä 1052 ½g¦^À³
|
³o»ò¦n¡A±þ§Cµ¹§O¤H¾ß«K©y¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/4/22 ¤U¤È 01:00:05²Ä 1051 ½g¦^À³
|
±qªYÄ£®³¨ì¬ü°êÃÄÃÒ´N¯à¦³°ò¥»½L10¢w60¤¸Àò§Q¡F¦¶¸³¿W¨¤Ã~¥ø¹Ï¤ß¡F¨ì¹Ú¤Ûªº¦Ü´LªÑ¤ý´Á«Ý¡A¥H¤Î³Ìªñ¼W¥[ªºªÍÀù¦ÑÃÄ·s¥Î¬ã¨s¥i¯à©Ê¡m´I¯Î´²¨B½ð¨ì¶Àª÷¶ô¡n¡C¦b¦bÅã¥Ü«D±`¼ÖÆ[ªº¥¼¨Ó¡In§ë¸ê´N¶X²{¦b¡Aµ¥ªÑ»ù¤W¥h´N¤£´±°l¤F¡C |
|
|
·|û¡G¤p¤å¤l10144877 µoªí®É¶¡:2021/4/21 ¤U¤È 07:51:40²Ä 1050 ½g¦^À³
|
¥Ø«e§Ú¦b³oª©±¤]¶È¥u¦b§ó·s¤½¥q³Ì·s®ø®§,¨Ã¥¼±ÀÂ˶R¶i.....¤§«e´N»¡¹L¦]¥»¨¯e¯f¤~Ãöª`ªYÄ£,¥B¤Ö¶q¶R¶i¥u¬O¥»¤H¹ï¤½¥qªº´Á³\¦Ó¤w.....§Æ±æ¤j®a¯uªº§O¤Ó¹L«×´Á«Ý¥LªÑ»ù¤Wªºªí²{,²LÀ|§Y¥i,¤d¸U§O«©ã.... |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/4/21 ¤U¤È 06:08:50²Ä 1049 ½g¦^À³
|
·|¦^µª¦¦^µª¤F¡A¤£·|¥Î½pÀq´Á¨Ó¾×°Õ ©ú¤Ñ´N¬O¦X§@«°Tµoªí¥|Ó¤ë¤F,ÁÙ¨S°ÊÀR? ªÑ³£·|¦pªG¤S¹J¨ì²{¼W½pÀq´Á,¬O§_¸³¨Æªø¥i¥H¤@·§¤£¦^µªªÑªFµo°Ý~!!?? |
|
|
·|û¡G¤p¤å¤l10144877 µoªí®É¶¡:2021/4/20 ¤U¤È 07:47:43²Ä 1048 ½g¦^À³
|
¥»¸ê®Æ¥Ñ¡@ (¿³Âd¤½¥q) 6634 ªYÄ£¡@¤½¥q´£¨Ñ §Ç¸¹ 2 µo¨¥¤é´Á 110/04/20 µo¨¥®É¶¡ 18:54:54 µo¨¥¤H ¦¶³Í¥Á µo¨¥¤H¾ºÙ ¸³¨ÆªøÝÁ`¸g²z µo¨¥¤H¹q¸Ü 02-27885365 ¥D¦® ¥»¤½¥q¯×ªÕ¨xª¢·sÃÄSNP-630¨ú±o¿D¬w±M§Q ²Å¦X±ø´Ú ²Ä 44 ´Ú ¨Æ¹êµo¥Í¤é 110/04/20 »¡©ú 1.¨Æ¹êµo¥Í¤é:110/04/20 2.¤½¥q¦WºÙ:ªYÄ£¥ÍÂåªÑ¥÷¦³¤½¥q 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q¡C 4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î¡C 5.µo¥Í½t¥Ñ: ¥»¤½¥q±µÀò©e¥ô±M§Q¨Æ°È©Ò³qª¾¡A¥»¤½¥q¯×ªÕ¨xª¢·sÃÄSNP-630¨ú±o¿D¬w±M§Q¡A ±M§Q¦WºÙ: ¡u¦³®Ä©óªvÀø¨x¬r©Ê¤Î¯×ªÕ¨x¯e¯fªº¤Æ¦Xª«¤Î¨ä¥Î³~(Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof)¡v¡C 6.¦]À³±¹¬I:¤£¾A¥Î¡C 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ: ¤@.¥»¤½¥q¯×ªÕ¨xª¢·sÃÄSNP-630¥ý«e¤wÀò±o¬ü°ê¤Î«n«D±M§Q¡A¤µ¤SÀò±o¿D¬w±M§Q¡A ¥ç¤w»¼¥æ¤¤°ê¡B¼Ú·ù(38Ó·|û°ê)¡B¤é¥»¡B¼Ú¨È±M§QÁp·ùµ¥¥@¬É¦U¦a±M§Q¥Ó½Ð®× ¥ç¬Ò¿n·¥¼f¬d¤¤¡C ¤G.¥»±M§Q¦³®Ä´Á³Ì¦h¥i¦Ü¤½¤¸2041¦~¡C ¤T.¥»¤½¥qªø´Á±Mª`©ó¯×ªÕ¨xª¢ªvÀø»â°ì¡ASNP-630¤wÀò¥xÆWFDA®Öã³q¹L¶i¦æÁ{§É ¤@´Á¸ÕÅç¡CSNP-630ªº¦³®Ä¥NÁª«¥ç¤w§¹¦¨²Ä¤G´ÁÁ{§É¸ÕÅç°ª¡B§C¤G¾¯¶q²Õ¦@ 36¦W ¨ü¸ÕªÌ¡A´Á¤¤¤ÀªRµ²ªGÅã¥Ü¦bÁ{§ÉÀø®Ä«ü¼Ð»P¥¼ªAÃÄ«e¤ñ¸û¡A§e²{·¥ÅãµÛªvÀø®ÄªG¡A ¦¨¥\¹F¦¨¦b¯×ªÕ¨xª¢ªvÀø¤Wªº¥Ø¼Ð¡CSNP-630¬°Àu¤Æ·s¤Æ¾Ç¹êÅé¯×ªÕ¨x·sÃÄ¡A°£¥»¨ ÃIJz¬¡©Ê§ó±j¥~¡A¥t¦³¥|Ó¥H¤W¬¡©Ê¥NÁª«¡A¤w¦bÅ餺¸ÕÅç¤WÃÒ¹ê¥iªvÀø¯×ªÕ¨xª¢¥B ¨ã°ª«×¦w¥þ©Ê¡A¥iª½±µ§@¥Î©ó¨xŦ¡A°§C¨x¯×¨Ã§ïµ½¯×ªÕ¨xµoª¢¡C ¥|.¥Ø«e¡u«D°sºë©Ê¯×ªÕ¨xª¢¡v©|µL¼Ð·ÇªvÀøÃĪ«¡A¼ç¦b°Ó¾÷Ãe¤j¡A¥þ²y©Ò¦³«n¤j Ãļt§¡¤w¿n·¥§ë¤J¬ãµo·sÃÄ¡A¦Ó¥Ø«e¶È¦³Ó¦ì¼Æ«~¶µ¶i¤JÁ{§É¼Ï¯Ã¸ÕÅç¡C®Ú¾Ú GlobalData 2017¦~5¤ëªº³ø§i¹w´ú¡A¥]¬A¬ü°ê¡A¼Ú·ù¤¤j°ê®a¡]ªk°ê¡A¼w°ê¡A¸q¤j§Q ¡A¦è¯Z¤ú©M^°ê¡^©M¤é¥»ªºNASH¥«³õ¡A¦b¥¼¨Ó¤Q¦~ªº½Æ¦X¦~¼Wªø²v¹F45¢H¡C¥t®Ú¾Ú ¼w·N§Ó»È¦æ¤ÎEvaluate Pharmaªº¹w´ú¡A¥þ²yNASHÃĪ«ªº¥«³õ³W¼Ò¦b2025¦~¤W¬Ý350»õ ~400»õ¬ü¤¸¡C¥Ø«e¥»¤½¥q¥¿¿n·¥´M¨D»P°ê¥~¦h®a¥Dn¤j¼t¦@¦P¦X§@©Î±ÂÅvµ¥¨Æ©y¡C ¤.·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¨Ã¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê±Á{·ÀI¡A §ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/4/20 ¤W¤È 11:19:32²Ä 1047 ½g¦^À³
|
©ú¤Ñ´N¬O¦X§@«°Tµoªí¥|Ó¤ë¤F,ÁÙ¨S°ÊÀR? ªÑ³£·|¦pªG¤S¹J¨ì²{¼W½pÀq´Á,¬O§_¸³¨Æªø¥i¥H¤@·§¤£¦^µªªÑªFµo°Ý~!!?? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/19 ¤U¤È 02:43:43²Ä 1046 ½g¦^À³
|
25ºØ³Ì¦MÀIªºÃĪ«(¥i¯à»P±z·Q¹³ªº¤£¤@¼Ë) ³Ì¦MÀIªºÃĪ«¤£¬Oªü¤ùÃþÃĪ« ²Ä1¦W³Ì¦MÀIªºÃĪ«¬O¹ï¤A酰®ò°ò×ô ²Ä25¦W¬O·Ï¯ó ÃĪ«¹L¶q¬O¬ü°ê·N¥~¦º¤`ªº¥Dnì¦]¡C¹ê»Ú¤W¡A¨C¦~¦º©óÃĪ«¹L¶qªº¬ü°ê¤H¤ñ¨C¦~¦]¨®º×¦Ó¦ºªº¬ü°ê¤HÁÙ¦h¡CŲ©ó³o¨ÇÅå¤Hªº²Îp¼Æ¾Ú¡AµØº¸µó24/7¸¹¤½¥q ³Ìªñ¶i¦æ¤F¤@¶µ·s¬ã¨s¡A¸Ó¬ã¨s¹ï25ºØ³Ì¦MÀIªºÃĪ«©MÃĪ«²V¦Xª«¶i¦æ¤F¤ÀÃþ¡C¬ã¨s¤Hû¦Ò¼{¤FÁp¨¹¬F©²¸ò踪ªº°Æ§@¥Î©M¦º¤`²v¡A¥H¤Î¥ÑÂåÀø«H®§²Õ´©Mºôµ¸¸ê·½¡]¨Ò¦pMedScape¡AWebMD©M¬ü°êÂå¾Ç·|¡^´ú¶qªºÃĪ«²Õ¦Xªº¼ç¦b·ÀI.... www.usatoday.com/story/news/health/2019/07/31/opioid-epidemic-25-most-dangerous-drugs-side-effects-death-rates/39807161/ ....¨Ò¦p¡A»P¥ô¦ó¨ä¥L¬r«~¬Û¤ñ¡A°sºë©M·Ï¯ó¾ÉPªº¦º¤`¤H¼Æn¦h±o¦h¡C°sºë»P¨C¦~¬ù88,000¤Hªº¦º¤`¦³Ãö¡A¦Ó§l·Ï»P¦h¹F540,000¤Hªº¦º¤`¦³Ãö¡C2016¦~°O¿ý¤F64,000¨ÒÃĪ«¹L¶q¦º¤`¡C¦ý¬O¡A¥Ñ©óµÒ°sªº¨Ï¥Î²v¤ñªü¤ùÃþÃĪ«°ª±o¦h¡A¦]¦¹¨C¦ì¨Ï¥ÎªÌªº¦º¤`²v±NÅã¥Ü¥X¤£¦Pªº¤ñ¸û¡C |
|
|
·|û¡G¥[¯Z¤H¥Í10148422 µoªí®É¶¡:2021/4/19 ¤W¤È 09:05:41²Ä 1045 ½g¦^À³
|
·PÁÂR¤j¤½¥¿¡A¤£¦n·N«ä¡A¤p§Ì»~¸Ñ¤F¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/19 ¤W¤È 08:39:53²Ä 1044 ½g¦^À³
|
20g»¡ªº¬O---¥ÌÅS¾J¡A¬ü°êFDA«Øij¥Î¶q¬°¨C¤é¹¥Î¤£¶W¹L20g¡C ¤£¬OSNP-810ªº¤é¦w¥þ¾¯¶q¡C ----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/5 ¤W¤È 06:11:44²Ä 462 ½g¦^À³ ........................................... SNP-810ªº¯S©w¡u¤½»{¦w¥þ¡v¤§¦¨¤À:¥ÌÅS¾J+¤T´â½©¿} SNP-8 ¨t¦C¦¨¤À: ¦Û¼Æ¦ÊºØ [¬ü°êFDA®Öã]¡B[±`¥Î¥B¦w¥þ]¡B[«K©yt¾á±o°_]¡B[¤HÅé¥i¹¥Î¦w¥þ¤Æ¦Xª«]... ¨ä¤@¤é¦w¥þ¨Ï¥Î¾¯¶q¥i¹F 20 g/person ¥H¤W¡A¥B¦b 200mg/person¾¯¶q¤U§Y¥i§í¨î²v¹F 60-88%¡C ............................................................................................... ¥ÌÅS¾J¡A¬ü°êFDA«Øij¥Î¶q¬°¨C¤é¹¥Î¤£¶W¹L20g¡C ¤T´â½©¿}¤f·P¤W»P½©¿}¤ñ¸û±µªñ¡A¦]¦¹¬O³Ì±`¥Îªº²¢¨ý´À¥N«~¡A¥Ø«e¼sªx¹B¥Î©ó¶¼®Æ¡B¿}¼ß¡B¨Å»s«~¡BªGÂæ¡B»eÀ^µ¥¥[¤u¹ª«¤§¤¤¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/19 ¤W¤È 08:31:20²Ä 1043 ½g¦^À³
|
¡§¨ä¤@¤é¦w¥þ¨Ï¥Î¾¯¶q¥i¹F 20 g/person¥H¤W¡A¡¨ ¨º¬q±Ôz¤£¬O«üFB-810ªº¤é¦w¥þ¨Ï¥Î¾¯¶q¡A¦Ó¬OFB-810¤º§tªº¦w¥þ¦¨¤Àªº¤é¦w¥þ¨Ï¥Î¾¯¶q¡C |
|
|
·|û¡G¥[¯Z¤H¥Í10148422 µoªí®É¶¡:2021/4/18 ¤U¤È 11:30:07²Ä 1042 ½g¦^À³
|
¬Ý¤½¥qªº¦~³ø¡A¸Ì±¦³¬q´yz¡C ¡§¨ä¤@¤é¦w¥þ¨Ï¥Î¾¯¶q¥i¹F 20 g/person¥H¤W¡A¡¨ ¬Ý°_¨Ó¦³¾÷·|¡A¦ý¥i¯à¨S¸ÕÅ緥ȡC ©Î³\ÁÙ»Ýn·f°t¼È½w¥B°±¤î¶}µoªº820¸Ñ¬r¾¯¡C¤~¦³¾÷·|¨C¤Ñ40g¥H¤W¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/4/18 ¤U¤È 01:39:06²Ä 1041 ½g¦^À³
|
²{¦b¤½¥q§â810¥Î¦bÀù¯gÃĬã¨s¬O«Ü¥i¦æªº¡Ff¥_·¥¬PÀùÃÄ¥un¯à©µªø±wªÌ¥Í©R¡A´N¬O¦¨¥\¤F¡C©Ò¥H·PÁ¦h¦h¤j¯à¶Ç¹F³o¸ê°Tµ¹¤½¥q¡AY¯à±Nr¤j¶K¤å®Ñ±¸ê®Æ¤@±i§ó¦³¨Ì¾Ú¡A·PÁ¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/16 ¤U¤È 04:04:20²Ä 1040 ½g¦^À³
|
An additional barrier to advancement of earlier clinical trials was the impracticality of administering 20 g/m2 of AAP orally (about 40 grams, or 80 extra strength acetaminophen tablets) ------------------------------------------------------------------------------------------------ ´N¬O¤j¾¯¶q40g¡A©Ò¥H±o¨Ï¥Î¸Ñ¬r¾¯¡A¦ý¥Î¤F¸Ñ¬r¾¯¤S·|°§CAAPªº§Ü¸~½F§@¥Î¡C «¥¤~±ÀÂ˪YÄ£¥i¥Hµû¦ôµL¨x¬rSNP-810°Ñ»P¤Uz¹Î¶¤ªºÁ{§É¬ã¨s¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/16 ¤U¤È 03:54:40²Ä 1039 ½g¦^À³
|
¬y·P¬Ì]¨C¦Ê¸U¾¯·|¥X²{ 1.3 ¨u¨£ªº¹L±Ó¤ÏÀ³ VS Pfizer·s«a¬Ì]¨C¦Ê¸U¾¯·|¥X²{ 29 ¨u¨£ªº¹L±Ó¤ÏÀ³ ¨Ò¦p¥Ø«e Pfizer-BioNTech ¬Ì] ¥´¤F¤d¦Ê¸U¾¯¡Aµo²{¬ù29¦ì¦³¨u¨£ªº¹L±Ó¤ÏÀ³¡A¬ù¬O¥´¤F¨C¦Ê¸U¾¯¡A¤~·|¥X²{ 11.1 ¦¸¹L±Ó¤ÏÀ³¡F³oÓ©M¬y·P¬Ì]¤ñ¸û¡A¥´¤F¨C¦Ê¸U¾¯¡A´N·|¥X²{ 1.3 ¨u¨£ªº¹L±Ó¤ÏÀ³¬O°ª¤F¤@¨Ç¡A¦ý¥Ø«e¥¼¦³¤H¦]¦¹Ãҹꦺ¤` ( No deaths were reported. )©M¬Ì]¦³Ãö¡A¥B¥i¥HÃĪ«±±¨î¡C ------------------------------------------------------------------------------------------- ¬ü°ê¬ù25%¤H¤f(8¤d¸U¤H)¨C¶g³£·|ªA¥Î¤AñQÓi×ô¡AÁ`·|¦³¨Ç¯S²§Åé½èªº¤H¡A¤£¥i¯à100%¦³®Ä¡C ³Ì¤j¾¯¶q¥Ñ¤½¥q¤½¥¬¾A©y¡C |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/4/16 ¤U¤È 03:29:36²Ä 1038 ½g¦^À³
|
½Ð±ÐR¤j,¨Ì±z¹ï¤§«e810¸ÕÅç¼Æ¾Ú ¬O§_µL¨x¬r¬O¨S©w¨Ï¥Î¦h¤Ö¾¯¶q,©M¹ï¨CÓ¤H³£¦³®Ä? «e¤@½g±z©Ò´£¤Î: ¦pªG¨S¦³¨Ï¥ÎNAC¸Ñ¬r¾¯¡A´N¤£¯à¨Ï¥ÎÁ{§É¸ÕÅ礤¨Ï¥ÎªºAAP¾¯¶q(40g) 40gªº¶qÀ³¸Ó¤w¸g«Ü¤j,810³o»ò¤j¶q¤]¥i¥HµL¨x¬r©Ê? ¨ì®ÉÔ¦p¤½¥qÁÙ¨S±ÂÅv´N·|¥h°Ñ¥[ªÑªF·|, §Ú¤]¦³¤@°ïºÃ°Ýn°Ý,¤]·|§â±z·Qª¾¹Dªº°ÝÃD°Ý¤@¤U¤½¥q~ |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/16 ¤U¤È 01:27:01²Ä 1037 ½g¦^À³
|
¯u¤ßı±o²{¦b¶RÓ´X±i¨Ó¦sªÑ¤£¿ù¡A¨S¤l¼u¥u¯à¶RÓ¹sªÑÃÙ§U¤@¤U¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/16 ¤W¤È 07:00:38²Ä 1036 ½g¦^À³
|
ªYÄ£¥i¥Hµû¦ôµL¨x¬rSNP-810°Ñ»P¤Uz¹Î¶¤ªºÁ{§É¬ã¨s¡C ¦]¬°¸ê®Æ´£¤Î...nª`·Nªº¬O¡A¦pªG¨S¦³¨Ï¥ÎNAC¸Ñ¬r¾¯¡A´N¤£¯à¨Ï¥ÎÁ{§É¸ÕÅ礤¨Ï¥ÎªºAAP¾¯¶q(40g)¡C [¤]¦]¦¹¼~¤ßNAC¸Ñ¬r¾¯ªº¨Ï¥Î·|°§CAAPªº§Ü¸~½F§@¥Î¡C] ----------------------------------------------------------------------------------------------- ³o²Õ¹Î¶¤13¦~ªº§V¤O¦¨ªG¤w§ÞÂàFennec Pharmaceuticals ( fennecpharma.com/pipeline/) 1.2009¦~10¤ë: §Q¥Î¹ï¤A酰®ò°ò×ôªº[¬r©Ê¾÷¨î¼W±j]¶¶¹`¦b¨xÀù©M¨x¥À²ÓM½F²ÓM¨t¤¤ªº¥\®Ä pubmed.ncbi.nlm.nih.gov/19794959/ µ²½×¡G§Ú̪ºµ²ªGªí©ú¡A¦P®É¨Ï¥ÎAAP©MCDDP¨Ã©µ¿ðNAC·m±Ïªº¤ÆÀø¤è®×¦³¥i¯à¼W±j¤ÆÀøÀø®Ä¡A¦P®É´î¤Ö¤£¨}¤ÏÀ³¡C µL½×²ÓMCYP2E1³J¥Õ¤ô¥¦p¦ó¡A³o¹ï©ó¨x¥À²ÓM½F³£¬O¤@ºØ¦³«e³~ªº¤èªk¡A¦ý¦b¨ä¥L´c©Ê¸~½F¤¤¤]¥i¯à¬O¦³¯qªº¡C 2.2014¦~ Á{§É«e¤j¾¯¶q¹ï¤A酰®ò°ò×ô»PN-¤A酰¥b¯Ö®ò»Ä·m±Ï´£°ª¤F¶¶¹`¤Æ¾ÇÀøªk¦b«D¨å«¬Teratoid¾î¯¾¦Ù½F¤¤ªºÀø®Ä¡C file:///C:/Users/USER/Downloads/preclinical-high-dose-acetaminophen-with-n-acetylcysteine-rescue-enhances-the-efficacy-of-cisplatin-chemotherapy-in-atypical-teratoid-rhabdoid-tumors.pdf µ²½×¡G§Ú̪ºµ²ªGªí©ú¡AAAP¥i¥H¥Î§@¼W±j¤Æ¾ÇÀøªkªºÃĪ«¡A¥H¼W±j¶¶¹`@ÃÄ©Ê¡A¯S§O¬O¦bÁ{§ÉÀô¹Ò¤¤¨ã¦³°ªGSH¤ô¥ªº¶¶¹`@ÃÄAT-RT¸~½F¤¤¡C 3. 2021¦~3¤ë www.sciencedirect.com/science/article/pii/S1476558621000075 ¤@¦W¨x¥À²ÓM½F±wªÌ¹ï©ó©Ò¦³¼Ð·ÇªvÀø§¡µL®Ä¡AµM«á¥ÎAAP 30 g / m 2¥[¶¶¹`ªvÀø. |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/15 ¤U¤È 12:30:41²Ä 1035 ½g¦^À³
|
·|¥hªÑªF·|ªºªÑªF¡A³Ò±´°Ý©³¤U¡AÁÂÁÂ~ 1.¸£Àù 2.¨x¥À²ÓM½F(©t¨à¤¤ªº©t¨à¡A±wªÌ«D±`¤Ö) ----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/15 ¤U¤È 12:09:01²Ä 1033 ½g¦^À³ ų©ó¤U¦Cªº¬ã¨sµ²ªGªí©ú:¼³¼ö®§µh¹ï½¦½è¥À²ÓM½F²ÓM¨ã¦³§Ü¸~½F§@¥Î!!! ªÑªF·|®É«ØijªYÄ£µû¦ôSNP-810¦b¸£Àùªº¾A¥Î©Ê??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/15 ¤U¤È 12:18:31²Ä 1034 ½g¦^À³
|
2021.4.13 ---韩国¤½¥q对¤¤国NASH·s药项¥Øªº韩国权¯q·P兴½ìwww.drugtimes.cn/2021/04/13/3968022ed9/ 韩国¦h®a¤½¥q §Æ±æ获±o¤¤国¦´ÁNASH·s药项¥Øªº 韩国权¯q ɬ¥ý¦Ò虑hit to lead阶¬qªº项¥Ø 欢ªï·P兴½ìªº¥ø业ÉO§Ú们联¨t¡I 请发°e邮¥ó¨ì BD@drugtimes.cn 请¦b邮¥ó¥D题栏¶ñ写¡G NASH项¥Ø韩国权¯q §Ú们将¥þ¤O协§U¡A°ª®Ä±À进 °J¤ß·P谢¡I ------------------------------------------------------------------------------------------ ªYÄ£SNP-610/ SNP-630¦³·NÄ@±ÂÅv´NÁpô§a! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/15 ¤U¤È 12:09:01²Ä 1033 ½g¦^À³
|
ų©ó¤U¦Cªº¬ã¨sµ²ªGªí©ú:¼³¼ö®§µh¹ï½¦½è¥À²ÓM½F²ÓM¨ã¦³§Ü¸~½F§@¥Î!!! ªÑªF·|®É«ØijªYÄ£µû¦ôSNP-810¦b¸£Àùªº¾A¥Î©Ê??? ½¦½è¥À²ÓM½F¡]GBM¡^¬O¤@Ãþ±`¨£ªºìµo©Ê´c©Ê¸£¸~½F¡C¥Ñ©ó³oÃþ¸~½F´c©Êµ{«×·¥°ª¡A©Ò¥Hµ´¤j³¡¤Àªº±wªÌ¹w«á·¥®t¡G½¦½è¥À²ÓM½F±wªÌ¸g¹L¤â³N©ñ¤ÆÀøµ¥ªvÀø¤â¬q«á¡A¨ä¥Í¦s¤¤¦ì¼Æ¶È¬°14Ӥ륪¥k¡A¤¦~¥Í¦s²v¤£¨ì5%¡C ¦b¹L¥hªº¤Q¦~¸Ì¡A¨S¦³¤@´ÚªvÀø½¦½è¥À²ÓM½Fªº·sÃÄÀò§å¤W¥«¡A¨ä¤¤«Ü¤jªºì¦]´N¬O¦å¸£«Ì»Ù¡]BBB¡^ªº¦s¦b¡A«ÜÃø¶}µo¥X¤@ºØ¥i¥H¬ð¯}¦å¸£«Ì»ÙªºÃĪ«ªvÀø½¦½è¥À²ÓM½F¡C ¦å¸£«Ì»Ùªº¦s¦b¡A¹ï©óªý¤î¦³®`ª«½è¥Ñ¦å²G¶i¤J¤j¸£¨ã¦³«n·N¸q¡AµM¦Ó¡A¦å¸£«Ì»Ù¦P®É¤]ªý¤î¤F¤j¦h¼Æ¤p¤À¤lÃĪ«©M¤j¤À¤l¡]¨Ò¦p肽¡A³J¥Õ½è©M°ò©ó°ò¦]ªºÃĪ«¡^ªºÂಾ¡AÄY«¨î¤F¯«¸g¤¤¼Ï¨t²Î¯e¯f¡]¨Ò¦p¯«¸g°h¦æ©Ê¯e¯f¡B¸£¸~½F¡A¸£³¡·P¬V©M¤¤·µ¥¡^ªºªvÀø¡C ------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/14 ¤W¤È 09:08:28²Ä 1026 ½g¦^À³ 2020.10.26¼³¼ö®§µh¹ï½¦½è¥À²ÓM½F²ÓM¼W´Þªº¼vÅT www.turkishneurosurgery.org.tr/pdf/pdf_JTN_2427.pdf µ²½×¡G§Ú̪º¬ã¨sµ²ªGªí©ú¼³¼ö®§µh¹ï½¦½è¥À²ÓM½F²ÓM¨ã¦³§Ü¸~½F§@¥Î¡A¨Ã¥B³oºØ¬¡©Ê¬O ¥Ñ¤£¦Pªº«H¸¹³q¸ô»¤¾É¡C ...§Ú̵o²{¼³¼ö®§µh´î¤Öªº²ÓM¼W´Þ¨ú¨M©ó [¾¯¶q]©M[«ùÄò®É¶¡].... |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/15 ¤W¤È 09:30:30²Ä 1032 ½g¦^À³
|
¾¤©ú«eªº¶Â·t°Ú ¦æ¨ì¤ô½a³B¡A§¤¬Ý¶³°_®É |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/4/15 ¤W¤È 07:42:51²Ä 1031 ½g¦^À³
|
¬Ý¤F¨é°Ó¶i¥X¡A«e¤Ñ¶Rªº¡A¬Q¤Ñ¦³¤j¥b±þ¥X¡A³o½L¦³³o»ò¥i©È? §ë¸ê·sÃįuªº«Ü¿i¤H¡A ¬Ý·Ç¡A©êºò¡Aµ¥¶}µP! |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/4/14 ¤U¤È 03:43:55²Ä 1030 ½g¦^À³
|
¤ßµh§r ±b±Á«¤j¤F ¥un810±ÂÅv ªÑ»ù¤Wº¦ §Úªº¤ß¯kµ´¹ï³Qªv¦n «OÃÒÀø®Ä «¢ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/14 ¤U¤È 02:34:08²Ä 1029 ½g¦^À³
|
¦P¤@¬ã¨s¹Î¶¤¸g¹L13¦~§V¤O²×©ó¦³¤FÁ{§ÉÀø®Ä! 2009¦~10¤ë: §Q¥Î¹ï¤A酰®ò°ò×ôªº[¬r©Ê¾÷¨î¼W±j]¶¶¹`¦b¨xÀù©M¨x¥À²ÓM½F²ÓM¨t¤¤ªº¥\®Ä pubmed.ncbi.nlm.nih.gov/19794959/ ----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/13 ¤U¤È 04:36:09²Ä 1021 ½g¦^À³ 2021¦~3¤ë www.sciencedirect.com/science/article/pii/S1476558621000075 ¤@¦W¨x¥À²ÓM½F±wªÌ¹ï©ó©Ò¦³¼Ð·ÇªvÀø§¡µL®Ä¡AµM«á¥ÎAAP 30 g / m 2¥[¶¶¹`ªvÀø. --------- |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/14 ¤U¤È 12:18:24²Ä 1028 ½g¦^À³
|
¥un810±ÂÅv ªÑ»ù¤Wº¦ §Úªº¤ß¯kµ´¹ï³Qªv¦n «OÃÒÀø®Ä «¢ |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/4/14 ¤U¤È 12:05:04²Ä 1027 ½g¦^À³
|
±q¨xÀù7¦~ªvÀø¤HÅ馨®Ä¡A¥ÎµL¬r810¥[«¾¯¶qªvÀøÀù¯g¡A¥i¥H§â³o¸ê°T¶Çµ¹¤½¥q¡A¤]¬O¬ã¨s¤îµh¾¯¥~ªº±d²ø¤j¹D¡C³o¬O¦ÑÃÄ·s¥Î¤]¬O¤j°Ó¾÷©M°^Äm¡C¨º¦ì¤j¤j¥i¥H¶Ç¹Fµ¹ªYÄ£°ª¼h¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/14 ¤W¤È 09:08:28²Ä 1026 ½g¦^À³
|
ºî¦X2½g¬ã¨s¡AÀ³¸Ó¥i¥H±À½×:[°ª¿@«×]+[µLNAC]ªºSNP-810§ó¦³Àø®Ä¡C 1.NAC·m±Ï¥i¯à·|°§CAAPªº§Ü¸~½F§@¥Î¡C(¦]¬°¨x¬r¤@¥¹¥ÎNAC³o¼ËÃĮīùÄò®É¶¡¤£°÷ªø) 2.§Ú̵o²{¼³¼ö®§µh´î¤Öªº²ÓM¼W´Þ¨ú¨M©ó [¾¯¶q]©M[«ùÄò®É¶¡].... --------------------------------------------------------------------------------- 2020.10.26¼³¼ö®§µh¹ï½¦½è¥À²ÓM½F²ÓM¼W´Þªº¼vÅT www.turkishneurosurgery.org.tr/pdf/pdf_JTN_2427.pdf µ²½×¡G§Ú̪º¬ã¨sµ²ªGªí©ú¼³¼ö®§µh¹ï½¦½è¥À²ÓM½F²ÓM¨ã¦³§Ü¸~½F§@¥Î¡A¨Ã¥B³oºØ¬¡©Ê¬O ¥Ñ¤£¦Pªº«H¸¹³q¸ô»¤¾É¡C ...§Ú̵o²{¼³¼ö®§µh´î¤Öªº²ÓM¼W´Þ¨ú¨M©ó [¾¯¶q]©M[«ùÄò®É¶¡].... ---------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/13 ¤U¤È 04:36:09²Ä 1021 ½g¦^À³ ...¤µ¤é¨«¶Õ¦b¤ÏÀ³³o«h½×¤å¶Ü??? 2021¦~3¤ë www.sciencedirect.com/science/article/pii/S1476558621000075 ¤@¦W¨x¥À²ÓM½F±wªÌ¹ï©ó©Ò¦³¼Ð·ÇªvÀø§¡µL®Ä¡AµM«á¥ÎAAP 30 g / m 2¥[¶¶¹`ªvÀø......¸Ó±wªÌ¦b¨ä¯f¨Ò³ø§iµo¥¬«áªº7¦~«á´X¥G§¹¥þ¤ÏÀ³¡A¤£¥uÁÙ¬¡µÛ¨Ã¥B¨S¦³¯e¯f ȱoª`·Nªº¬O¡A¦pªG¨S¦³¨Ï¥ÎNAC·m±Ï¡A´N¤£¯à¨Ï¥ÎÁ{§É¸ÕÅ礤¨Ï¥ÎªºAAP¾¯¶q¡C¦]¦¹¡A¥i¯à·|¾á¤ßNAC·m±Ï·|°§CAAPªº§Ü¸~½F§@¥Î¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/14 ¤W¤È 08:38:03²Ä 1025 ½g¦^À³
|
¦]¬°APAP¨x¬r©Ê¦Ò¶q¡AÁú°êªvÀøªÍÀù¬ã¨s¨Ï¥Î§C¿@«×APAP¡AY§ï¦¨[°ª¿@«×]µL¨x¬rªºSNP-810¡Aµ²ªG¦³¥i¯à§óÅãµÛ??? ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/13 ¤U¤È 04:36:09²Ä 1021 ½g¦^À³ ...AAP...¥Î©ó§ÜÀù¾AÀ³¯gªºÃĪ«¦A§Q¥Î¬O¤@Ó§Ö³tµo®iªº»â°ì¡A¥¦¬°±N¬ã¨sÂà¤Æ¬°Á{§É´£¨Ñ¤F¤@±ø¦³®Ä³~®|¡A¨Ã¥B¤ñ±qÀYÃĪ«µo²{¥¥x¨ã¦³©úÅ㪺Àu¶Õ¡C ----------------------------------------------------------------------------------------- 2019.9¤ëÁú°ê¬ã¨s ¹ï¤A酰®ò°ò×ô©Mù¦Ì¦a¨¯§ïµ½«D¤p²ÓMªÍÀù²ÓMªºÁp¦XÀù¯gªvÀø¡Cwww.bslonline.org/journal/view.html?doi=10.15616/BSL.2019.25.4.293 ...¹ï¤A酰®ò°ò×ô»Pù¦Ì¦a¨¯ªº²Õ¦XÀ³³Q»{¬°¬OªvÀøªÍÀùªº¦³«e³~ªºµ¦²¤¡C ..µM¦Ó¡Aªø´ÁªA¥Î¹ï¤A酰®ò°ò×ô¥i¯à·|¾ÉPÄY«ªº¨x¬r©Ê¡A³o¬O¨ä¥Dnªº°Æ§@¥Î¡C¦]¦¹¡A½T©w¦X¾Aªº¹ï¤A酰®ò°ò×ôªvÀø¿@«×À³¸Ó¬OªvÀø¨Mµ¦¤¤ªº¥Dn¦Ò¼{¦]¯À¡C ...¦]¦¹¡A§Ú̹w´Á[§C¿@«×]ªº¹ï¤A酰®ò°ò×ô©M¨ä¥L§ÜÀùÃĪº²Õ¦X¦bÀù¯gªvÀø¤¤¥i¯à¨ã¦³¨ó¦P§@¥Î¡A¨Ã¥B¥i¥H³Ì¤jµ{«×¦a´î¤Ö³o¨Ç°Æ§@¥Î¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/14 ¤W¤È 06:59:47²Ä 1024 ½g¦^À³
|
2014¦~Nature´Á¥Z....³¯Û`§¡µoªí¥þ²yº¨ÒªÍÀù·F²ÓM¬ã¨s...¬ã¨s¹Î¶¤¤]¤w¸gµo²{¤£¤ÖÁ{§ÉÃĪ«¡A¦³®Ä¤ÁÂ_ªÍÀù·F²ÓM»PÅÖºû¥À²ÓMªºÁpô¡A¥¼¨Ó¤£±Æ°£[¦ÑÃÄ·s¥Î]ªº¥i¯à¡C [¦ÑÃÄ·s¥Î]---SNP-810??? ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/14 ¤W¤È 06:32:47²Ä 1023 ½g¦^À³ ¥O¤HÅå³Yªº¬O¡AAAP¥i¯à¨ã¦³§ÜÀù¯g·F²ÓMCSC¯S©Ê??? ....¡A¥]¬A«D¤p²ÓMªÍÀù¡C ----------------------------------------------------------------------------------------------- 2014-04-15»O¤jªÍÀù·F²ÓM¬ã¨s¬ð¯} ¬ãµo·sÃIJ{«´¾÷ ¥Ñ»O¤j®Õªø·¨Ìñ¦À²v»âªº¬ã¨s¹Î¶¤¤é«e«Å¥¬¡A¦¨¥\«Ø¥ß¦b¤HÅé¥~°ö¾iªÍÀù·F²ÓMªº¼Ò¦¡¡AªÍÀù·F²ÓM¸gÅé¥~°ö¾i«á¡A ¥¼¨Ó¥i¥Hª½±µ°w¹ïÀù·F²ÓM¡]cancer stem cells, CSCs)µo®i·sªº§ÜÀùÃĪ«¡A´ÀªÍÀùªvÀø±a¨Ó·s«´¾÷¡C ¹L¥hÀù¯g¬ã¨s¦h¥H°ö¾iÀù²ÓM¬°¥D¡A¤£¹L¤@¥¹°ö¾i¥XÀù²ÓM©P³òªºÅÖºû¥À²ÓM¡A¹êÅç¤w§i¥¢±Ñ¡F¦ý»O¤j®Õªø·¨Ìñ¦À»P¥L«ü¾Éªº³Õ¤h¥Í³¯Û`§¡¡A«o¦b°ö¾i¥XÅÖºû¥À²ÓMªº¦P®É¡A·N¥~µo²{´N¬O³oºØÅÖºû¥À²ÓM¡A¡u¾i¬¡¡v¤FÀù·F²ÓM¡C¬ã¨s¹Î¶¤µo²{¡AÅÖºû¥À²ÓM³z¹L¤@ºØ¦W¥s¡u®Çªc¯À¡v(paracrine)ªº²ÓM¿E¯À¡A¨Óºû«ùÀù·F²ÓMªº¥Íªø¡F¦p¦¹¤@¨Ó¡A¥un¤ÁÂ_³oºØ¶Ç»¼¸ô®|¡A´N¯à°w¹ïÀù·F²ÓMµo®i¥X·s¿³§ÜÀùÃĪ«¡C³o¶µ¬ã¨s¦¨ªG¤w¦b°ê»Úª¾¦Wºô¸ôÂå¾Ç´Á¥Z¡m¦ÛµM¶Ç¼½¡n¡]Nature Communications¡^¤Wµoªí¡C ³o¶µµo²{ªº«n©Ê¬°¦ó¡H¸~½F¨Ã«D¥Ñ³æ¤@ºØÀù²ÓM²Õ¦¨¡A¨ä¤¤¦s¦b¤@¸s³\¦hÃþ¦ü·F²ÓM¯S©ÊªºÀù²ÓM¡AºÙ¤§¬°¡uÀù·F²ÓM¡v¡C¨CÁû¸~½F¤º³¡³£¦³0.1%¨ì10%¤£µ¥ªº·F²ÓM¡A§êºtµÛ²ÓM½Æ»s¡B¤À¤Æªº¨¤¦â¡A»PÀù¯g´_µo¡B¸~½FÂಾ¡B§ÜÃÄ©Ê®§®§¬ÛÃö¡C¦]¦¹¡A°w¹ï³o¸sÀù·F²ÓMµo®i·s¤@¥N§ÜÀùÃĪ«¡A¤w¬O·í«eÀù¯gªvÀø»P¬ã¨sªº«n¥ô°È¡C ³z¹L»O¤j¤Wz¬ã¨s¡A¦³¤F°»´ú¡B¤ÀÂ÷Àù·F²ÓMªº§Þ³N¡A¤]µo²{¥¦ªº¡u«á¶Ô¸Éµ¹¯¸¡v¡Aµ¥©óÅýªÍÀùªvÀø¦³¤F¡u¾à¸é¥ý¾à¤ý¡vªº¥i¯à¡F¨Æ¹ê¤W¡A¬ã¨s¹Î¶¤¤]¤w¸gµo²{¤£¤ÖÁ{§ÉÃĪ«¡A¥i¥H¦³®Ä¤ÁÂ_ªÍÀù·F²ÓM»PÅÖºû¥À²ÓMªºÁpô¡A¥¼¨Ó¤£±Æ°£¦ÑÃÄ·s¥Îªº¥i¯à¡C»O¤j¤U¤@¨B±N»P¤¤¥¡¬ã¨s°|¦X§@¡A¬ãµo¹ï§ÜªÍÀù·F²ÓMªºÃĪ«¡AªvÀøªÍÀù¡A±N¦³¾÷·|ª½±µ¡u±Ù¯ó°£®Ú¡v¡C ¾¨ºÞ³o¥u¬O°w¹ïªÍÀùªº¬ã¨s¡A¦ý¦]¬°¥ô¦ó¸~½F²ÓM¤¤³£¦³Àù·F²ÓM¡A©P³ò¤]³£·|¦³¬ÛÃöªºÅÖºû¥À²ÓM¡A¦P¼Ëªº²z½×¤]¾A¥Î©ó¨ä¥LÀù¯g¡A¹ïªvÀøÀù¯g¶}±ÒµL¥i¯à¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/14 ¤W¤È 06:32:47²Ä 1023 ½g¦^À³
|
¥O¤HÅå³Yªº¬O¡AAAP¥i¯à¨ã¦³§ÜÀù¯g·F²ÓMCSC¯S©Ê??? ·|¥hªÑªF·|ªºÀ°¦£°Ý¤@¤U¡ASNP-810¦³¨S¦³¥Î©ó§ÜÀù¾AÀ³¯gªº³W¹º??? ----------------------------------------------------------------------------------------- ¦b²§½è©Ê¸~½F·LÀô¹Ò¤¤¡A©~¦íµÛ¦h¯àÀù¯g·F²ÓM¡]CSC¡^...³\¦h«Iŧ©ÊÀù¯gªº¦æ¬°¡A¥]¬AÂಾ©M¤ÆÀø¾ÉPÀù¯g¦A¥Íªø ¦]¦¹¡A§í¨îCSCªí«¬ªº¤À¤l¥i¯à·|ÅãµÛ§ïµ½»PÀù¯g¬ÛÃöªºµ²ªG¡C©|µLFDA§å㪺¨ã¦³¤wª¾§ÜCSC§@¥ÎªºÃĪ«¥Î©ó¹êÅé½F¡A¥]¬A«D¤p²ÓMªÍÀù¡C¥Ñ©óAAP...¨¾¤î¤F¤ÆÀø«á¤j¹«ªº¸~½F¦A¥Í¡A¦]¦¹¥O¤HÅå³Yªº¬O¡AAAP¥i¯à¨ã¦³§ÜCSC¯S©Ê¡C |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/4/13 ¤U¤È 11:53:35²Ä 1022 ½g¦^À³
|
R¤j¤Ó¯«¤F¡A¯à°÷§ä¨ì³Ì·s§ÜÀùÀøªk½×¤å¡A¯uªº¬Ý¨ì²´ªá!! ¦ý¤p§Ì±À¦ô¤µ¤é¥u¬O¤§«e¶]¥hª±IC³]pªº§ë¸ê¤HÂk¶¤¡A ²Ä¤@ª÷ÁÙ¦b¥Î¤O¨ÑÄw½X¡A¤£ª¾¦ó®É¤î!! ·Q·Q¦pªG¿ì²{¼W«eñ¬ù¡A´N¦³¤jµ§¦¬¤J¡AÃÒ´Á§½·|ã¿ì²{¼W? Â÷¶}µP¥i¯àÁÙn¤TÓ¤ë?! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/13 ¤U¤È 04:36:09²Ä 1021 ½g¦^À³
|
J&J»PªYÄ£°ª¼hª¾¹D¶Ü???? SNP-810»ùÈn½¿Åo!!! ¤j¾¯¶qAPAP¯à°÷ªvÀøÀù¯g¡A¦ý¦pªG¨S¦³¨Ï¥ÎNAC·m±Ï¡A´N¤£¯à¨Ï¥ÎÁ{§É¸ÕÅ礤¨Ï¥ÎªºAAP¾¯¶q!!! ¤j¾¯¶qAPAP¯à°÷ªvÀøÀù¯g¡A¦ý¦pªG¨S¦³¨Ï¥ÎNAC·m±Ï¡A´N¤£¯à¨Ï¥ÎÁ{§É¸ÕÅ礤¨Ï¥ÎªºAAP¾¯¶q!!! ¤j¾¯¶qAPAP¯à°÷ªvÀøÀù¯g¡A¦ý¦pªG¨S¦³¨Ï¥ÎNAC·m±Ï¡A´N¤£¯à¨Ï¥ÎÁ{§É¸ÕÅ礤¨Ï¥ÎªºAAP¾¯¶q!!! AAP§@¬°¸Ñ¼ö©MÂíµhÃĬO¥@¬É¤W³Ì±`¥ÎªºÃĪ«¤§¤@¡C¥Î©ó§ÜÀù¾AÀ³¯gªºÃĪ«¦A§Q¥Î¬O¤@Ó§Ö³tµo®iªº»â°ì¡A¥¦¬°±N¬ã¨sÂà¤Æ¬°Á{§É´£¨Ñ¤F¤@±ø¦³®Ä³~®|¡A¨Ã¥B¤ñ±qÀYÃĪ«µo²{¥¥x¨ã¦³©úÅ㪺Àu¶Õ¡C ¤µ¤é¨«¶Õ¦b¤ÏÀ³³o«h½×¤å¶Ü??? 2021¦~3¤ë www.sciencedirect.com/science/article/pii/S1476558621000075 ¤@¦W¨x¥À²ÓM½F±wªÌ¹ï©ó©Ò¦³¼Ð·ÇªvÀø§¡µL®Ä¡AµM«á¥ÎAAP 30 g / m 2¥[¶¶¹`ªvÀø......¸Ó±wªÌ¦b¨ä¯f¨Ò³ø§iµo¥¬«áªº7¦~«á´X¥G§¹¥þ¤ÏÀ³¡A¤£¥uÁÙ¬¡µÛ¨Ã¥B¨S¦³¯e¯f ȱoª`·Nªº¬O¡A¦pªG¨S¦³¨Ï¥ÎNAC·m±Ï¡A´N¤£¯à¨Ï¥ÎÁ{§É¸ÕÅ礤¨Ï¥ÎªºAAP¾¯¶q¡C¦]¦¹¡A¥i¯à·|¾á¤ßNAC·m±Ï·|°§CAAPªº§Ü¸~½F§@¥Î¡C ¥Ñ©óNAC¬OAAP¬r©Êªº¸Ñ¬r¾¯¡A¬O½\¯Ö¥Ì肽ªº«eÅé¡A¦]¦¹³o¨Çµ²ªGªí©úNAC¥i¥H¿ï¾Ü©Ê¦a®¾±Ï¨xŦ¡A¦ý¤£¯à³q¹L¤j¾¯¶qAAPªvÀø®¾±Ï¸~½F¡C |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/12 ¤U¤È 04:52:18²Ä 1020 ½g¦^À³
|
2¤ë»¡n§ó·sºô¶¬ãµo²£«~¶i«×¡A²{¦b4¤ë¤FÁÙ¤£¨£§ó·s? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/11 ¤W¤È 10:09:58²Ä 1019 ½g¦^À³
|
¤jÃļt¬°¦ó¤£±N[¹ï¤A酰®ò°ò×ô]+[¸Ñ¬r¾¯¥b¯Ö®ò»ÄNAC]²Õ¦¨µL¨x¬r©Ê½Æ¤è¤îµhÃÄ? 2021.3.12 ¤¤¬ã°|¼B²h¥ú³Õ¤h½×¤å: N-Acetyl Cysteine Overdose Inducing Hepatic Steatosis and Systemic Inflammation in Both Propacetamol-Induced Hepatotoxic and Normal Mice file:///C:/Users/USER/Downloads/antioxidants-10-00442-v2.pdf ... NAC¾¯¶q¿ù»~·|¾ÉPÄY«ªº°Æ§@¥Î¡A¬Æ¦Ü¾ÉPAPAP¹L¶q±wªÌ¦º¤`[9]¡CNACªº¥Dn¬r©Ê¥]¬A¤£´r§Öªº¨ý¹D©MG¸z¹D¤£¾A¡C¦bPhase1ªºÃÄ¥N°Ê¤O¾Ç©MÃĮľǬã¨s¡A¥Ñ©ó¬r©Ê¹L¤j¡A¸Ó¬ã¨s³Q´£«e²×¤î[10]..... ... µ²ªGªí©ú¹L¶qªA¥ÎNAC¦³¤Þ°_¯×ªÕ¨x©M¥þ¨©Êª¢¯gªºÅãµÛ·ÀI¡AÄY«ªº±¡ªp¥i¯à¬OP©Rªº¡C ............................................................................................. ·|û¡GROGER588910148151 µoªí®É¶¡:2020/9/16 ¤U¤È 10:45:00²Ä 355 ½g¦^À³ ¨ä¥LÃļt¦¦³¬ã¨s±N[¹ï¤A酰®ò°ò×ô]»P[¸Ñ¬r¾¯]¦p¥b¯Ö®ò»ÄNAC¡B³J®ò»Ä©ÎªÌ¥ÒÙæ«}Ðg²Õ¦¨½Æ¤è»s¾¯¥H§JªA¨x¬r©Ê.... §O®a§ð¤£¯}ªº[ÃøÂI]¡AªYÄ£¤@Á|¯}ÂI¦p¦¹¦Ó¤w..... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/10 ¤W¤È 05:37:47²Ä 1018 ½g¦^À³
|
¬ü°ê¬F©²¾~¤ù¾Ôª§¹wºâ110»õ¬ü¤¸! ¬ü°êªF³¡®É¶¡2021¦~4¤ë9¤é¤¤¤È12:01 «ôµnªº¹wºâÄ@±æ²M³æ¡G«ì´_¯e¯f¹w¨¾±±¨î¤¤¤ß¡A«Ø¥ß·sªºNIH¬ã¨s¤¤¤ß¡A§ë¤J¼Æ¤Q»õ¬ü¤¸¨Ó²×µ²ªü¤ùÃþÃĪ«©M¦ã´þ¯f¬rªº¬y¦æ «ôµn´£¥Xªº2022°]¦~ªº²Ä¤@Ó¹wºâ½Ð¨D¥]¬ACDCªº¤j¶q¸êª÷¬y¤J¡Ap¹º¦bNIH¤º«Ø¥ß¤@Ó·sªº65»õ¬ü¤¸ªº¬ã¨s¤¤¤ß¡A¥H¤Î±Nªñ110»õ¬ü¤¸¨Óµ²§ôªü¤ùÃþÃĪ«ªº¬y¦æ¡A¥t¥~ÁÙ¦³6.7»õ¬ü¤¸¥Î©ó¿n·¥´î¤Ö·sªºHIV·P¬V¯f¨Ò¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/9 ¤W¤È 09:58:59²Ä 1017 ½g¦^À³
|
§ó¥¿:ñ¬ùª÷¡B¨½µ{ª÷¡B¤Î²£«~¤W¥««á¾P°â¤§Åv§Qª÷(²Ä¤G¶¥¬q)¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/9 ¤W¤È 09:50:22²Ä 1016 ½g¦^À³
|
¥Í§Þ·sÃÄ¡u¹Ú¤u¼t¡v! ¦X§@¶}µo¨óij--->°Ó«~©Î³Ò°È¦¬¤J(²Ä¤@¶¥¬q)--->ñ¬ùª÷¡B¨½µ{ª÷¡B¤Î²£«~¤W¥««á¾P°â¤§Åv§Qª÷(²Ä¤@¶¥¬q)¡C IFRS 15¡u¨Ó¦Û«È¤á¦X¬ù¤§¦¬¤J¡v:IFRS 15¤§®Ö¤ßì«h¬°¡A¥ø·~À³¥H¯à´yz°Ó«~©Î³Ò°È²¾Â઺¤è¦¡»{¦C¦¬¤J¡A¸Ó¦¬¤Jª÷ÃBÀ³¯à¤Ï¬M¥ø·~¹w´Á¥H¸Óµ¥°Ó«~©Î ³Ò°È¦³Åv¨ú±o¤§¹ï»ù¡C 2017¦~2¤ë13¤é ¶h¹F¥Í§Þ»P¥þ²yÐ`肽ÃÄ«~¤j¼t·ç¤h Ferring Pharmaceuticals ñq¦X§@¶}µo¨óij ±Mºë©ó½wÄÀ°w¾¯§ï¨}¾¯«¬¤Î³Ð·s¤À¤l·sÃĶ}µoªº¶h¹F¥Í§Þ (6576.TWO) »PÁ`³¡¦ì©ó·ç¤hªº¥þ²yÐ`肽ÃÄ«~¤j¼t Ferring Pharmaceuticals (½÷â»sÃÄ)©ó¤G¤ë¤E¤é¦@¦P«Å¥¬¡AÂù¤èñq¦X§@¶}µo¨óij¡C¶h¹F±N¥H¨ä¿W®a¬ãµo¤§Ã©w°w¾¯¥¥x§Þ³N (Stabilized Injectable Formulation, SIF) ¨ó§U Ferring ¶}µo¨ä¤@Ð`肽½wÄÀ°w¾¯¡C ¦¹¦X§@¤À¨â¶¥¬q¡AFerring±N¤ä¥I¶h¹F²Ä¤@¶¥¬q¬ÛÃöªº¬ã¨s¶O¥Î¡F«Ýµû¦ôªì¨B¬ãµo¦¨ªG«á¡AÂù¤è¦A¦æ°Q½×±Ò°Ê²Ä¤G¶¥¬q¬ãµo¤§时¶¡¡C«Ý¶i¤J²Ä¤G¶¥¬q«á¡A¶h¹F±N¥iÀò±oÃB¥~ªºÃ±¬ùª÷¡B¨½µ{ª÷¡B¤Î²£«~¤W¥««á¥ÑFerring¾P°â¤§Åv§Qª÷¡C ¶h¹F¥Í§Þ¸³¨Æªøº[Á`¸g²z²»Ê¹F³Õ¤hªí¥Ü¡G¡u§ÚÌ«D±`°ª¿³¯à»P Ferring ¦X§@¡CFerring ¬O¥@¬É¯ÅÐ`肽°w¾¯·sÃĶ}µo¤½¥q¡A¦b³Ð·s»s¾¯À³¥Î¤ÎÃÄ«~¶Ç¿é§Þ³N¬ãµo¦³±y¤[¦¨¥\ªº¾ú¥v¡C§Ṳ́Q¤À´Á«Ý»P Ferring ¦P¤ß¨ó¤O¡A¥H¶h¹F¯S¦³ªº SIF ½wÄÀ°w¾¯¥¥x§Þ³N¬° Ferring ªº²£«~²Õ¦X³Ð³y§ó°ª»ùÈ¡C¡v Ferring ¬ãµo¥DºÞ¿ì¤½«Ç¸ê²`°ÆÁ` Alan S. Harris ªí¥Ü¡G¡u§Ú̹ï¶h¹Fªº¦¨´N»P SIF ½wÄÀ°w¾¯¥¥x§Þ³Nªº»ùȦL¶H²`¨è¡C¶h¹F¦b¶}µoéw½wÄÀÐ`肽»s¾¯ (FP-001) ®É¡A¦¨¥\§JªA¤FÃöÁ䪺§Þ³N²~ÀV¡A¥O§Ú̹ï¶h¹F SIF ½wÄÀ°w¾¯¥¥x§Þ³NÀ³¥Î©ó¶}µo Ferring ½ÆÂøÐ`肽ÃÄ«~ªº¼ç¤O²`¨ã«H¤ß¡C¤Q¤À´Á«Ý»P¶h¹Fªº¦X§@¶}µo¡I¡v |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/4/9 ¤W¤È 09:44:29²Ä 1015 ½g¦^À³
|
¥un±z«÷¬x¯î¥þ¤O¦³25±i¡A¤@ªÑ4000¤¸¡Aè¦n¤@»õ¤¸¡C³oÓ¹Ú¦bªYÄ£¬O¥i¯à¦¨¨Æ¹êªº¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/9 ¤W¤È 09:41:39²Ä 1014 ½g¦^À³
|
107¦~¶h¹F²{¼W¤½¶}»¡©ú®Ñ ¥»¤½¥q¤Î¤l¤½¥q©ó 106 ¦~ 2 ¤ë»P Ferring ñq¦X§@¶}µo¨óij¡A¬°´£¨Ñ¬ãµo¸ÕÅç ªA°È©Ò²£¥Í¤§ [³Ò°È¦¬¤J]¡Cwww.kgieworld.com.tw/UpLoadFiles/Underwrite/Announce/190429_0_165113463.pdf |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/9 ¤W¤È 08:59:54²Ä 1013 ½g¦^À³
|
½²¤j¤W»õ ¹ê¦b«ÜÃø·Q¹³¡A«¢¡A¦ýn½¨¯uªºn¾a¥Í§Þ¡A¤×¨ä¬O·sÃĪѡA¤@¥¹¦¨¥\±ÂÅv¡AªÑ»ù¦Ü¤Ö½¿¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/8 ¤U¤È 11:03:14²Ä 1012 ½g¦^À³
|
¶V¨Ó¶V¥Ö¡AÁÙ¤£¨£§ó·s! ------------------------------------------------------------------------------------------- ·|û¡GRock00910149258 µoªí®É¶¡:2021/2/23 ¤U¤È 06:44:48²Ä 836 ½g¦^À³ ¤µ¤é¦³»P¤½¥q¤HûP¹qÁpô ªñ´Á·|§ó·s©xºô¤Wªº¬ãµoùµ{»P¶i«×®Éµ{ ¦U¦ì¤£³X¦³ªÅ¥i¥H¥h¦h«ö´X¦¸«·s¾ã²z¬Ý¬Ý¦³µL§ó·s!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/8 ¤U¤È 10:28:21²Ä 1011 ½g¦^À³
|
·s´ÚSNP-830/840 ----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/26 ¤U¤È 01:41:11²Ä 586 ½g¦^À³ ...pµe¦WºÙ¡G·s±j®Ä¤£¦¨Å}¤îµh²Õ¦XÃÄ Sebacoyl Dinalbuphine Ester ¤ÎµL¨x¬r¤AñQÓi×ô¥Î©óÂù °¼½¥Ãö¸`¸m´«³N«á¤§¤¤«×¦ÜÄY«¯kµhªvÀø ¥»°| IRB ½s¸¹¡G2020-11-005A ³o¬O¼t°ÓÃÙ§UªºÀH¾÷¡BÂùª¼ªº²Ä I/II ´ÁÁ{§É¸ÕÅç¡A... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/8 ¤U¤È 10:18:35²Ä 1010 ½g¦^À³
|
2019.10.23 ¬ü°êª©¡u¾~¤ù¾Ôª§¡v ½ß´Ú®£ªñ¤¦Ê»õ¬ü¤¸ www.businesstoday.com.tw/article/category/80392/post/201910230050/%E7%BE%8E%E5%9C%8B%E7%89%88%E3%80%8C%E9%B4%89%E7%89%87%E6%88%B0%E7%88%AD%E3%80%8D%20%20%20%E8%B3%A0%E6%AC%BE%E6%81%90%E8%BF%91%E4%BA%94%E7%99%BE%E5%84%84%E7%BE%8E%E5%85%83 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/8 ¤U¤È 10:09:22²Ä 1009 ½g¦^À³
|
¾~¤ù¾Ôª§¡A¼È°±ì°t¤è¶}µo! ÀÀ¥H¤£¦¨Å}¡AµL©I§l§í¨î¤§Sebacoyl Dinalbuphine Ester(SDE©Macetaminophen§@¬°³Ì¨Î¤§½Æ¤è²Õ¦X) ©Ò¥HSNP-830»PSNP-840§ï¦¨·s°t¤è:SNP-810 + ¶¶Ãįǯk¸ÑSDE(ªø®Ä¤fªA¾¯) ----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/30 ¤W¤È 09:11:10²Ä 638 ½g¦^À³ ì©l°t¤è: SNP-830¡GSNP-810 + oxycodone(ßm¤G²B¥i«Ý¦]à¬) SNP-840¡GSNP-810 + hydrocodone (²B¥ià¬) ¦]¬°oxycodone»Phydrocodone³£¬O¾~¤ùÃþÂíµhÃÄ §ï¦¨·s°t¤è:SNP-810 + ¶¶Ãįǯk¸ÑSDE(¤fªA¾¯) |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/4/8 ¤U¤È 09:54:09²Ä 1008 ½g¦^À³
|
½Ð°Ýºô¶¤W¤£¬O¼g830/840°±¤î¶}µo?? ÁÙ·|¦³Ãļtn½ä±ÂÅv¶Ü ªYÄ£610¡B810¡F630¡B830¡B840¥ô¦ó¤@²Õ±ÂÅv¥X¥h³£¬OªÑ¤ý¡A§ó¦óªp¬O¦XÅé¡I¡I±N¨Ó¤£·íªÑ¤ý³£Ãø¡C¹w¯¬¥»²ÕªÑªF±N¨Ó¯à¤W»õ¤¸¸ê²£¡C |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/4/8 ¤U¤È 09:08:27²Ä 1007 ½g¦^À³
|
¦^R¤j¡A¥u¬O·Qª¾¹D¥xÆW¾Ç¦WÃĨúÃÒ¤j·§¦b´X¤ë¡A©M¨úÃÒ¶i«×©µ¿ð¦h¤[,(¤½¥q¨S´£¨Ñ¸ê°T¡A¦Û¤v±À´ú)¡A¤Ï¥¿·sÃĤ£·|¦³·Ç®Éªº¡A¥u¯àÄ~Äòµ¥¤U¥h¤F... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/4/8 ¤U¤È 08:44:40²Ä 1006 ½g¦^À³
|
®É¶¡¦³ºÝÙ? ------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2020/12/29 ¤U¤È 08:32:10²Ä 442 ½g¦^À³ ...2020.12.14ªYÄ£ºô¶§ó·s¤º®e:SNP-630 ©ú¦~Q1¥Ó½ÐTFDA IND---®É¶¡³o»ò±µªñ¡AIND¤£¦Ü©ó©µ´Á¤~¬O¡C -------------------------------------------------------------------------------------- ·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/4/8 ¤U¤È 03:08:26²Ä 1003 ½g¦^À³ 3¤ëÀ禬944¸U¡A½Ð°Ý¦³¤j¤jª¾¹D¥Ø«e¬ãµo¶i«×ªººô¶¤j·§¬O¦ó®É¤W½uªº¡A·PÁ´£¨Ñ~ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/4/8 ¤U¤È 05:53:52²Ä 1005 ½g¦^À³
|
¨º§Ún¦Ü¤Ö200¿ ¤W»õªº¸Ü¡A¤£´±·Q ----------------------- ªYÄ£610¡B810¡F630¡B830¡B840¥ô¦ó¤@²Õ±ÂÅv¥X¥h³£¬OªÑ¤ý¡A§ó¦óªp¬O¦XÅé¡I¡I±N¨Ó¤£·íªÑ¤ý³£Ãø¡C¹w¯¬¥»²ÕªÑªF±N¨Ó¯à¤W»õ¤¸¸ê²£¡C |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/8 ¤U¤È 04:26:37²Ä 1004 ½g¦^À³
|
944(¤d¤¸) |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/4/8 ¤U¤È 03:08:26²Ä 1003 ½g¦^À³
|
3¤ëÀ禬944¸U¡A½Ð°Ý¦³¤j¤jª¾¹D¥Ø«e¬ãµo¶i«×ªººô¶¤j·§¬O¦ó®É¤W½uªº¡A·PÁ´£¨Ñ~ |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/8 ¤U¤È 02:38:44²Ä 1002 ½g¦^À³
|
¹³¤£¹³³QÀ£§C¦Y³f¡A¿³Âd»ù¦ì·Pı¯uªº®e©ö³Q¾ÞÁa¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/4/8 ¤W¤È 11:24:25²Ä 1001 ½g¦^À³
|
ªYÄ£610¡B810¡F630¡B830¡B840¥ô¦ó¤@²Õ±ÂÅv¥X¥h³£¬OªÑ¤ý¡A§ó¦óªp¬O¦XÅé¡I¡I±N¨Ó¤£·íªÑ¤ý³£Ãø¡C¹w¯¬¥»²ÕªÑªF±N¨Ó¯à¤W»õ¤¸¸ê²£¡C |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/8 ¤W¤È 08:12:28²Ä 1000 ½g¦^À³
|
n§ë¸ê³oÀÉn©ê¨c ©êºò ©ê¤[ ¦Ü¤Ö¤@ ¤G¦~¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/4/7 ¤U¤È 11:56:48²Ä 999 ½g¦^À³
|
¬Ý¨Ó¤£§®¡Aªø§ë³ø¨c |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/4/7 ¤W¤È 11:37:28²Ä 998 ½g¦^À³
|
¤µ¤Ñ¬On¬~Äw½X¶Ü?ÁÙ¬O¤[µ¥¤£@ªº§ë¸êªÌ±þ¥X?¶X§C¾ß¤@±i.¨S¤l¼u¤F |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/4/1 ¤U¤È 07:03:01²Ä 997 ½g¦^À³
|
¤TÁ` ¤ßÂÃ¥~¬ì ¥h¬d¤@¤U´N¦³¤F ¦³®ø®§¤W¨Ó¤À¨É¤@¤U§a µ¥§Aµ¥¨ì§Ú¤ßµh |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/30 ¤U¤È 06:52:04²Ä 996 ½g¦^À³
|
2017¦~6¤ë13¤é·s»D:¦¶³Í¥Á¨C©P¶È¦³¤@ӰݶE®É¬q¡A¥Dn¬O¡uªA°È¦nªB¤Í¡v¡C 2021¦~ÁÙ¦³¬Ý¶E¡uªA°È¦nªB¤Í¡v??? |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/3/30 ¤U¤È 04:04:05²Ä 995 ½g¦^À³
|
me too ¥h±¾¦¶³Í¥Áªº¸¹§Ú¬Ý¤ñ¸û§Ö §Ú¤£¦b¥_³¡¡A¤£µM´N¥h¤F -------------------------- ¥´¹q¸Ü¡A¼gmail¹L¥h³£¬O®ö¶O®É¶¡¡C ¤°»ò°T®§³£¨S±o¨ì¡C ½Ð°Ý¦³¤H¯uªº¯à¹q³X¨ìµo¨¥¤H¶Ü¡H |
|
|
·|û¡G¥[¯Z¤H¥Í10148422 µoªí®É¶¡:2021/3/30 ¤U¤È 02:45:53²Ä 994 ½g¦^À³
|
½Ð±Ð¦U¦ì¤j¤j¡A ³ÌªñªÑ»ù«Ü¸Þ²§ªº¥ÀR¡AÀ³¸Ó¬O¡K¡Kµ¥810¶R®a¦^À³ÁÙ¬O®Ú¥»ÁÙ¦b¸ÕÅç¡H ¤£ª¾¹D¦ó®É¦³µ²ªG¡H ¥´¹q¸Ü¡A¼gmail¹L¥h³£¬O®ö¶O®É¶¡¡C ¤°»ò°T®§³£¨S±o¨ì¡C ½Ð°Ý¦³¤H¯uªº¯à¹q³X¨ìµo¨¥¤H¶Ü¡H ÁÙ¬O¥u¦³¥D¤O¯à¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/30 ¤W¤È 09:00:32²Ä 993 ½g¦^À³
|
¥Í§ÞªÑ¤ý¨S¤J¦C´N¬O²Ä2®a¡AÆp¤û¨¤¦yÅo¡C ªk¤H¤£¤j·|µÛ¾¥¿³ÂdªÑ(¤pªÑ¥»¬y³q©Ê¡A¤£¦P©ó¤W¥«Âdªº¥æ©ö¡A¿³ÂdªÑªºÄ³»ù¥æ©ö«Ü®e©ö¾Þ±±) ------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/6 ¤W¤È 09:59:54²Ä 905 ½g¦^À³ 2021.3.5·s«a·sÃÄ¥_¬ü±ÂÅv¦³ÃÐ ªø¸tµn¥Í§ÞªÑ¤ý ¥Í§ÞªÑ¤ýÄ_®y´«¤H¡Iªø¸t¡]6712¡^®µµÛÂÀ±a¶¡½è·F²ÓMUMSC01°ê»Ú±ÂÅv¦³¾÷·|©é¦b¤W¥b¦~¶Ç¥X³ß°T..... ------------------------------------------------------------------------------------------- ¤j¤á«ç»ò¤£µ¥°ê»Ú±ÂÅv??? |
|
|
·|û¡G´MÄ_10151381 µoªí®É¶¡:2021/3/29 ¤U¤È 09:55:43²Ä 992 ½g¦^À³
|
¸gÀÙ¤é³ø¦b2021/03/21¤@½g¡u»sÃĪѪïÂצ¬ ©u©u¦³ÃD§÷¡v´£¨ì¤F¤µ¦~²Ä¤@¡ã²Ä¥|©u¤W¥«Âd¡]¥]¬A¿³Âd¡^¤½¥q»sÃĪѤw¹ê²{¤Îªk¤H¹w¦ô¥i¯àªº±ÂÅvª÷¡A°ß¿W¨S¦³´£¨ì¡§ªYÄ£¡¨¡Cªk¤H°é¤£¬Ý¦n¶Ü¡H |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/3/26 ¤U¤È 11:20:18²Ä 991 ½g¦^À³
|
¤j¤j«Ü§Q®`¡A·sÃİݤ£¥X¨Ó ¥h°Ý¦X¤@ «¢«¢ ¬Ý¨Ó¦X¤@¥u¬O³æ¯Â«ù¦³??¤£´±»¡¤Óº¡ ¤T¤ë³£§Ö¹L§¹¤F¡A¦n®ø®§§Ö¨Ó§r Ä_ÄÖªº¦n®ø®§¤]µL¤O¤Wº¦ |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/3/26 ¤U¤È 07:51:03²Ä 990 ½g¦^À³
|
¦X¤@°Ýµª¤W±¬Ý¨ìªº Q ¤µ¦~¥i»¡¬O¦X¤@¸ÀÅܦ¨ªøªº«¤jÃöÁä¦~¡A¥xÆW¾ãÅé¥Í§Þ·~¤]³vº¥¦¨¼ô¦³¾÷·|¬D¾Ô°ê»Ú¬×¡A½Ð°Ý¦X¤@ªñ´Á¬O§_¦³³W¹º¨ÖÁʦ³¼ç¤Oªº·sÃĤ½¥q¡H¦p¦P¶°¹ÎªºªYÄ£¦bµL¨x¬r¤îµhÃÄ»P«D°sºë©Ê¯×ªÕ¨xª¢³£¬O¥«³õ¬Û·í¬Ý¦nªº¬ãµo¤¤·sÃÄ¡C ¦X¤@·í«e°£¤F«ùÄò¬ãµo·sÃÄ»Pon101ªº¥«³õã¤J¬°«ÂI¥Ø¼Ð¥~¡A±j±j¨ÖÁʬO§_¤]¬°¦X¤@«ÂIµ¦²¤¡H A ¨ÖÁÊ»P¬¡¤ô´`Àô¬O¦X¤@¥¼¨Óµo®iªº«nµ¦²¤¡A¦X¤@±NµøÃĪ«±ÂÅv¶i«×¡B¬ãµoª¬ªp¡A¤Î¨ÖÁʻݨD¡A¥HªÑªF§Q¯q³Ì¤j¤Æ¬°¦Ò¶q¡A¨M©w¬O§_¹ï¥~¶i¦æ¨ÖÁÊ¡A¦p¦³¥ô¦ó¨M©w·|¥¿¦¡¤½§i¡C Q 1.¤¤¤Ñ¥Í§Þ©³¤U¦³ÁÞ°ò¡BªYÄ£¥ÍÂå¹wp¦ó®É¤W¥«¤WÂd¡H 2.ªYÄ£³Ìªñ¦³¦b½Í¤°»ò¶µ¥Øªº±ÂÅvª÷¶Ü¡H ¥H¤W·PÁ¡C A 1. ¤¤¤Ñ¥Í§Þ«Y³z¹LÂà§ë¸ê¤§Æp¥Û¥Í§Þ§ë¸êªÑ¥÷¦³¤½¥q¡A¶¡±µ«ù¦³ÁÞ°ò»PªYÄ£¥ÍÂåªÑ¥÷¡C 2. ¦³ÃöÁÞ°ò¤ÎªYÄ£¥ÍÂå¹wp¤W¥«¤WÂd®É¶¡¡A¤ÎªYÄ£¥ÍÂ嬢½Í±ÂÅvª÷µ¥¨Æ©y¡A½Ð³w¬¢¦U¸Ó¤½¥qµo¨¥¤H¡C |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/3/26 ¤U¤È 07:42:42²Ä 989 ½g¦^À³
|
²q·Q³Ò°È¦¬¤JÀ³¸Ó¬O810ªº§a¡I¥H¦X¤@ªº°Ýµª²q·Qªº ¦X¤@©ó¤½¶}¸ê°TÆ[´ú¯¸¤½§i10¤ëÀç·~¦¬¤J¸ê°T¡A¦³ÃöÀç·~¦¬¤JÅܤƻ¡©ú¬°¡u¥»¤ëÀç·~¦¬¤J¼W¥[¡A¥D«Y³Ò°È¦¬¤J¼W¥[;¥»¦~Àç·~¦¬¤J¼W¥[¡A¥D«Y¼W¥[¦A±ÂÅv¦¬¤J¡v¡C10¤ë¨ÃµL¦A±ÂÅv¦¬¤J¡A¨ä¤¤·í¤ëÀç·~¦¬¤J§¡¬°¬ãµo¤¤¤ß°Êª«¸ÕÅç³B°õ¦æ°Êª«¥\®Ä©Ê»P¦w¥þ©Ê¹êÅ礧¥~³¡³Ò°È¦¬¤J¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/26 ¤W¤È 11:00:49²Ä 988 ½g¦^À³
|
ì¨Ó¬O¨p¶Ò! 6576)¶h¹F-¤½§i¥»¤½¥q¸³¨Æ·|¨Mij¿ì²z²{ª÷¼W¸ê¨p¶Ò´¶³qªÑ 1.¸³¨Æ·|¨Mij¤é´Á:110/03/25 2.¨p¶Ò¦³»ùÃÒ¨éºØÃþ:´¶³qªÑ -------------------------------------------------------------------------- ·|û¡Gdk10140377 µoªí®É¶¡:2021/3/9 ¤W¤È 09:23:24²Ä 934 ½g¦^À³ ¨S¿ù¡A³o´N¬O§Ú»¡Ä_0¤§«eµ¹¬ü¼t½æ¬O¤@¼Ëªº¡C¦pªG¯à½Í¨ì¤j¼t´N¤£¤@¼Ë¤F¡C ¤µ¤Ñ¤S¬O½Ä¤£¤W¥hªº¤@¤Ñ?? «Ü¦n©_³Ò°È¦¬¤J¬O¤°»ò ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ¶h¹F±ÂÅvIntas Pharmaceuticals¡A¥Ñ¬ü°ê¤l¤½¥qAccordt³dCamcevi©ó¬ü°ê¤§¥«³õ¾P°â¡C ±qªÑ»ùªí²{¨Ó¬Ý¡A§ë¸ê¤H¦ü¥G¹ï±ÂÅv¤@®a¦L«×¤½¥q¦³©ÒºÃ¼{¡A¾á¤ß¾P°â¤£¦p¹w´Á¡C |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/3/25 ¤U¤È 05:05:17²Ä 987 ½g¦^À³
|
ªYÄ£«e¦¸¼W¸ê¶i«×: 108/11/8¨Mij¼W¸ê 108/12/27¼W¸ê¤½¶}»¡©ú®Ñ½Z¥»¤W¶Ç 109/02/17²{ª÷¼W¸ê»{ªÑ°ò·Ç¤é ¬ù¤TÓ¤ë¤S¤Q¤Ñ~ ¥»¦¸¶i«×: 110/3/10¨Mij¼W¸ê ... ªÑªF·|¥l¶}¤é´Á:110/06/10 ¼W¸ê»{ªÑ°ò·Ç¤é¥i¯à¦bªÑªF·|¤§«á? ±ÂÅv¦³¾÷·|¦bþ®Éµo¥Í?! ¥t¥~²Ä¤@ª÷ ¦³½æ¤£§¹ªºÄw½X!¼F®`! §¡½u¤]ªÈµ²¦b¤@°_,¬O§_¦b¬~¤@¦¸~ |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/3/25 ¤U¤È 01:10:39²Ä 986 ½g¦^À³
|
¨ÌªYÄ£¥Ø«e±¡ªp¡A¬ù5¢w10¦~´N¬OªÑ¤ý¤F¡C5ÁûÃħC¦ô20»õ¬ü¤¸±ÂÅvª÷¢w600»õ¥x¹ô¢w¨CªÑ1200¤¸¡A30¦~§¡¤À40¤¸¡F5ÁûÃĤÀ¼íª÷§C¦ô3»õ¬ü¤¸¢w90»õ¥x¹ô¡A¨CªÑ180¤¸¡A¦Xp220¤¸¡C ¥H«e¤£À´¥Í§ÞªÑ¡A¬Ý¨ìÀ禬0¤¸¡A´N®`©È¤£´±¸I¡C¬Ý¨£r¤j±M·~±Ôz¤~ºCºCÀ´¥Í§ÞªÑ¡AÁÂÁ±z¡I ¤Ï¦Ó¥Í§ÞªÑÀò§Q¹w¦ô¸û³æ¯Â¡A¤£¹³¹q¤lªÑÅܦ]¦h¡C¥H¤WÓ¤H±À¦ô¡A½Ð¦U¤j¤j«ü±Ð¡C |
|
|
·|û¡G´MÄ_10151381 µoªí®É¶¡:2021/3/24 ¤U¤È 08:15:05²Ä 985 ½g¦^À³
|
·PÁ¦h¦h¤jªºÄÀºÃ¡I |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/3/23 ¤U¤È 10:50:48²Ä 984 ½g¦^À³
|
ÂùÅT¯¥½Ö¥ýÅT³£¬OÅå³ß¡B¤j§Q¦h¡AÂùÅT¯¥«O¦u»ù15»õ¬ü¤¸¡A¤µ¦~n¤WÂd¤]¬O¤j§Q¦h¡C©ú¦~¦³830¡B840¡A«á¦~¶W¯Å630¡C½Ö¯à«rºòªÑ²¼¤£½æ¡A¤~¬O¯u¥\¤Ò¡C¤j®a¥[ªo¡I |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/3/23 ¤U¤È 04:33:44²Ä 983 ½g¦^À³
|
½²¤j¤@°_¥[ªo ´I¥Ð¬O¹B®ð¦n¤@¨Ç ¶Rªº®É¾÷ÂI¤ñ¸û¦n ªYÄ£¤¶¤J¦b90ªìÀY ¥Ø«e¤p½ß ¬Oªø´Áªº¸êª÷ ¥ýµ¥«Ý810©M610ªº±ÂÅv¶i«× ¤£ª¾R¤j»¡ªº¤û¦~ÂùÅT¯¥¡AþÓ·|¥ýÅT? |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/3/23 ¤U¤È 02:42:55²Ä 982 ½g¦^À³
|
´MÄ_¤j: ±z¾á¼~¤F,¥h¦~©³¶h¹F¤£¬O¿ì¤F²{¼W? ¦bú´Ú«e¦³¤¤°ê±ÂÅvú´Ú«á¦³¬ü°ê±ÂÅv ¤ÏˬO¶h¹F²{¼Wªº¤½¶}®Ñ©ú®Ñ¦³Åv§Qª÷ªº¹w¦ô¦¬¤J¥i±Àª¾¶i«×¤@¤G «Ü´Á«ÝªYÄ£ªº¤½¶}»¡©ú®Ñ¬O«ç»ò¼gªº,¦ý§Ú·Q¤]¤£·|¼g¤~¬O!! ¥h¦~12/21«°T º¡¤TÓ¤ë¤F ÁÙ¬O¨S°ÊÀR~ µ¥ªü,µ¥µ¥µ¥µ¥µ¥... |
|
|
·|û¡G´MÄ_10151381 µoªí®É¶¡:2021/3/23 ¤U¤È 02:33:12²Ä 981 ½g¦^À³
|
3/10¤½§i¸³¨Æ·|¨Mij¿ì²z²{¼W¡A¬O§_·N¿×µÛ¤µ¦~«×¤£·|¦³±ÂÅvª÷©Î¨½µ{¸Oª÷¤J±b¡H |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/3/23 ¤W¤È 08:43:37²Ä 980 ½g¦^À³
|
ªü§»§ë¸ê¼Ðªº¸ò§Ú¹p¦P¡A¤£¹L±z¸û±jÁÙÁÈ¿ú¡A§Ú´I¥ÐÁ«50¸U¤¸¡A«e´X¤Ñ¥þ³¡¶]¨ìªYÄ£¨Ó¡C«¥ªYÄ£¬O§Ú¥Ø«e³Ì¬Ý¦nªºªÑ²¼¡A¤@°_¥[ªo¡I |
|
|
·|û¡G¤p¤å¤l10144877 µoªí®É¶¡:2021/3/21 ¤W¤È 10:09:39²Ä 979 ½g¦^À³
|
¾¾¹À©OÎN¹À«¡¤j¡G §A¦³µo²{±M§Q¤¤¦³Ô£¿ß¿°¶Ü¡C¡C¡C |
|
|
·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2021/3/20 ¤U¤È 10:33:26²Ä 978 ½g¦^À³
|
Ãö©ó±M§Q patents.justia.com/assignee/sinew-pharma-inc |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/3/20 ¤W¤È 09:04:08²Ä 977 ½g¦^À³
|
¶¢¶¢¨Ó¬Ý ¨S³o§Öªº·Pı ------- °ÝSNP-810²£«~¬ãµoµ¦²¤¬°¦ó¡H §Ú̲{¦b¬O¤@Ãä¥Ó½Ð¬ü°ê FDAªºOTC¡A monograph¡A¤@Ãä½Í°ê»Ú±ÂÅv¡A´Á±æ¦b³Ì¾A©yªº±ø¥ó¤U¡A¹F¦¨±ÂÅv¨Ã¤W¥«¡C SNP-810¬ãµoªºµ¦²¤¬°¦³¤GÓ¥D¶b¥¦æ¶i¦æ¡A¤@¬O¡u¦X§@±ÂÅv¡v¡A¤@¬O°µ¼Ï¯Ã¸ÕÅç¡A¡u¨ú±oÃÄÃÒ¡v¡A¦A¥Í²£¾P°â¡C±ÂÅv»P¼Ï¯Ã¸ÕÅç»ôÀY¨Ã¶i¡C ¡u¦X§@±ÂÅv¡v¥Ø«e¶i«×¨}¦n¡A¥xÆWFDA¼Ï¯Ã©Ê¸ÕÅç¤]¤w®Öã¶i¦æ¡C SNP-810²£«~¬ãµoµ¦²¤¬°¥Ó½Ð¦U°êÃÄÃÒ¡A§¹¦¨Á{§É¸ÕÅç«á¡A¦A¥Ó½Ðק令µL¨x¬r©Ê¤§¥é³æ¡A¥i¥ý¥H±M§Q¤Îµoªíªº½×¤å¶}©l¡A¨Ã¥i±ÂÅv¥H OTC¤è¦¡³c½æ¡C ²{¦bªºÃÄÃҥӽЬO¦h¤è¨Ã¶i(¤@)¥Ó½Ð¬ü°ê monographªºOTCÃÄ«~ (¤G)¥Ó½Ð¥xÆW¾Ç¦WÃÄ(¥Î·s±M§Q°t¤è¦ý¼È¤£×§ï¥é³æĵ»y) (¤T)¼Ï¯ÃÁ{§É¸ÕÅ秹¦¨«á¦A¥Ó½Ð¥xÆW°§C°Æ§@¥Î¤§·sÃĤΥӽЬü°ê505b2·s¾¯«¬·sÃÄ(µL¨x¬r©Ê·sÃÄ)¡F ¥t¡ASNP-810¥Ó½ÐUS FDA ¤ÎTFDA¤W¥«¡A¤]¯à¼W¥[¹ï¥@¬É¤jÃļt±ÂÅv½Í§PÄw½X¡A¨Ã¦³§U©ó½Æ¤è¤îµhÃĪº¬ãµo¡A¬O¾P°âµ¦²¤¤§¤@¡I |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/3/19 ¤U¤È 04:56:02²Ä 976 ½g¦^À³
|
R¤j±M·~ «e³~¥¼©ú/«á¦³°l§L ´Á±æ·sÃĦ³¦n®ø®§¾¨§Ö«Å¥¬ µ¹°l§LªïÀYµhÀ» ¥Ø«e´N¥u¯àµ¥¤U¥h¤F -------------------------------------------------------- 2020.11.21--Paracetamol analogues conjugated by FAAH induce TRPV1-mediated antinociception without causing acute liver toxicity FAAH°¸Ápªº¼³¼ö®§µhÃþ¦üª«¥i»¤¾ÉTRPV1¤¶¾ÉªºÂíµh§@¥Î¡A¦Ó¤£·|¤Þ°_«æ©Ê¨x¬r©Ê |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/3/17 ¤U¤È 09:46:39²Ä 975 ½g¦^À³
|
½Ð°Ý ¸m³»ªº¸ê®Æ ªÑ¥»¯à§ï¤@¤U¶Ü |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/17 ¤U¤È 12:41:49²Ä 974 ½g¦^À³
|
Âi±¤W§Ú©Ò¬Ý¨ì§ë¤J¶}µoµL¨x¬r©ÊAPAPªºÄvª§ªÌ: 1.즨¤ÀAPAPªº·s½Æ¤èÃÄ:ªYÄ£»P1®a¬ü°ê¶¤ 2.APAPµ²ºcÃþ¦üª«:3®a¬ü°ê¶¤¡A1®a¼Ú¬w¶¤¡C ---------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/8 ¤U¤È 08:57:53²Ä 926 ½g¦^À³ «ç»ò¶}©l¬y¦æ¦Y¿}ªvÀø¨x¬r???(ÁÙ¯u¦³®Ä!) 2021.2.23 °ªªG¿}¶¼¹¥i¥H¹w¨¾ÃĪ«¤Þ°_ªº¨x·l¶Ë¶Ü¡H aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep4.1683 ¤@Ó¬ã¨s¤p²Õ±´°Q¤F¦b¤p¹«¤¤¹ï¤A酰®ò°ò×ô¹L¶q®É¹¥Î´I§tªG¿}ªº¶¼¹ªº«OÅ@¯à¤O¡C ..±i¼w±j³Õ¤h»â¾Éªº¤@¶µ·s¬ã¨s¤¤¡C±K·²®Ú¤j¾ÇÂå¾Ç°|¤À¤l»P¾ã¦X¥Í²z¾Ç¨tªº¤@¦ì¬ã¨s¤Hû¡A®ï±Ð±Â©M¤@²Õ¬ã¨s¤Hû..¡§§Ú̵o²{¡A¦b¤p¹«¤¤¡A¦b¹ï¤A酰®ò°ò×ô¹L¶q¤§«eµu®É¶¡¹¥Î°ªªG¿}¶¼¹¹ê»Ú¤W¥i¥H´£¨Ñ§Ü¨x·l¶Ëªº«OÅ@¡A¡¨ Yin»¡¡C¡§³o¯u¥O¤HÃø¥H¸m«H¡C¡¨ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/17 ¤U¤È 12:12:54²Ä 973 ½g¦^À³
|
SNP-810Ävª§¹ï¤â¦A+1(¼Ú¬w¶¤¡A¤]¬OAPAPµ²ºcÃþ¦üª«)! 2020.11.21--Paracetamol analogues conjugated by FAAH induce TRPV1-mediated antinociception without causing acute liver toxicity FAAH°¸Ápªº¼³¼ö®§µhÃþ¦üª«¥i»¤¾ÉTRPV1¤¶¾ÉªºÂíµh§@¥Î¡A¦Ó¤£·|¤Þ°_«æ©Ê¨x¬r©Ê ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/16 ¤U¤È 04:13:56²Ä 790 ½g¦^À³ SNP-810Ävª§¹ï¤â¦A+1¡A¬ü°ê¶¤¤w¦³3®a(¦³2®a®³¨ì¬ü°ê°ê¥ß½Ã¥Í¬ã¨s°|¡]NIH¡^ÃÙ§U)!!! 3®a¬ü°ê¶¤¥þ¬OAPAPµ²ºcÃþ¦üª«¡A»PªYÄ£SNP-810(¨Ï¥Îì¨Ó¦³®Ä¦¨¤À¡A¤S¤£¦A¦³¥ô¦ó¨x¬r©Ê)§@¥Î¾÷¨îºIµM¤£¦P¡C |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/3/16 ¤U¤È 05:36:43²Ä 972 ½g¦^À³
|
¥»©P¤é´N¬O»P°ê»ÚÃļtñqSNP-810¬ãµo¦X§@¨óij«°T¤½§iªº¤TÓ¤ë¬ö©À¤é¤F~ ¥Ñ©ó¤½¥qªº¤£³z©ú,¥u¦n¦X²zªº±À²z·Q¹³¤@¤U §ë¸ê§O®a¥Í§ÞªÑ³£¥i¥H¸g¥Ñ«°T¹w¦ô¥i¯àµo¥Íªº®É¶¡ÂI,ªYÄ£¦ü¥GµLªk±À¦ô ¬O¬°¤FÁקKµu½u«È¾Þ§@?¥u¿W«p¶Ì©I©Iªºªø½u§ë¸ê¤H!!?? ¬d¤F³\¦h¿ì²z²{¼Wªºq»ù¤è¦¡¤j¦h¥H¤U¦C¬°·Ç: ¹ê»Úµo¦æ»ù®æÀÀ±ÂÅv¸³¨Æªø¨Ì¾Ú¡u¤¤µØ¥Á°êÃÒ¨é°Ó·~¦P·~¤½·|©Ó¾P°Ó·|û»²¾Éµo¦æ¤½¥q¶Ò¶°»Pµo¦æ¦³»ùÃÒ¨é ¦Û«ß³W«h¡v²Ä¤»±ø²Ä¤@¶µ³W©w¡A¥Hq»ù°ò·Ç¤é(°£Åv¥æ©ö¤é«e¤ÓÀç·~¤é)«e¤@¡B¤T¡B¤ÓÀç·~¤é¾Ü¤@pºâ¤§ ¥»¤½¥q´¶³qªÑ¦¬½L»ù²³æºâ³N¥§¡¼Æ70%~90%¤º»P¥D¿ì©Ó¾P°Ó¨Ì·í®É¥«ªp¦@¦Pij©w¤§¡C ¤½¥q³ºµMq¤F¤@Ó120¤é§¡»ùªº¤K§é°_¸õ»ù ¥t¥~¦b¥xÆW¥Í§Þ¤½¥q¥Ó½Ð¼W¸ê¤Ö¦³¤@¦¸¹LÃöªº,¥¼¨Ó¨ì¹ê»Ú²{¼W¿ì²z¥i¯àÁÙn³\¤[ ³o¤¤¶¡¬ð¦p¦³±ÂÅvªÑ»ù½Ä¤Ñ,¨ºq»ù¶Õ¥²«Ü°ª,©Ò¥H±Ä¥Î120¤é§¡»ù? ©Ò¥H¼ÖÆ[¹w¦ô±ÂÅv¦b±æ!! ¨ä¥L½Ñ¦p¬ü°êOTCÀòã,630®Öã¸ÕÅç©M§Y±N¥i¯à¨ú±o¥xÆW¾Ç¦WÃÄÃÒ³q³q¨S¬Ý¨ì¨Æ«e¤½¥¬°e¥ó¸ê°T ³o¤]¤Ó¯S¨Ò¤F!¤Ö¦³¤½¥q¦p¦¹¯«¯µ§C½Õ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/16 ¤U¤È 02:27:57²Ä 971 ½g¦^À³
|
¦]¬°¶}µo¤£¥XµL¨x¬rAPAP¡A¦³¥i¯à³Q¸T¡A©Ò¥HJ&J¤l¤½¥qMcNeil(Tylenol)¤£¿ò¾l¤O¸ê§UAPAP¸Ñ¬r¾¯NAC¶}µo¡C 1. 1988.12.15---Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985) www.nejm.org/doi/pdf/10.1056/NEJM198812153192401 ..Supported in part by McNeil Consumer Products 2. 2008.7.17---Acetylcysteine for Acetaminophen Poisoning ....Dr. Heard reports receiving grant support from McNeil Consumer Products ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/15 ¤U¤È 07:58:11²Ä 967 ½g¦^À³ ...ÅýÂå¾Ç±M®aWilliam M. Lee³o»ò¼g:¦pªG¨S¦³¸Ñ¬r¾¯¡AAPAP¥i¯à¦´N³Q§¹¥þ¸T¤î¤F¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/16 ¤U¤È 12:39:13²Ä 970 ½g¦^À³
|
¥Í§ÞÂåÀø»sÃIJ£·~¤½¥qY¥H¬ì§Þ¨Æ·~¨¤À¥Ó½ÐªÑ²¼¤W¥«©Î¤WÂd¡A°£³]¥ß¦~¤£¨ü¨î¥~¡AÀò§Q¯à¤O¥ç¤£¨ü¨î¡A¶È¨ü¡u³Ìªñ´Á²bȤ£§C©óªÑ¥»2/3¡v³W½d¡F home.kpmg/tw/zh/home/insights/2018/08/tw-kpmg-healthcare-12-courses-ch7.html ¦b¥_·¥¬Ý¨ì¡A©Î³\ªYÄ£ªº¼W¸ê°£¤FÀç¹B¥Î³~¡A¬O§_¤]¦³¤W¥«Âd«e´£°ª²bȪº¦Ò¶q? |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/3/16 ¤W¤È 11:09:16²Ä 969 ½g¦^À³
|
ÁÙ¬O±j½Õ§ë¸ê¬O¦Û¤wªº¨Æ¡A¦³ªø¦³µu¡C®³·ç¹©¨Ó¤ñ³ë¤]¤£¥¢¦n¨Ò¤l¡A¦ý·ç¹©³£·|°t®§¡C¥Í§Þ³£¬O©MªÑªF®³¿úªº¦h¡C¤§«e»¡¹L¤F¡A®³¦X¤@(¬u²±)¨Ó¤ñÁÙ¦X¾AÂI¡CÄ@·N½äªº´N©ñ¡A¤£n½äªº³£¨«¡AÄ@½äªA¿é¡C¨S¤º½u´N¥u¯à¾a¦Û¤w¡C¤O´¹/´I¥Ð³£³ø«Ü¤[¡C¤O´¹ÁÙ§Ú¤u¹D¡C¦ý´I¥Ð´N........... ¤½¥q¦³«O±KÀ£¤O¡A¤£«K¦^µª¤]³\============>¦Ü¤Ön¦^À³¦³«O±K¤£¯à¦^µª§a¡A¥u¬O¥s§A¥hºô¶¤W¯d¨¥¡A¯d¤F¤S¤£¦^¡A¬O¨º©Û¡F¤§«e§ë°¿é¤@¥b¤]¬O¦]¬°¤u¥q¤£³z©ú |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/3/16 ¤W¤È 12:23:06²Ä 968 ½g¦^À³
|
±qÂX¤j¦X§@¨Æ©y±À·Q¤@¦¸¦Y¨âÁûºâÀu´f»ù¤]¦Eºâ¡A¥[¤W630§¹¦¨¡A¦Ü¤Ö2023¦~±N·|¬O¸û¬ü¦n§ë¸ê®É¶¡¡A¶V¤[¶V²z·Q¡C¹jÂz·ç¹©¤]¬O10¦~¥H¤W§ë¸ê¡Aªñ´Á¤~¤jÃzµo¡AÁöµM¨S¦³§ë¸ê¡A¤]¯¬ºÖ¥L们¡C·|Á|·ç¹©¨Ò¤l¡A¬O«jÀy¤j®an¦³@©Ê¡A¥]¬A¦Û¤v¡C¤j®a¦@«j¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/15 ¤U¤È 07:58:11²Ä 967 ½g¦^À³
|
2020¦~¤j³°±ÂÅv24¥ó¡A¦³7¥ó(~30%)¨S¦³¤½¥¬[¤Þ¶i¤è]©Î[±ÂÅvª÷ÃB]©Î [±ÂÅv²£«~]¡C ¦ý¬OªYÄ£:¦³³Ì·s¶i®i¡A±NÀH®É¤½§i--->³o¥y¤£¬Oªí©ú·|¤½¥¬¦a·N«ä? ¦³¨x¬rAPAP¬JµMÅýFDA³o»òÀYµh¡AÅý¯Ã¬ù¯kµhºÞ²z±M®aHausknecht³Õ¤h³o»ò»¡:®õ¿Õ¬O¡§¨´¤µ¬°¤î³Ì¦MÀIªºÃĪ«¡AÅýÂå¾Ç±M®aWilliam M. Lee³o»ò¼g:¦pªG¨S¦³¸Ñ¬r¾¯¡AAPAP¥i¯à¦´N³Q§¹¥þ¸T¤î¤F¡C(´M§ä¤@ºØ·sªº¤îµhÃÄ¡A¸Ó¤îµhÃĪº¯S©Ê»PAPAP¬Û¦P¦ýµL¬r©Ê...³oºØ·s«¬¤îµhÃĪº¦^³ø±N¬O¥¨¤jªº)¡C ¥[¤W2®a¥DnªºAPAP¤jÃļt½T¹ê·mµÛn....¡A¤Ï¥¿±ÂÅvª÷Y¬O°ª¤£¥ÎÁ§ڡA§C¤]§O«è§Ú´N¬O! -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/11 ¤U¤È 02:48:09²Ä 956 ½g¦^À³ 2020¦~¤¤国药¥øLicense out¤õÃz¡I热门¥æ©ö领°ì¥¼变www.cccmhpie.org.cn/Pub/1773/177541.shtml §ó¥¿:¦³7®a¨S§åÅS¡A¨ä¤¤2®a¬O¤£¤½¥¬[¤Þ¶i¤è]¡A¦ý¦³¤½¥¬±ÂÅvª÷ÃB¡C «ö¦³¤½¥¬±ÂÅvª÷ÃB±Æ§Ç¡A¦X¤@FB825ªº5.3»õ¬ü¤¸¬O²Ä6¦W¡C |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/3/15 ¤U¤È 07:20:08²Ä 966 ½g¦^À³
|
¦pªG¬Ý¦n810±ÂÅv¡A§Úı±oÁÙ¬O´¤µÛªù²¼¸û¦n¡A§Ṳ́£¬O¯«¡A¤]¤£¬Oµu½u°ª¤â¡A½æ°ª¶R§C°µ»ù®t¡A¸U¤@±ÂÅv¤½§i³Q¬~¥X¥h¨º´N«è¹Ä¤F¡A810ªº¬ü°êÃÄÃÒ³q¹L«áº¦¤F´X¤Ñ¡AªÑ»ù¨S¦h¤[¤S¦^¨ìÃÄÃÒ¥¼³q¹L®ÉªºªÑ»ù¤F¡A¤]¬O¦³ÂIµL©`¡A¥Ø«e±b±Á«·l5¦ì¼Æ¡A¦AÄ~Äò¶^¡A¥i¯àÁ«·l´N·|¯}6¦ì¼Æ¤F😳¡C¨S¤l¼u¥[½X¤F¡A³£¦³ÂI·Q½æ´X±i´I¥Ð¨Ó¥[½X¤F¡A´I¥Ð³£©ê2¦~¦h¤F¡AªYÄ£µ¹§A©êӦܤ֤@¦~¡A¤£«H¤µ¦~¤º810±ÂÅv¨S¶i«×¡A¥[ªo¡C |
|
|
·|û¡G½²ºû¤¯10143700 µoªí®É¶¡:2021/3/15 ¤U¤È 06:21:46²Ä 965 ½g¦^À³
|
¤½¥q¦³«O±KÀ£¤O¡A¤£«K¦^µª¤]³\¡F¨üÅvª÷ÃB¬O«ÂI¡A¤]¬O«O±K¥Dn¡F§Ú̪ѪF²q²qˬO¥i¥H¡A§Ú²q5¢w8»õ¬ü¤¸¡F¦n©_Åv«Âr¤j¤ß¤¤ªº·Pı»ù¡H |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/3/15 ¤U¤È 05:49:06²Ä 964 ½g¦^À³
|
·«B«eªº¹çÀR??ÁÙ¬On¸¨¶]ªº«eÆJ?? °Ýªº°ÝÃD¡A¤½¥q³£¤£¦^À³¡A¬Ý¨Ón¥h¤@½ëªÑªF·|¤F¡A¦ý¦pªGªÑªF·|«e³£ÁÙ¨S¦n®ø®§¡AªÑ»ù´N....... |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/3/12 ¤U¤È 08:27:11²Ä 963 ½g¦^À³
|
ì¨Ó¬O³o¼Ë°Ú¡AÁÂÁÂR¤j»¡©ú¡C§Æ±æSNP8¨t¦C¯à¦¤é±ÂÅv¦¨¥\¡C´Á«Ý¼W¸ê«e¤½¥q¤]¦³§Q¦hµo¥¬¡A¨ë¿E¤@¤UªÑ»ù¡A¥[ªo¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/12 ¤U¤È 05:32:22²Ä 962 ½g¦^À³
|
±`¨£¤îµhÃÄ¥i°Ï¤À¬°¤TºØ¡A®ÄªG¥Ñ®z¨ì±j¤À§O¬O¡G 1.¤AñQÓi×ô (acetaminophen)------SNP-810³Ì¤j§Q°ò¦b©ó¸Ñ¨MAPAPªº¨x¬r©Ê(³Ì¤j©ÎªÌ»¡¬O°ß¤@ªº¸nªù)¡A ¤îµh®ÄªG¨ä¹ê¬Û·í(»´«×¨ì¤¤«×¯kµh)¡CAPAP¬O¨ã¦³°h¿N¥\¯à¡A¥i½w¸Ñ½Ñ¦h¤é±`¯kµh¦pÀYµh¡B¤úµh¡B¦Ù ¦×µmµhµ¥¡C 2.«DÃþ©T¾J®øª¢¤îµhÃÄ (NSAID)--ªø´ÁªA¥Î®e©ö¤Þ°_G¸z¹D¼ìºÅ (¤]¦³Ãļt¦b§ð§J³o¸nªù)¡C 3.¾~¤ùÃþ¤îµhÃÄ (opioid analgesics)---¦b¸~½F¤è±ªº¤îµh®ÄªG»P»ù®æ¦]¯À¡A«ÜÃø³Q¥þ±¨ú¥N(¦pªG¤£¦s¦b¬rÅ} ©Ê°ÝÃD¡AÀ³¸Ó¬O¯«ÃÄ)¡C ÁöµM©³¤UªºÁpÃĪvÀø¦³±j¤j¤îµh®ÄªG¡A¦ý³o¬O¤ú¬ì¤è±ªº¼Æ¾Ú¡A¥i¯à¤£¾A¥Î©óÀù¯g¡C ------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/1 ¤W¤È 11:11:55²Ä 882 ½g¦^À³ 2018¦~¬ü°ê¤ú¬ì¨ó·|´Á¥Z«Ê± ¥¬¬¥ªâ(Advil)©M¹ï¤A酰®ò°ò×ô(APAP)ªº²Õ¦X [Àu©ó] ©Ò¬ã¨sªº¥ô¦ó§tªü¤ùÃþªº¤îµhÃĪ«¡C |
|
|
·|û¡Gªü§»10146981 µoªí®É¶¡:2021/3/12 ¤U¤È 04:26:34²Ä 961 ½g¦^À³
|
~5¦~¤ÆÀø30¦¸ªº§Ebºö¦¨¥\¹ï§Ü¯fÅ]¡A°Z®Æ¹L¦~«e´_µo¡A¨x¸ò²O¤Ú¥X²{Àù²ÓM¸~½F¡A¦o©ó2¤ë¤J°|¹q¿NªÍ³¡ªº1Áû¸~½F¡A¦ý¥»¨¹ï¶Ü°Øµ¥¤îµh¾¯¹L±Ó¡A¦bÂå¥Í«Øij¤U¤£¬I¥´¡A¨Ï±o¦o¦bªvÀø¹Lµ{¤¤µh¨ì¤ú¾¦¤£Â_Ÿ§Ý. ®z®zªº½Ð±ÐR¤j SNP810ªº°Ý¥@ ¹ï¸Ñ±Ï³oÃþ±wªÌ¬O¤£¬O¤@¤jºÖµ©O? |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/3/12 ¤U¤È 02:44:48²Ä 960 ½g¦^À³
|
¤G´ÁÁ{§É 610 2021 Q4 630 2023 Q3 ¼Ï¯Ã¸ÕÅç ¥Ó½ÐÃÄÃÒ 810 2020 Q4 2021 Q2 830 2021 Q2 2021 Q4 840 2021 Q2 2021 Q4 ¥H¤W¬°¥h¦~¤½¥qºô¤Wªº°T®§¡Apo¨S¦h¤[´NºM¤U¤F¡A§ï¦¨¥Ø«eªº |
|
|
·|û¡G¤p¤å¤l10144877 µoªí®É¶¡:2021/3/12 ¤W¤È 05:56:33²Ä 959 ½g¦^À³
|
¥xÆW°ê²£¬Ì]±Ò°Ê²Ä¤G´Á¤HÅéÁ{§É¸ÕÅç¡A¹wp©Û¶Ò3700¦W¨ü¸ÕªÌ¡C¡C¡C¬Ì]¤HÅé¸ÕÅ糺¦³ª÷¿ú¦^õX¡A·í¤Ñ©â§¹¦å´N¥ý»â¤d¤¸¡A1¤HÁ`¦@¥iÀò1¸U3¤d5¦Ê¤¸¡C¡C¡CÃø©ÇÁ{§É¸ÕÅç«D±`¿N¿ú¡C¡C¡CªYÄ£¨x·sÃıҰʥx¬ü¤GÃä¦P®ÉÁ{§É¤G´Á¡A¦p¨S·N¥~¡A¹wp¤µ¦~¤»¤ë¶}©l¦¬®×¡A§Æ±æ©¡®É¦³¦n®ø®§ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/11 ¤U¤È 04:04:01²Ä 958 ½g¦^À³
|
±qµïµ·°¨¸ñ¨Ó¬Ý¡A1¤ë»P2¤ëªº³Ò°È¦¬¤J(~100%¬OªYÄ£¬£û»Y¼t§Þ³N«ü¾É¶O)»PSNP-610¬ÛÃö! 2020.12¤ëÀ禬46¸U¤¸¬O»P¦X¥þÃÄ·~»´ä¦³¤½¥q©e°UÃÄ«~¦X¦¨¬ÛÃö¨Æ©y ¦X¥þÃÄ·~»´ä¦³¤½¥q¬OÃÄ©ú±d¼w(¤¤°ê±Æ¦W«e¤T¤jÃļt)ªº¤l¤½¥q¡C ---------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/31 ¤W¤È 09:03:12²Ä 645 ½g¦^À³ SNP-610[¬°°t¦X°ê»Ú¤jÃļt¤§¦X§@¡B§ÞÂà¡B±ÂÅv¤§»Ýn ]¨Æ¥ó®É¶¡¶b 1. 2018-09-21 ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/20 ¤W¤È 05:26:34²Ä 525 ½g¦^À³ 2018-09-21 [¾Ú¤F¸Ñ¡A¤¤°ê±Æ¦W«e¤T¤jÃļt¤w¸g©MªYÄ£¶i¤@¨B¬¢½Í¡C]??? www.gbimonthly.com/2018/09/32593/ ....ªYÄ£Á`¸g²z¦¶³Í¥ÁÂå®vªí¥Ü¡ASNP-6¨ã¦³¦h«§@¥Î¾÷Âà... 2. 2020¦~7¤ë ´Á¤¤¤ÀªRµ²ªG¥¿¦V SNP-610¶}©ñ¦¡Á{§É¤G´Á¬ã¨s¤wÀò±oÅãµÛ¤HÅéÀø®ÄÃÒ¾Ú...¥Ø«e¤´¦b¶i¦æ¤¤¡A¹wp¨ì109¦~©³¡C 3. 2020¦~10¤ë29¤é ·|û¡GROGER588910148151 µoªí®É¶¡:2020/10/29 ¤U¤È 09:24:42²Ä 373 ½g¦^À³ SNP-610¬°°t¦X°ê»Ú¤jÃļt¤§¦X§@.±ÂÅv.§ÞÂध»Ýn¤w§¹¦¨....(¦rùئ涡¥[²`¶Â¦r¦³¬Æ·N«ä???) 4. 2020.12¤ë ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/8 ¤U¤È 02:53:10²Ä 471 ½g¦^À³ 1~11¤ëÀ禬0 12¤ëÀç·~¦¬¤J46.2¸U--«Y¾P°â¹«~¤¤¶¡Åé©ÒP¡C 5. 2020/12/29 ¤½§i¥»¤½¥q¯×ªÕ¨xª¢·sÃÄSNP-610¨ú±o¬ü°ê±M§Q ....²{¥¿¿n·¥±À°Ê°ê»ÚÃļt¦X§@©Î±ÂÅvµ¥¨Æ©y¡C ----------------------------------------------------------------------------------------------- |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/3/11 ¤U¤È 03:17:46²Ä 957 ½g¦^À³
|
µo¦æ»ù®æ:¼Èq¬°q»ù¤é«e¤»Ó¤ë¤º¿³Âd¦¨¥æ§¡»ù¤§80%~100% ¤£¬O±Ä¥Î¤@¯ë30¤Ñªº¥æ©ö¤é§¡»ù!! ¬Ý¬Ý²{¦b¥b¦~½u¦bþ78.52½w¨B¤W¤É¤¤~ ¦pªG©w»ù«e¤½¥¬±ÂÅv¨g¼Q ì©lªÑªF©Mû¤u¶Õ¥²n¥I¥X§ó°ª¸êª÷»{ÁÊ (¦¹®É¥i¯à±Ä¥Î§¡»ù80%©w»ù) ©w»ù«á¤½¥¬±ÂÅv´N±Ä¥Î100%?¤Ï¥¿¤j®a³£Ãº±o°_(É°ª§Q¶U¤]¦Eºâ) ©¹¦n³B·Q ´N¬OªÑ»ùnÀ£§C¯}©³¥b¦~½u¾÷·|¤£¤j ±Ä¥Î180¤Ñ¬O©È¸U¤@©w»ù«e¤½¥¬±ÂÅv,¦pªG±Ä¥Î30¤Ñ§¡»ù¨CªÑn»ù250¨º°Z¤£¬O¨S¤Hú±o°_~ ¦]¬°¦³²{¼W«Ü¦hª£µu¨S@¤ßªº¤µ¤é°h³õ?©^ÄUnª±¥Í§ÞªÑªºµu½u«È§O¶i³õªü ·|³Q¾ã«Ë~ ²{¼W¥Ó½Ð¨ì¿ì²z§¹¦¨¦Ü¤Ö¤TÓ¤ë¥b¦~§a~½T¹ê±ÂÅvÂI¨ì©³¦bþªü!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/11 ¤U¤È 02:48:09²Ä 956 ½g¦^À³
|
2020¦~¤¤国药¥øLicense out¤õÃz¡I热门¥æ©ö领°ì¥¼变www.cccmhpie.org.cn/Pub/1773/177541.shtml §ó¥¿:¦³7®a¨S§åÅS¡A¨ä¤¤2®a¬O¤£¤½¥¬[¤Þ¶i¤è]¡A¦ý¦³¤½¥¬±ÂÅvª÷ÃB¡C «ö¦³¤½¥¬±ÂÅvª÷ÃB±Æ§Ç¡A¦X¤@FB825ªº5.3»õ¬ü¤¸¬O²Ä6¦W¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/11 ¤U¤È 02:02:24²Ä 955 ½g¦^À³
|
¤£©ÜÅS¤£·|¨u¨£°Ú¡AªYÄ£:¦³³Ì·s¶i®i¡A±NÀH®É¤½§i--->³o¥y¸Ü§Ú¦a¸ÑŪ¬O·|¤½§i¡C 2021¦~01¤ë04¤é·s®ö医药www.cccmhpie.org.cn/Pub/1773/177541.shtml ¦³5®a¨S©ÜÅS(1®aAbbVie/1®a½÷·ç...) 2020¦~¤j³°¤Ñ¹Ò»PAbbVie±ÂÅv°O¿ý30»õ¬ü¤¸ Orz. Orz. Orz.¨ØªA¦Ü·¥! ------------------------------------------------------------------------------------ ·|û¡G´MÄ_10151381 µoªí®É¶¡:2021/3/11 ¤U¤È 01:21:49²Ä 950 ½g¦^À³ ñ¬ùª÷À³¸Ó¦bñ¬ù®É´Nn»{¦C¡A¦A¥[¤W¨u¨£ªº¤£¤½§G¤º®e¡A¦³¥i¯à®Ú¥»´N¨S¦³....¡H¡H¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/11 ¤U¤È 01:42:48²Ä 954 ½g¦^À³
|
³o´XӤ몺³Ò°È¦¬¤J¤£¯à½T»{´N¬O»PSNP-810¬ÛÃö³á¡A¤]¦³¥i¯à¬OSNP-610!!! ------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/8 ¤U¤È 08:23:00²Ä 764 ½g¦^À³ ¤]¦³¥i¯à¬O³oµ§! 12¤ë³¯ó¥ý¦æ¡A 1¤ë¬£û¨ì¼t§Þ³N«ü¾É¡C --------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/21 ¤U¤È 04:22:05²Ä 811 ½g¦^À³ SNP-810:¥@¬Éº¤äµL¨x¬rAPAP·sÃÄ¡A2020.12.23¸ò°ê»Ú¤j¼tñ¦X§@¨óij! SNP-6:P2¼Æ¾ÚÀu©ó¹w´Á·|¦b2020®Öã¤W¥«ªº Ocaliva¡]µ²§½¬O³QFDA§_¨M)! ¥çÀu©ó±µ¤U¨Ó·~¬É»{¬°2023¦~²Ä1¤ä¤W¥«ªºNASHÃĪ«: MGL3196¡]Resmetirom¡^? 2020.12¤ëÀ禬46¸U¤¸¬O»P ¦X¥þÃÄ·~»´ä¦³¤½¥q 109/12~ÃÄ«~¦X¦¨¥X³f ©e°UÃÄ«~¦X¦¨¬ÛÃö¨Æ©y 2021.1¤ëÀ禬264¸U¡A³Ò°È¦¬¤J ¦Ñ½Õ«¼u¡A°£¤Fµ¥ÁÙ¬Oµ¥¡A§OµL¥Lªk¡A¦]¬°±µ¤U¨Ó¤½¥¬ªº·¥¦³¥i¯à´N¬OSNP-810©ÎSNP-610ªº±ÂÅv? ---------------------------------------------------------------------------------------------- ·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/2/8 ¤U¤È 02:59:09²Ä 761 ½g¦^À³ ¤W¤ëÀ禬264¸U¡A³Ò°È¦¬¤J ------------------------------------------------------------------------------------------- ·|û¡G¾¾¹À©OÎN¹À«¡10150521 µoªí®É¶¡:2021/1/19 ¤U¤È 10:44:38²Ä 524 ½g¦^À³ ¦~³ø¦³§ó·s¤WӤ리¤J¬O»P ¦X¥þÃÄ·~»´ä¦³¤½¥q 109/12~ÃÄ«~¦X¦¨¥X³f ©e°UÃÄ«~¦X¦¨¬ÛÃö¨Æ©y |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/3/11 ¤U¤È 01:39:37²Ä 953 ½g¦^À³
|
¨S¦³±ÂÅvª÷¡C¥u¦³Ã±¬ùª÷»P¨½µ{ª÷ ³Ò°È¦¬¤J·|¤£·|¬O¦X§@¨óij¬£¤H¥h°ê»Ú¤j¼t¨ºÃ䪺¥´¤u¶O |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/11 ¤U¤È 01:35:32²Ä 952 ½g¦^À³
|
ªYÄ£»P°ê»ÚÃļtñqSNP-810¬ãµo¦X§@¨óij ¡P¥»¤½¥qSNP-810·sÃÄ»P°ê»ÚÃļtñq·sÃĬãµo¦X§@¨óij¡A¶i¦æÀø®Ä½T»{µ¥¬ÛÃö¹êÅç¡A°ê»ÚÃļt¨Ì¾Ú¥»¦X§@¨óij±N¤ä¥I¥»¤½¥q¤@©wª÷ÃB¤§Ã±¬ùª÷¤Î¨½µ{¸Oª÷¡C ²{¥¿¿n·¥¶i¦æ½T»{¸ÕÅç confirmation study)¤¤¡A¦³³Ì·s¶i®i¡A±NÀH®É¤½§i¡C ------------------------------------------------------------------------------------------ ¥H¤W¤½¥qì¤å! Ó¤H»{ª¾:Àø®Ä½T»{µL»~-->¤½§iÂàñ±ÂÅv¬ù¦¬Ã±¬ùª÷»P¨½µ{ª÷¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/3/11 ¤U¤È 01:27:58²Ä 951 ½g¦^À³
|
À³¸Ó¤£·|¬O¶BÄF¡A¤£¹L®É¶¡¬O©ì¤F¤[¤F¤@ÂI¡C ¤£¤½¥¬¤]¨S¥L¥Ö±ø¡C ³o¤½¥q³W¼Ò¤£ª¾¬O¤Ó¤pÁÙ¬O«ç¼Ë¡A³£¨S±M·~ªº¹ïÀ³µ¡¤f¡A¤£³z©ú¡C ¥´¥h°Ý³£»¡¤Wºô¯d¨¥¡A¦ý³£¤£¦^À³¡C «Ü¦n©_³Ò°È¦¬¤J¤£¬O¬O¥]§t¦bñªº¤£¥µ¥±ø¬ù¤º «¢ ¨S¿ù¡A¦ýn¥Î¦b¤M¤f¤W ¥t¥~¦³¤@¥ó¨Æ¡A§¡»ù¬O¥b¦~¨Óºâ..... n³Â´N¬O¦b²{¼W«e¨g©Ô¡A¤£µM§Ú¯u·d¤£À´¬°¤°»ò¬O¥Î¥b¦~!!¥i¯à§Ú¤Ö¨£¦h©Ç ------------------------------------ ¼W¸ê§Ú·Q³oÓ¨S¤Ó¤jªº°ÝÃD¡A·sÃÄ¿N¿ú«Ü¥¿±` ¦Ü©ó¦³¬Æ»òºÃ°Ý¤j®a¥i¥H§â°ÝÃD¥á¥X¨Ó¡A¥i°Q½×¡B¥iµo°Ý ¬Æ¦Ü¯àÅý¥hªÑªF·|ªºªÑ¤ÍÌ¥h´£°Ý |
|
|
·|û¡G´MÄ_10151381 µoªí®É¶¡:2021/3/11 ¤U¤È 01:21:49²Ä 950 ½g¦^À³
|
ñ¬ùª÷À³¸Ó¦bñ¬ù®É´Nn»{¦C¡A¦A¥[¤W¨u¨£ªº¤£¤½§G¤º®e¡A¦³¥i¯à®Ú¥»´N¨S¦³....¡H¡H¡H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/11 ¤U¤È 01:19:03²Ä 949 ½g¦^À³
|
ñ¬ùª÷¦b°ê»Ú¥Dn¤îµhÃĤj¼t¤f³U¸Ì¡A½T»{¤£¬O¶BÄF¤~¥I´Ú¡C ·sÃĬãµo¦X§@¨óij--->¶i¦æÀø®Ä½T»{¹êÅç--->°ê»ÚÃļt¨Ì¾Ú¨óij¤ä¥I¤@©wª÷ÃB¤§Ã±¬ùª÷¤Î¨½µ{¸Oª÷¡C ----------------------------------------------------------------------------------------- ª¿¨¦Åå¤Ñ¤jÄF§½¡Iwww.storm.mg/lifestyle/940097?page=1 ¦o´¿³Q¡m´I¤ñ¥@¡nµû¬°¬ü°ê³Ì¦~»´ªº»õ¸U¤k´I»¨¡A¦~¶È19·³«K¥Õ¤â°_®a¡A³Ð¥ß¤Fª¿¨¦³Ì·|§lª÷ªºÂåÀø¬ì§Þ·s³ÐTheranos¡A¦³±æ¥H¿W³Ð§Þ³N½Âà¾ãÓÂåÀø²£·~¡C¬ü°ê¦U¬É¬F°Ó¦W¬y·m§ë¸ê¡A¥þ¬ü³Ì¤j³sÂêÃħ½«ü©w¦X§@¡A¥«ÈÁÙ¤@«×öt¹F90»õ¬ü¤¸¡A§¹¥þ¬Oª¿¨¦³Ì°{Ä£ªº·s¬P¡C --------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/4 ¤W¤È 08:52:06²Ä 674 ½g¦^À³ ½T»{¤£¬O¶BÄF¤~¥I´Ú©Ô! ---------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/26 ¤W¤È 08:13:06²Ä 580 ½g¦^À³ ü¤S ¹ê¦b¬O²³æ¨ìÅý§ÚÃhºÃµL¨x¬r©Ê·|¤£·|¬O¶BÄF??? |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/3/11 ¤U¤È 01:07:10²Ä 948 ½g¦^À³
|
2ºØ¥i¯à 1.ÁÙ¨S»{¦C 2.¨C¤ëÀ禬??-------->¨º´N«ÜºG¤F ----------------------------------- ½Ð±Ð¤j®a¤@Ó°ÝÃD¡A2020/12/21µo§Gªº«°T¸Ì´£¨ì¡G¥Ø«e¥»¤½¥qSNP-810·sÃĤw»P°ê»Ú¥Dn¤îµhÃĤj¼tñq¦X¬ù¡A°£¦³Ã±¬ùª÷¥t¦³¨½µ{¸Oª÷¡C ½Ð°Ýñ¬ùª÷¦bþ¸Ì¡H |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2021/3/11 ¤W¤È 11:43:22²Ä 947 ½g¦^À³
|
¼W¸ê§Ú·Q³oÓ¨S¤Ó¤jªº°ÝÃD¡A·sÃÄ¿N¿ú«Ü¥¿±` ¦Ü©ó¦³¬Æ»òºÃ°Ý¤j®a¥i¥H§â°ÝÃD¥á¥X¨Ó¡A¥i°Q½×¡B¥iµo°Ý ¬Æ¦Ü¯àÅý¥hªÑªF·|ªºªÑ¤ÍÌ¥h´£°Ý |
|
|
·|û¡G´MÄ_10151381 µoªí®É¶¡:2021/3/11 ¤W¤È 11:23:26²Ä 946 ½g¦^À³
|
½Ð±Ð¤j®a¤@Ó°ÝÃD¡A2020/12/21µo§Gªº«°T¸Ì´£¨ì¡G¥Ø«e¥»¤½¥qSNP-810·sÃĤw»P°ê»Ú¥Dn¤îµhÃĤj¼tñq¦X¬ù¡A°£¦³Ã±¬ùª÷¥t¦³¨½µ{¸Oª÷¡C ½Ð°Ýñ¬ùª÷¦bþ¸Ì¡H |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/3/11 ¤W¤È 11:01:27²Ä 945 ½g¦^À³
|
3.µo¦æªÑ¼Æ(¦pÄݬվlÂà¼W¸ê¡A«h¤£§t°tµoµ¹û¤u³¡¥÷):8,000,000~16,000,000ªÑ¡C 4.¨CªÑ±ÃB:·s¥x¹ô10¤¸¡C 5.µo¦æÁ`ª÷ÃB:«ö±ÃBp·s¥x¹ô80,000,000~160,000,000¤¸¾ã¡C 6.µo¦æ»ù®æ:¼Èq¬°q»ù¤é«e¤»Ó¤ë¤º¿³Âd¦¨¥æ§¡»ù¤§80%~100%¡C -------------------- ¦³¨S¤Hn¥h°Ñ¥[ªÑªF·|¡A°Ý¤@¤U¶i«×¡C ¤Sn¨Ó©MªÑªFn¿ú¤F¡A§Æ±æ¤£nÅýªÑªF¥¢±æ§r~~ ¥Í§Þ³£¬O³o¼Ë --------------------------------- |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/3/11 ¤W¤È 09:03:48²Ä 944 ½g¦^À³
|
1.Á«·l¤ñ«e¦~¤Ö¤F... 2.¥Í§ÞªÑ²{ª÷¼W¸ê¬O©ÔªÑ²¼¥Îªº... ¥[ªo |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/11 ¤W¤È 09:01:42²Ä 943 ½g¦^À³
|
ªYÄ£109¦~«×[²Ö¿n]Á«·l¬°·s¥x¹ô305,781,083¤¸¡A¹F¤½¥q¹ê¦¬¸ê¥»ÃB¤G¤À¤§¤@¡C(2014~2020) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/11 ¤W¤È 08:34:23²Ä 942 ½g¦^À³
|
¤W¦¸¼W¸ê¸I¤W·s«a¬Ì±¡Ãº´Ú²v¤£¨Î¡A©¯¿àÄ_¨Î°]¹Î§]¤U¡C [SNP-810·sÃĤw»P°ê»Ú¥Dn¤îµhÃĤj¼tñq¦X¬ù...¦³³Ì·s¶i®i¡A±NÀH®É¤½§i¡C]--·|¦b³o¦¸¼W¸ê«e©Î¼W¸ê«á¤½§i??? --------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/14 ¤W¤È 11:02:52²Ä 137 ½g¦^À³ 13600±i¼W¸ê¡A´²¤á»{ªÑú¿ú®£©È¤£¨ì1400±i¡A³Ñ¤Uªº¥þ³Q¥Ñ¯S©w¤H»{ÁÊ! ............................................................................. ·|û¡G³¯¥¿¤¤10149420 µoªí®É¶¡:2020/7/4 ¤U¤È 04:47:19²Ä 52 ½g¦^À³ 2~3¤ë·í®É¥þ²yªÑ¥«±Y½L¡ã ¥[¤W¥«»ù»·§C©ó25¤¸¡ã ¨S½æ´N¤£¿ù¤F¡ã«ç´±¶R¡H ¦ý¬O¡ã¦³¤@Ó¤j¤áªk¤H«i´±ªº¶R¤F¤j¦h¼Æ©ñ±óªº¼W¸êªÑ¡ã²{¦b¥~¦bÀô¹ÒÅܦn¤F¡ã¤½¥q¯à¤£¯à±ÂÅv¦¨¥\¬OÃöÁä ¥¿©Ò¿×¬K¦¿¤ô·xÀn¥ýª¾¡ã¤dª÷Ãø¶R¦ª¾¹D¡ã¥¼¨Ó¦p¦ó¡ã¤j®aµø¥Ø¥H«Ý |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/11 ¤W¤È 08:16:42²Ä 941 ½g¦^À³
|
1.109¦~«×[²Ö¿n]Á«·l¹F¹ê¦¬¸ê¥»ÃB¤G¤À¤§¤@¡C109¦~Á«·l8201¸U¤¸¡A¨CªÑµ|«á-1.65¤¸¡C(³oµ¥ªá¶O¦b·sÃĤ½¥qºâ¬O¤p¿ú) 2.109/02/27¤½§i²{¼W¦¬¨¬ªÑ´Ú3.4»õ¤¸¡A109¦~²Ä¤G©u°]³ø´Á¥½²{ª÷0.44»õ + 3Ó¤ë¥H¤W»È¦æ©w¦s2.8»õ ---±À¦ô¦Ü109.12.31¸êª÷0.44+2.8-(8201/2)=2.82»õ («ö¦~ªá¶O8000¸U¬Ý¡A¤]¤£¬O¯Ê¿ú¤Õ«æ¡A·íµM©¹«áªá¶O¥i¯à·U ¨Ó·U¤j) 3.ÃB©w¸ê¥»ÃB8»õ¡A¥Ø«e¹ê¦¬¸ê¥»5.229»õ¡A¥[¤W¹wp¼W¸ê0.8~1.6»õ«á¡A¹ê¦¬ªÑ¥»6~6.8»õ¡C |
|
|
·|û¡G´MÄ_10151381 µoªí®É¶¡:2021/3/10 ¤U¤È 08:25:12²Ä 940 ½g¦^À³
|
¤@¶}©l¥H¬°¬O¡G¥»¤½¥qµL¨x¬r©Ê¤AñQÓi×ô¤îµh·sÃÄSNP-810(¦w®õ®³¯k)±ÂÅvXX°ê»ÚÃļt¡AXX»õ¬üª÷¡A¥¢±æ¡I |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/3/10 ¤U¤È 08:03:22²Ä 939 ½g¦^À³
|
¤îµhÃĨú±o¤é¥»±M§Q¡AªÑªF·|¨S¦³´£Âà¤WÂd°Q½×¡AÀÀ¿ì²{ª÷¼W¸ê!¤j®a«ç»ò¬Ý~ |
|
|
·|û¡GRock00910149258 µoªí®É¶¡:2021/3/9 ¤U¤È 04:34:20²Ä 938 ½g¦^À³
|
¥»ºô¸T¤î¦b¦¹¯d¤U¥ô¦ó§Î¦¡¤§Ápµ¸¤è¦¡(¥]§tÁܬù)¡A ¬°¤Fºô¯¸ºÞ²z¤§¦Ò¶q¡A·q½Ð°t¦X¡AÁÂÁ¡IBY¥²´Iºôª©¥D |
|
|
·|û¡G¬K¤Ñô10143192 µoªí®É¶¡:2021/3/9 ¤W¤È 10:31:31²Ä 937 ½g¦^À³
|
¤S¬O¶}°ª¨«§C⋯⋯ 95¥H¤W«Ü¹³¥Xªº«Ü²n⋯⋯ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/9 ¤W¤È 09:58:04²Ä 936 ½g¦^À³
|
¬Ý¨ì°ªªG¿}¶¼¹¹ïAPAP¤Þ°_ªº¨x·l¶Ë¦³«OÅ@®ÄªG(ÁÙ¦b°Êª«¹êÅ綥¬q¡A¸¨«áªYÄ£¬Æ¤[)¡A±K·²®Ú¤j¾Çªº¾ÇªÌ³o»ò§Î®e: ¡§This was incredibly revealing.¡¨ labblog.uofmhealth.org/industry-dx/can-a-high-fructose-diet-protect-against-drug-induced-liver-damage §Ú³oºØ¥b±í¤ô¦a¬Ý¨ìSNP-810°t¤è¦p¦¹Â²³æ¤£¹L¡A·íµM·|·P¨ì¤£¥i«äij¦Ó¦³ºÃ¼{! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/9 ¤W¤È 09:28:19²Ä 935 ½g¦^À³
|
ì¨Ó±þ¤â¬O¥L¡C (1789)¯«¶©-¥»¤½¥q³B¤À¦³»ùÃÒ¨é¹FÀ³¤½§i¼Ð·Ç 1.ÃÒ¨é¦WºÙ:¶h¹F´¶³qªÑ 2.¥æ©ö¤é´Á:109/6/16~110/3/8 3.¥æ©ö¼Æ¶q¡B¨C³æ¦ì»ù®æ¤Î¥æ©öÁ`ª÷ÃB: ¥æ©ö¼Æ¶q(ªÑ)¡G2,761,269 ³æ¦ì»ù®æ(¤¸)¡G111.14 |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2021/3/9 ¤W¤È 09:23:24²Ä 934 ½g¦^À³
|
¨S¿ù¡A³o´N¬O§Ú»¡Ä_0¤§«eµ¹¬ü¼t½æ¬O¤@¼Ëªº¡C¦pªG¯à½Í¨ì¤j¼t´N¤£¤@¼Ë¤F¡C ¤µ¤Ñ¤S¬O½Ä¤£¤W¥hªº¤@¤Ñ?? «Ü¦n©_³Ò°È¦¬¤J¬O¤°»ò ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ¶h¹F±ÂÅvIntas Pharmaceuticals¡A¥Ñ¬ü°ê¤l¤½¥qAccordt³dCamcevi©ó¬ü°ê¤§¥«³õ¾P°â¡C ±qªÑ»ùªí²{¨Ó¬Ý¡A§ë¸ê¤H¦ü¥G¹ï±ÂÅv¤@®a¦L«×¤½¥q¦³©ÒºÃ¼{¡A¾á¤ß¾P°â¤£¦p¹w´Á¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/9 ¤W¤È 09:19:15²Ä 933 ½g¦^À³
|
¶h¹F±ÂÅvIntas Pharmaceuticals¡A¥Ñ¬ü°ê¤l¤½¥qAccordt³dCamcevi©ó¬ü°ê¤§¥«³õ¾P°â¡C ±qªÑ»ùªí²{¨Ó¬Ý¡A§ë¸ê¤H¦ü¥G¹ï±ÂÅv¤@®a¦L«×¤½¥q¦³©ÒºÃ¼{¡A¾á¤ß¾P°â¤£¦p¹w´Á¡C |
|
|
·|û¡G¤ý¥ý¥Í10149972 µoªí®É¶¡:2021/3/8 ¤U¤È 11:44:31²Ä 932 ½g¦^À³
|
R¤j¡F©êºp¥¢¨¥¤F |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/8 ¤U¤È 11:39:47²Ä 931 ½g¦^À³
|
ð±G:¥@¤H¯º§Ú¤ÓºÆÅö¡A§Ú¯º¥L¤H¬Ý¤£¬ï¡C ~100%(Áͪñ100%)¤£¬O¦Ê¤À¦Ê¡CªYÄ£¤½¥qªºQ&A¤£¦p¦X¤@ªº¦³°Ý¥²µª»P§Ö°Ý§Öµª¡A§ë¸ê¤H½M¤lºN¶Hªºª¬ªp¤£¯à¦³¥ô¦ó½èºÃ??? ¤ý¥SY¬OJ±Ð±Â¹Î¶¤©Î¤½¥q¹Î¶¤¤@û¡A¦ÛµM¹ïXX¤G¦r¤£®®¡A«¥¦b¦¹»¡Án©êºp¡A¦p¤£±ó¶û©|±æ«üÂI¤@¤G¡C |
|
|
·|û¡G¤ý¥ý¥Í10149972 µoªí®É¶¡:2021/3/8 ¤U¤È 10:38:14²Ä 930 ½g¦^À³
|
¤S¬O¶BÄF¤S¬O¦Ê¤À¤§¦Ê¥¿±µ²ªGR¤j¤j§A¨ì©³¦b¼g¤°»ò¡AÀ£¤O¤Ó¤j¤F¬O¶Ü |
|
|
·|û¡G¸¹§b10151262 µoªí®É¶¡:2021/3/8 ¤U¤È 10:06:31²Ä 929 ½g¦^À³
|
SNP-630 ¥»pµe¹wp¦¬¯Ç¨ü¸ÕªÌ¤H¼Æ¡G¥xÆW¤H¼Æ 14 ¤H¡A¥þ²y¤H¼Æ 14 ¤H |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/8 ¤U¤È 09:57:43²Ä 928 ½g¦^À³
|
¥Ñ²Ä3¤è:±K·²®Ú¤j¾Çµoªíªº¦Y°ªªG¿}ªvÀø¨x¬r©Ê¬ã¨s¨Ó§PÂ_¡A ªYÄ£»P°ê»Ú¥Dn¤îµhÃĤj¼t¥¿¶i¦æªºSNP-810½T»{¸ÕÅç~100%¬O¥¿±µ²ªG! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/8 ¤U¤È 09:21:34²Ä 927 ½g¦^À³
|
¥Ñ±K·²®Ú¤j¾Çªº¦Y¿}ªvÀø¨x¬r©Ê¬ã¨s¡AÃø¥H¸m«H¦³®Ä¡A±o¥XSNP-810¬O¶BÄF~0! (µ²®×) ----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/26 ¤W¤È 08:13:06²Ä 580 ½g¦^À³ ü¤S ¹ê¦b¬O²³æ¨ìÅý§ÚÃhºÃµL¨x¬r©Ê·|¤£·|¬O¶BÄF??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/8 ¤U¤È 08:57:53²Ä 926 ½g¦^À³
|
«ç»ò¶}©l¬y¦æ¦Y¿}ªvÀø¨x¬r???(ÁÙ¯u¦³®Ä!) 2021.2.23 °ªªG¿}¶¼¹¥i¥H¹w¨¾ÃĪ«¤Þ°_ªº¨x·l¶Ë¶Ü¡H aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep4.1683 ¤@Ó¬ã¨s¤p²Õ±´°Q¤F¦b¤p¹«¤¤¹ï¤A酰®ò°ò×ô¹L¶q®É¹¥Î´I§tªG¿}ªº¶¼¹ªº«OÅ@¯à¤O¡C ..±i¼w±j³Õ¤h»â¾Éªº¤@¶µ·s¬ã¨s¤¤¡C±K·²®Ú¤j¾ÇÂå¾Ç°|¤À¤l»P¾ã¦X¥Í²z¾Ç¨tªº¤@¦ì¬ã¨s¤Hû¡A®ï±Ð±Â©M¤@²Õ¬ã¨s¤Hû..¡§§Ú̵o²{¡A¦b¤p¹«¤¤¡A¦b¹ï¤A酰®ò°ò×ô¹L¶q¤§«eµu®É¶¡¹¥Î°ªªG¿}¶¼¹¹ê»Ú¤W¥i¥H´£¨Ñ§Ü¨x·l¶Ëªº«OÅ@¡A¡¨ Yin»¡¡C¡§³o¯u¥O¤HÃø¥H¸m«H¡C¡¨ ------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/26 ¤W¤È 07:06:34²Ä 577 ½g¦^À³ ¸¹¥~! ¸¹¥~! »·¦b¤ÑÃäªñ¦b²´«e¡AJ&J/GSKÀ£®Ú¨S·Q¨ì¦Û®a°t¤è¤¤¥Î¨Ó¸Ñ¨MW¨ýªº¿}¾J¡A¤]¯à¸Ñ¨M¨x¬r©Ê!!!!! ¿}¾J:¥ÌÅS¾J /³ÁªÞ¿}¾J /¤s±ù¿}¾J / ¤ìÁÞ¾J (¦PÃþ) ¤T´â½©¿} |
|
|
·|û¡G¤p¤å¤l10144877 µoªí®É¶¡:2021/3/8 ¤U¤È 08:37:32²Ä 925 ½g¦^À³
|
¥»¸ê®Æ¥Ñ¡@ (¿³Âd¤½¥q) 6634 ªYÄ£¡@¤½¥q´£¨Ñ §Ç¸¹ 1 µo¨¥¤é´Á 110/03/08 µo¨¥®É¶¡ 20:07:14 µo¨¥¤H ¦¶³Í¥Á µo¨¥¤H¾ºÙ ¸³¨ÆªøÝÁ`¸g²z µo¨¥¤H¹q¸Ü 02-27885365 ¥D¦® ¥»¤½¥q¬ãµo¤¤ªvÀø¡u«D°sºë©Ê¯×ªÕ¨xª¢¡v¤§·s¦¨¤À·sÃÄ SNP-630¡A¤µ¤éÀò±o¥xÆW½Ã¥ÍºÖ§Q³¡¹«~ÃĪ«ºÞ²z¸p(TFDA)³qª¾ ¡A¦P·N¶i¦æ¤HÅé²Ä¤@´ÁÁ{§É¸ÕÅç(IND NO: 1096041999)¡C ²Å¦X±ø´Ú ²Ä 44 ´Ú ¨Æ¹êµo¥Í¤é 110/03/08 »¡©ú 1.¨Æ¹êµo¥Í¤é:110/03/08 2.¤½¥q¦WºÙ:ªYÄ£¥ÍÂåªÑ¥÷¦³¤½¥q 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q 4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î 5.µo¥Í½t¥Ñ: ¥»¤½¥q¬ãµo¤¤ªvÀø¡u«D°sºë©Ê¯×ªÕ¨xª¢¡v¤§·s¦¨¤À·sÃÄSNP-630(¤wÀò±o¬ü°ê¤Î«n«D±M §Q)¡AÀò±o¥xÆW½Ã¥ÍºÖ§Q³¡¹«~ÃĪ«ºÞ²z¸p(TFDA)¦P·N¶i¦æ¤HÅé²Ä¤@´ÁÁ{§É¸ÕÅç (IND NO: 1096041999)¡C 6.¦]À³±¹¬I:¤£¾A¥Î 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ: ¤@.¬ãµo·sÃĦWºÙ©Î¥N¸¹¡G SNP-630¡C ¤G.¥Î³~¡GNon-alcoholic Steatohepatitis («D°sºë©Ê¯×ªÕ¨xª¢)¡C ¤T.¹wp¶i¦æ¤§©Ò¦³¬ãµo¶¥¬q¡G¶i¦æ²Ä¤@´Á¸ÕÅç¡A¨Ã¦P®É°Ó½Í°ê»Ú±ÂÅv¡C ¥|.¥Ø«e¶i¦æ¤¤¤§¬ãµo¶¥¬q¡G (¤@)´£¥X¥Ó½Ð¡þ³q¹L®Öã¡þ¤£³q¹L®Öã¡þ¦U´Á¤HÅéÁ{§É¸ÕÅçµ²ªG¡G ¤wÀò¥xÆW½Ã¥ÍºÖ§Q³¡¹«~ÃĪ«ºÞ²z¸p(TFDA)¦P·N¶i¦æ¤HÅé²Ä¤@´ÁÁ{§É¸ÕÅç¡C (¤G)¥¼³q¹L¥Øªº¨Æ·~¥DºÞ¾÷Ãö³\¥iªÌ¡A¤½¥q©Ò±Á{¤§·ÀI¤Î¦]À³±¹¬I¡G ¤£¾A¥Î¡C (¤T) ¤w³q¹L¥Øªº¨Æ·~¥DºÞ¾÷Ãö³\¥iªÌ¡A¥¼¨Ó¸gÀç¤è¦V¡G ±N¨Ì¸ÕÅçpµe¶i¦æÁ{§É¸ÕÅç¡C (¥|) ¤w§ë¤J¤§²Ö¿n¬ãµo¶O¥Î¡G ¦]¯A¤Î¥¼¨Ó°ê»Ú±ÂÅv½Í§P¸ê°T¡A¬°ÁקK¼vÅT±ÂÅvª÷ÃB¡A«O»Ù§ë¸ê¤HÅv¯q¡A¼È¤£´¦ÅS¡C ¤.±N¦A¶i¦æ¤§¤U¤@¬ãµo¶¥¬q¡G (¤@)¹wp§¹¦¨®É¶¡¡G¹wpªñ´Á¤º§¹¦¨²Ä¤@´ÁÁ{§É¸ÕÅç¡A¹ê»Ú®Éµ{±N¨Ì°õ¦æ¶i«×¶i¦æ¡C (¤G)¹wpÀ³t¾á¤§¸q°È¡GµL¡C ¤».¥«³õ²{ªp¡G ¥Ø«e¡u«D°sºë©Ê¯×ªÕ¨xª¢¡v©|µL¼Ð·ÇªvÀøÃĪ«¡A¼ç¦b°Ó¾÷Ãe¤j¡A¥þ²y©Ò¦³«n¤jÃļt §¡¤w¿n·¥§ë¤J¬ãµo·sÃÄ¡A¦Ó¥Ø«e¶È¦³Ó¦ì¼Æ«~¶µ¶i¤JÁ{§É¼Ï¯Ã¸ÕÅç¡C®Ú¾ÚGlobalData 2017¦~5¤ëªº³ø§i¹w´ú¡A¥]¬A¬ü°ê¡A¼Ú·ù¤¤j°ê®a¡]ªk°ê¡A¼w°ê¡A¸q¤j§Q¡A¦è¯Z¤ú©M ^°ê¡^©M¤é¥»ªºNASH¥«³õ¡A¦b¥¼¨Ó¤Q¦~ªº½Æ¦X¦~¼Wªø²v¹F45¢H¡C¥t®Ú¾Ú¼w·N§Ó»È¦æ¤Î Evaluate Pharmaªº¹w´ú¡A¥þ²yNASHÃĪ«ªº¥«³õ³W¼Ò¦b2025¦~¤W¬Ý350»õ~400»õ¬ü¤¸¡C ¤C.¥»¤½¥qSNP-630¬°SNP-610¤§²Ä¤G¥N²£«~¡ASNP-610¤w§¹¦¨²Ä¤G´ÁÁ{§É¸ÕÅç°ª¡B§C¨â ¾¯¶q²Õ¦@ 36¦W¨ü¸ÕªÌ¡A´Á¤¤¤ÀªRµ²ªGÅã¥Ü¡ASNP-610¦bÁ{§ÉÀø®Ä«ü¼Ð»P¥¼ªAÃÄ«e¤ñ¸û ¡A§e²{·¥ÅãµÛªvÀø®ÄªG¡A¦¨¥\¹F¦¨SNP-610¦b¯×ªÕ¨xª¢ªvÀø¤Wªº¥Ø¼Ð¡CSNP-630¸g°Êª« ¹êÅçÃÒ¹ê¡A¸ûSNP-610¬°ÃIJz¬¡©Ê§ó±j¤§²£«~¡C ¤K.¥Ø«eSNP-630¤wÀò±o¬ü°ê¤Î«n«D±M§Q¡A¨ä¥¦¥@¬É¦U°ê±M§Q¥ç¿n·¥¼f®Ö¤¤¡C ¤E.·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¨Ã¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê±Á{·ÀI¡A §ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/3/8 ¤U¤È 03:17:09²Ä 924 ½g¦^À³
|
±M§Q¥Ó½Ð¬O«Ü²`¶øªº¤@ªù¾Ç°Ý,¤@¯ë¥Ó½Ð¤£·|¥u³æ¤@»¡¥u¨Ï¥Î¬Y¤@ºØ¯S©w»Ã¯À¥h¥Ó½Ð!! ¥i¯à¬O¥un²K¥[»Ã¯Àªkªº¾ãÓ½d³ò³£³q³q²[»\,¥H«á¥un¬O¨Ï¥Î¨ä¥L»Ã¯À³£ºâ«IÅv?! |
|
|
·|û¡G¦h¦h10137435 µoªí®É¶¡:2021/3/8 ¤U¤È 02:36:27²Ä 923 ½g¦^À³
|
¤G¤ëÀ禬¤½¥¬49.8¸U³Ò°È¦¬¤J |
|
|
|